p.value	odds_ratio	overlap	adj_p.value	genes
Activation of the pre-replicative complex R-HSA-68962	4.88693758393784e-14	100.529498490017	11/14	1.2969932347771e-10	RPA3;MCM6;MCM8;CDC45;CDC6;CDC7;MCM3;MCM4;POLE3;POLA2;POLE
DNA strand elongation R-HSA-69190	1.09097484740029e-12	90.7109069333551	10/13	1.44772362250018e-09	RPA3;MCM6;MCM8;CDC45;MCM3;MCM4;POLA2;POLD2;PCNA;GINS3
Cell Cycle R-HSA-1640170	1.90485968977747e-10	3.76681049497596	42/400	1.68516587222314e-07	CCNA2;YWHAB;TUBB4B;DYNLL1;TFDP1;E2F1;POLR2K;POLR2L;H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3;RPA3;MCM6;MCM8;CDC45;CDC6;CDC7;MCM3;MCM4;YWHAQ;MAPK1;POLE3;POLA2;POLE;SEC13;ZWINT;SUMO1;RAB1A;POLD2;PCNA;MYC;RAN;NHP2;NOP10;GINS3;TOP2A;E2F4;CKS1B
Activation of ATR in response to replication stress R-HSA-176187	1.44727999031362e-09	53.8278639915617	8/12	9.60270273573087e-07	RPA3;MCM6;MCM8;CDC45;CDC6;CDC7;MCM3;MCM4
Unwinding of DNA R-HSA-176974	2.56107234577097e-09	Inf	6/6	1.35941720113523e-06	MCM6;MCM8;CDC45;MCM3;MCM4;GINS3
Cell Cycle, Mitotic R-HSA-69278	4.68858799169348e-09	3.6477704730153	36/341	2.07391875499242e-06	CCNA2;TUBB4B;DYNLL1;TFDP1;E2F1;H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3;RPA3;MCM6;MCM8;CDC45;CDC6;CDC7;MCM3;MCM4;MAPK1;POLE3;POLA2;POLE;SEC13;ZWINT;SUMO1;RAB1A;POLD2;PCNA;MYC;RAN;GINS3;TOP2A;E2F4;CKS1B
Folding of actin by CCT/TriC R-HSA-390450	1.00971280325253e-08	62.3510654636312	7/10	3.34972222479027e-06	CCT8;CCT3;CCT5;CCT2;TCP1;CCT6A;CCT4
G1/S Transition R-HSA-69206	9.0557045516471e-09	6.56144517993666	18/96	3.34972222479027e-06	CCNA2;TFDP1;E2F1;RPA3;MCM6;MCM8;CDC45;CDC6;CDC7;MCM3;MCM4;POLE3;POLA2;POLE;PCNA;MYC;E2F4;CKS1B
DNA Replication R-HSA-69306	2.17229816831404e-08	4.97254037951577	22/150	5.94537099976827e-06	CCNA2;H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3;RPA3;MCM6;MCM8;CDC45;CDC6;CDC7;MCM3;MCM4;POLE3;POLA2;POLE;POLD2;PCNA;GINS3
Mitotic G1 phase and G1/S transition R-HSA-453279	2.24015486050048e-08	5.76641512745725	19/113	5.94537099976827e-06	CCNA2;TFDP1;E2F1;RPA3;MCM6;MCM8;CDC45;CDC6;CDC7;MCM3;MCM4;POLE3;POLA2;POLE;PCNA;MYC;TOP2A;E2F4;CKS1B
Telomere Maintenance R-HSA-157579	4.68942449420216e-08	7.22748311512418	15/73	1.13143023705568e-05	CCNA2;POLR2K;POLR2L;H2BC17;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3;RPA3;POLA2;POLD2;PCNA;NHP2;NOP10
mRNA Splicing - Major Pathway R-HSA-72163	6.25010497028369e-08	5.66926692309718	18/108	1.38231488259441e-05	HSPA8;POLR2K;POLR2L;PRPF19;LSM2;LSM5;HNRNPK;SNRPD1;SNRPG;SNRPD3;SNRPB;SNU13;BCAS2;PPIL1;SF3B6;BUD31;HNRNPH2;FAM32A
S Phase R-HSA-69242	9.31731249191067e-08	5.19959157500123	19/123	1.90216518104084e-05	CCNA2;TFDP1;E2F1;RPA3;MCM6;MCM8;CDC45;CDC6;MCM3;MCM4;POLE3;POLA2;POLE;POLD2;PCNA;MYC;GINS3;E2F4;CKS1B
mRNA Splicing R-HSA-72172	1.48009948729641e-07	5.30643974911344	18/114	2.80584574234619e-05	HSPA8;POLR2K;POLR2L;PRPF19;LSM2;LSM5;HNRNPK;SNRPD1;SNRPG;SNRPD3;SNRPB;SNU13;BCAS2;PPIL1;SF3B6;BUD31;HNRNPH2;FAM32A
Chromosome Maintenance R-HSA-73886	2.0236791002138e-07	6.34061225569954	15/81	3.35677770747964e-05	CCNA2;POLR2K;POLR2L;H2BC17;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3;RPA3;POLA2;POLD2;PCNA;NHP2;NOP10
Processing of Capped Intron-Containing Pre-mRNA R-HSA-72203	2.02156586129627e-07	4.67848151007831	20/142	3.35677770747964e-05	HSPA8;POLR2K;POLR2L;SEC13;PRPF19;LSM2;LSM5;HNRNPK;SNRPD1;SNRPG;SNRPD3;SNRPB;SLBP;SNU13;BCAS2;PPIL1;SF3B6;BUD31;HNRNPH2;FAM32A
Transcription of E2F targets under negative control by DREAM complex R-HSA-1362277	2.54195658084656e-07	26.7066075303783	7/14	3.96844280327457e-05	TFDP1;E2F1;CDC6;PCNA;MYC;TOP2A;E2F4
Association of TriC/CCT with target proteins during biosynthesis R-HSA-390471	6.77733101860628e-07	15.3539421240051	8/22	9.4668613280953e-05	CCT8;CCT3;CCT5;CCT2;TCP1;CCT6A;CCT4;AP3M1
G0 and Early G1 R-HSA-1538133	6.77733101860628e-07	15.3539421240051	8/22	9.4668613280953e-05	CCNA2;TFDP1;E2F1;CDC6;PCNA;MYC;TOP2A;E2F4
BBSome-mediated cargo-targeting to cilium R-HSA-5620922	1.01103328675701e-06	31.8324375611425	6/11	0.000134164117152655	CCT8;CCT3;CCT5;CCT2;TCP1;CCT4
Metabolism of proteins R-HSA-392499	1.14757097301758e-06	2.30274530594217	64/998	0.000145031112494698	EIF2S2;CCNA2;HSPA8;TUBB4B;DYNLL1;H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3;SEC13;CTSC;SEC23A;SEC61G;UBA3;UBE2F;SEC22B;DDOST;SUMO1;COPB1;TRAPPC3;RAB1A;B4GALT2;TMED2;CNIH1;ALG5;CCT8;CCT3;CCT5;CCT2;TCP1;CCT6A;CCT4;AP3M1;RPL17;PCNA;MYC;NEDD8;TOP2A;HSPA9;SRPRB;H2AC12;HCFC1;H2AC13;RAB5C;USP10;DTL;SNX3;HNRNPK;SEC11A;PRELID1;DPP4;MRPL52;SAE1;SSR2;TRAM1;MRPL43;PLA2G7;AURKAIP1;TBCA;MRPL34;MRPL36
Extension of Telomeres R-HSA-180786	1.30916871069328e-06	18.692997044832	7/17	0.000157933352644544	CCNA2;RPA3;POLA2;POLD2;PCNA;NHP2;NOP10
DNA Replication Pre-Initiation R-HSA-69002	1.77027842838263e-06	4.36998310909151	18/134	0.000204274736909891	H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3;RPA3;MCM6;MCM8;CDC45;CDC6;CDC7;MCM3;MCM4;POLE3;POLA2;POLE
Base Excision Repair R-HSA-73884	2.87457171881571e-06	7.14159438268591	11/53	0.00030912556376976	H2BC17;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3;RPA3;POLE3;POLE;POLD2;PCNA
Formation of tubulin folding intermediates by CCT/TriC R-HSA-389960	2.91188360747702e-06	11.9336796306157	8/26	0.00030912556376976	TUBB4B;CCT8;CCT3;CCT5;CCT2;TCP1;CCT6A;CCT4
PCNA-Dependent Long Patch Base Excision Repair R-HSA-5651801	3.59308204569195e-06	43.8882289515427	5/8	0.000366770759587171	RPA3;POLE3;POLE;POLD2;PCNA
Prefoldin mediated transfer of substrate  to CCT/TriC R-HSA-389957	5.43287469871994e-06	10.7368954638437	8/28	0.000534031461126027	TUBB4B;CCT8;CCT3;CCT5;CCT2;TCP1;CCT6A;CCT4
Synthesis of DNA R-HSA-69239	6.15607928406582e-06	4.95662360896805	14/92	0.000583508372139667	CCNA2;RPA3;MCM6;MCM8;CDC45;CDC6;MCM3;MCM4;POLE3;POLA2;POLE;POLD2;PCNA;GINS3
DNA Repair R-HSA-73894	7.76307215904795e-06	3.5785617977616	20/178	0.000693556231908477	CCNA2;POLR2K;POLR2L;H2BC17;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3;RPA3;KPNA2;POLE3;POLE;SUMO1;POLD2;PCNA;USP10;DTL;RAD51AP1;PRPF19
Resolution of AP sites via the multiple-nucleotide patch replacement pathway R-HSA-110373	7.83974640439123e-06	32.9310084698809	5/9	0.000693556231908477	RPA3;POLE3;POLE;POLD2;PCNA
Recognition of DNA damage by PCNA-containing replication complex R-HSA-110314	9.66063825263332e-06	17.6865111529752	6/15	0.00082707528782222	RPA3;POLE3;POLE;POLD2;PCNA;DTL
Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding R-HSA-6814122	1.36361076484622e-05	11.6729037958896	7/23	0.00113094467809433	CCT8;CCT3;CCT5;CCT2;TCP1;CCT6A;CCT4
G1/S-Specific Transcription R-HSA-69205	1.49800119583471e-05	15.9161664250258	6/16	0.00120475611325616	TFDP1;E2F1;CDC45;CDC6;PCNA;E2F4
COPII-mediated vesicle transport R-HSA-204005	1.61716952602705e-05	8.94074958295794	8/32	0.00126234350649288	SEC13;CTSC;SEC23A;SEC22B;TRAPPC3;RAB1A;TMED2;CNIH1
Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding R-HSA-389958	2.06731790765364e-05	8.58159775729984	8/33	0.00156761763626079	TUBB4B;CCT8;CCT3;CCT5;CCT2;TCP1;CCT6A;CCT4
Termination of translesion DNA synthesis R-HSA-5656169	2.24368355479766e-05	14.4676630455694	6/17	0.00165409337623139	RPA3;POLE3;POLE;POLD2;PCNA;USP10
DNA Damage Bypass R-HSA-73893	2.50919363349082e-05	10.3747684717343	7/25	0.00179983781169855	RPA3;POLE3;POLE;POLD2;PCNA;USP10;DTL
Gap-filling DNA repair synthesis and ligation in TC-NER R-HSA-6782210	2.61814817372723e-05	8.25012267059365	8/34	0.00180139050167111	POLR2K;POLR2L;RPA3;POLE3;POLE;POLD2;PCNA;PRPF19
Processive synthesis on the lagging strand R-HSA-69183	2.71498191661056e-05	52.3855627442998	4/6	0.00180139050167111	RPA3;POLA2;POLD2;PCNA
Removal of the Flap Intermediate R-HSA-69166	2.71498191661056e-05	52.3855627442998	4/6	0.00180139050167111	RPA3;POLA2;POLD2;PCNA
Dual incision in TC-NER R-HSA-6782135	3.28687758624942e-05	7.94323482168908	8/35	0.00212765197900145	POLR2K;POLR2L;RPA3;POLE3;POLE;POLD2;PCNA;PRPF19
G alpha (i) signalling events R-HSA-418594	4.49833552322897e-05	4.05220780011191	14/109	0.00271331419969311	GNAI3;KPNA2;MAPK1;ADORA3;CCR5;CCL20;CCL4;CXCR3;CXCL9;CXCL11;CXCL10;FPR3;ANXA1;CCL4L2
Gap-filling DNA repair synthesis and ligation in GG-NER R-HSA-5696397	4.49439588900814e-05	18.829051796033	5/12	0.00271331419969311	RPA3;POLE3;POLE;POLD2;PCNA
Resolution of Abasic Sites (AP sites) R-HSA-73933	4.49439588900814e-05	18.829051796033	5/12	0.00271331419969311	RPA3;POLE3;POLE;POLD2;PCNA
Membrane Trafficking R-HSA-199991	4.93232622474792e-05	2.72626890084094	25/287	0.00290897640010688	YWHAB;HSPA8;TUBB4B;DYNLL1;YWHAQ;SEC13;CTSC;AP1M1;SEC23A;CD3D;VAMP8;SEC22B;CLTA;COPB1;TRAPPC3;RAB1A;TMED2;CNIH1;ULK1;ARPC5;ARPC3;VAMP7;NEDD8;RAB5C;TBC1D14
DNA replication initiation R-HSA-68952	5.20955463290104e-05	Inf	3/3	0.00300568652080856	POLE3;POLA2;POLE
Lagging Strand Synthesis R-HSA-69186	6.14969244501182e-05	34.8731264175186	4/7	0.00347261356363008	RPA3;POLA2;POLD2;PCNA
DNA Double-Strand Break Repair R-HSA-5693532	7.49728773579785e-05	4.08775206514585	13/100	0.00414537534391823	CCNA2;H2BC17;H2BC12;H2BC14;H2BC3;RPA3;KPNA2;POLE3;POLE;SUMO1;POLD2;PCNA;RAD51AP1
Viral Infection Pathways R-HSA-9824446	7.65921332505765e-05	2.1983680866924	39/567	0.00414848003361286	PPIA;YWHAB;HSPA8;TUBB4B;DYNLL1;SUPT4H1;POLR2K;POLR2L;H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3;YWHAQ;KPNA2;SEC13;AP1M1;SEC23A;CLTA;DDOST;STAT1;SUMO1;OAS2;RPL17;CCR5;RAN;H2AC12;H2AC13;RAB5C;IFNGR1;HNRNPK;SNRPD1;RANBP1;SEC11A;SNRPG;SNRPD3;SNRPB
HCMV Late Events R-HSA-9610379	7.96460231753841e-05	4.73765123456606	11/74	0.00422761091014939	H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3;SEC13;H2AC12;H2AC13;HNRNPK
Cargo trafficking to the periciliary membrane R-HSA-5620920	8.68032162254619e-05	10.6023216820255	6/21	0.004430302612738	CCT8;CCT3;CCT5;CCT2;TCP1;CCT4
Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template R-HSA-110313	8.68032162254619e-05	10.6023216820255	6/21	0.004430302612738	RPA3;POLE3;POLE;POLD2;PCNA;USP10
Protein folding R-HSA-391251	9.62207618147409e-05	5.0966668021105	10/63	0.00481830003502495	TUBB4B;CCT8;CCT3;CCT5;CCT2;TCP1;CCT6A;CCT4;AP3M1;TBCA
Gene Silencing by RNA R-HSA-211000	9.99528041413833e-05	4.24385551263172	12/89	0.00491249522576354	POLR2K;POLR2L;H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3;SEC13;RAN;PLD6
Cell Cycle Checkpoints R-HSA-69620	0.000110041320155756	3.09146865077247	18/180	0.00530999388533412	CCNA2;YWHAB;DYNLL1;H2BC17;H2BC12;H2BC14;H2BC3;RPA3;MCM6;MCM8;CDC45;CDC6;CDC7;MCM3;MCM4;YWHAQ;SEC13;ZWINT
Chemokine receptors bind chemokines R-HSA-380108	0.000113477476892053	7.77165605983696	7/31	0.00537802185127694	CCR5;CCL20;CCL4;CXCR3;CXCL9;CXCL11;CXCL10
G2/M Checkpoints R-HSA-69481	0.00011970691971152	3.65645939464397	14/119	0.00547762353300645	YWHAB;H2BC17;H2BC12;H2BC14;H2BC3;RPA3;MCM6;MCM8;CDC45;CDC6;CDC7;MCM3;MCM4;YWHAQ
SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs R-HSA-77588	0.000119400766854545	26.1864106723751	4/8	0.00547762353300645	SNRPG;SNRPD3;SNRPB;SLBP
Transcription-Coupled Nucleotide Excision Repair (TC-NER) R-HSA-6781827	0.00013174922576903	6.29727675889089	8/42	0.00592648212188145	POLR2K;POLR2L;RPA3;POLE3;POLE;POLD2;PCNA;PRPF19
Vesicle-mediated transport R-HSA-5653656	0.00013458935996271	2.53852868208406	25/305	0.00595333602235054	YWHAB;HSPA8;TUBB4B;DYNLL1;YWHAQ;SEC13;CTSC;AP1M1;SEC23A;CD3D;VAMP8;SEC22B;CLTA;COPB1;TRAPPC3;RAB1A;TMED2;CNIH1;ULK1;ARPC5;ARPC3;VAMP7;NEDD8;RAB5C;TBC1D14
HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) R-HSA-5693567	0.000146392930743823	4.38411279631643	11/79	0.00626656190635655	CCNA2;H2BC17;H2BC12;H2BC14;H2BC3;RPA3;POLE3;POLE;POLD2;PCNA;RAD51AP1
Transcriptional regulation by small RNAs R-HSA-5578749	0.000146392930743823	4.38411279631643	11/79	0.00626656190635655	POLR2K;POLR2L;H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3;SEC13;RAN
Infectious disease R-HSA-5663205	0.000169968817461444	2.04220688101831	43/673	0.00716027367528051	GNAI3;PPIA;YWHAB;HSPA8;TUBB4B;DYNLL1;SUPT4H1;POLR2K;POLR2L;H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3;YWHAQ;KPNA2;MAPK1;SEC13;AP1M1;SEC23A;CLTA;DDOST;STAT1;SUMO1;OAS2;ARPC5;ARPC3;RPL17;CCR5;RAN;H2AC12;H2AC13;RAB5C;IFNGR1;HNRNPK;SNRPD1;RANBP1;SEC11A;SNRPG;SNRPD3;SNRPB
Homology Directed Repair R-HSA-5693538	0.000184057731337779	4.25664545120001	11/81	0.00763264404641352	CCNA2;H2BC17;H2BC12;H2BC14;H2BC3;RPA3;POLE3;POLE;POLD2;PCNA;RAD51AP1
Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) R-HSA-5358606	0.000202619574771853	77.8171645702801	3/4	0.00827311309914612	RPA3;POLD2;PCNA
Nucleotide Excision Repair R-HSA-5696398	0.000226425348304755	5.03598269150345	9/57	0.00910504355152757	POLR2K;POLR2L;RPA3;POLE3;POLE;SUMO1;POLD2;PCNA;PRPF19
HCMV Infection R-HSA-9609646	0.000264975126155001	3.54438789041874	13/113	0.0104961788778414	TUBB4B;DYNLL1;H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3;SEC13;H2AC12;H2AC13;HNRNPK
Transport to the Golgi and subsequent modification R-HSA-948021	0.000281111893535842	3.74687228918388	12/99	0.0109716318447665	TUBB4B;DYNLL1;SEC13;CTSC;SEC23A;SEC22B;COPB1;TRAPPC3;RAB1A;B4GALT2;TMED2;CNIH1
Cargo concentration in the ER R-HSA-5694530	0.00030133641036259	10.9780655749951	5/17	0.0114249547586045	CTSC;SEC23A;SEC22B;TMED2;CNIH1
Dual Incision in GG-NER R-HSA-5696400	0.00030133641036259	10.9780655749951	5/17	0.0114249547586045	RPA3;POLE3;POLE;POLD2;PCNA
Chaperonin-mediated protein folding R-HSA-390466	0.000337849276595919	4.73613871069862	9/60	0.0124534997234107	TUBB4B;CCT8;CCT3;CCT5;CCT2;TCP1;CCT6A;CCT4;AP3M1
Telomere C-strand (Lagging Strand) Synthesis R-HSA-174417	0.000337612463955112	17.461086524648	4/10	0.0124534997234107	RPA3;POLA2;POLD2;PCNA
mRNA Splicing - Minor Pathway R-HSA-72165	0.000367474307677027	6.20883768110256	7/37	0.0133599563366415	POLR2K;POLR2L;SNRPD1;SNRPG;SNRPD3;SNRPB;SF3B6
HCMV Early Events R-HSA-9609690	0.000372657154967581	3.61861833748755	12/102	0.0133652985038373	TUBB4B;DYNLL1;H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3;SEC13;H2AC12;H2AC13
Golgi Associated Vesicle Biogenesis R-HSA-432722	0.000392655539254072	7.56730533264575	6/27	0.0138947706824041	HSPA8;AP1M1;VAMP8;CLTA;VAMP7;RAB5C
Leading Strand Synthesis R-HSA-69109	0.000492564621638733	39.0085739619287	3/5	0.0165476772889772	POLA2;POLD2;PCNA
Mismatch Repair R-HSA-5358508	0.000492564621638733	39.0085739619287	3/5	0.0165476772889772	RPA3;POLD2;PCNA
Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) R-HSA-5358565	0.000492564621638733	39.0085739619287	3/5	0.0165476772889772	RPA3;POLD2;PCNA
Polymerase switching R-HSA-69091	0.000492564621638733	39.0085739619287	3/5	0.0165476772889772	POLA2;POLD2;PCNA
Peptide ligand-binding receptors R-HSA-375276	0.000622143611832178	4.30815608447864	9/65	0.0206396143225325	CCR5;CCL20;CCL4;CXCR3;CXCL9;CXCL11;CXCL10;FPR3;ANXA1
ER to Golgi Anterograde Transport R-HSA-199977	0.000687569504888897	3.57801350249428	11/94	0.0225285119256189	TUBB4B;DYNLL1;SEC13;CTSC;SEC23A;SEC22B;COPB1;TRAPPC3;RAB1A;TMED2;CNIH1
Class A/1 (Rhodopsin-like receptors) R-HSA-373076	0.000715584851829603	3.84293090518025	10/80	0.0231605145945825	ADORA3;CCR5;CCL20;CCL4;CXCR3;CXCL9;CXCL11;CXCL10;FPR3;ANXA1
Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 R-HSA-1362300	0.000750157011776265	13.0905981637386	4/12	0.0239869483042676	CCNA2;TFDP1;E2F1;E2F4
Asparagine N-linked glycosylation R-HSA-446203	0.000881571916753976	2.93452811908958	14/144	0.0262886726636523	TUBB4B;DYNLL1;SEC13;CTSC;SEC23A;SEC22B;DDOST;COPB1;TRAPPC3;RAB1A;B4GALT2;TMED2;CNIH1;ALG5
HDR through Homologous Recombination (HRR) R-HSA-5685942	0.000862358767801202	6.34983677137233	6/31	0.0262886726636523	RPA3;POLE3;POLE;POLD2;PCNA;RAD51AP1
Metabolism of RNA R-HSA-8953854	0.000877441953252897	2.13829358757111	27/384	0.0262886726636523	YWHAB;HSPA8;POLR2K;POLR2L;SEC13;RPL17;RAN;NHP2;NOP10;PRPF19;LSM2;LSM5;HNRNPK;SNRPD1;SNRPG;SNRPD3;SNRPB;SLBP;SNU13;RRP9;UTP3;BCAS2;PPIL1;SF3B6;BUD31;HNRNPH2;FAM32A
Metabolism of non-coding RNA R-HSA-194441	0.000877147784618375	8.22928287462687	5/21	0.0262886726636523	SEC13;SNRPD1;SNRPG;SNRPD3;SNRPB
Transcriptional regulation of granulopoiesis R-HSA-9616222	0.000871650918823709	3.73445243730062	10/82	0.0262886726636523	TFDP1;E2F1;H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3;MYC
snRNP Assembly R-HSA-191859	0.000877147784618375	8.22928287462687	5/21	0.0262886726636523	SEC13;SNRPD1;SNRPG;SNRPD3;SNRPB
Polymerase switching on the C-strand of the telomere R-HSA-174411	0.000957979424111361	26.0176658093377	3/6	0.0279393119955116	POLA2;POLD2;PCNA
Removal of the Flap Intermediate from the C-strand R-HSA-174437	0.000957979424111361	26.0176658093377	3/6	0.0279393119955116	RPA3;POLD2;PCNA
Inhibition of DNA recombination at telomere R-HSA-9670095	0.00101437515268126	4.4455121806229	8/56	0.029262517991479	POLR2K;POLR2L;H2BC17;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3
RNA Polymerase I Promoter Escape R-HSA-73772	0.00107807783355375	3.95026339018625	9/70	0.0307657910779748	POLR2K;POLR2L;H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3
rRNA modification in the nucleus and cytosol R-HSA-6790901	0.0011011082141406	7.74440715764529	5/22	0.0310887361737144	NHP2;NOP10;SNU13;RRP9;UTP3
E2F mediated regulation of DNA replication R-HSA-113510	0.00143016960608601	10.4766941060353	4/14	0.0399544224689713	TFDP1;E2F1;MCM8;POLA2
Processive synthesis on the C-strand of the telomere R-HSA-174414	0.00163034129885729	19.5191023590362	3/7	0.0441523041547678	RPA3;POLD2;PCNA
SLBP independent Processing of Histone Pre-mRNAs R-HSA-111367	0.00163034129885729	19.5191023590362	3/7	0.0441523041547678	SNRPG;SNRPD3;SNRPB
Telomere Extension By Telomerase R-HSA-171319	0.00163034129885729	19.5191023590362	3/7	0.0441523041547678	CCNA2;NHP2;NOP10
Pre-NOTCH Expression and Processing R-HSA-1912422	0.00165333188592766	3.39720325076712	10/89	0.0443226548005254	TFDP1;E2F1;H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3;TMED2
Lysosome Vesicle Biogenesis R-HSA-432720	0.00167240799335103	6.92520767129261	5/24	0.0443857081435363	HSPA8;AP1M1;VAMP8;CLTA;VAMP7
B-WICH complex positively regulates rRNA expression R-HSA-5250924	0.00177377158546144	3.64604270077541	9/75	0.0466097998793531	POLR2K;POLR2L;H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3
Processing of Capped Intronless Pre-mRNA R-HSA-75067	0.00189370222602711	9.52065743911905	4/15	0.0492733892929015	SNRPG;SNRPD3;SNRPB;SLBP
Activation of BH3-only proteins R-HSA-114452	0.002028001298937	6.57763041443825	5/25	0.0522554897803767	YWHAB;DYNLL1;TFDP1;E2F1;YWHAQ
Defective pyroptosis R-HSA-9710421	0.00221375963544622	3.87354139533116	8/63	0.0564934430045603	H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3;POLA2
Mitotic Prophase R-HSA-68875	0.00230944017070554	3.23018823216242	10/93	0.0583738496481191	H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3;MAPK1;SEC13;RAB1A
HDACs deacetylate histones R-HSA-3214815	0.00255734490919812	3.4345143856152	9/79	0.0634317139159982	H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3;H2AC12;H2AC13
NoRC negatively regulates rRNA expression R-HSA-427413	0.00255734490919812	3.4345143856152	9/79	0.0634317139159982	POLR2K;POLR2L;H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3
Intrinsic Pathway for Apoptosis R-HSA-109606	0.00260232539831078	4.95331630729123	6/38	0.0639497371029334	YWHAB;DYNLL1;TFDP1;E2F1;YWHAQ;MAPK1
Assembly of the pre-replicative complex R-HSA-68867	0.00263311832548528	2.8140118939533	12/127	0.0641128076682379	H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3;MCM6;MCM8;CDC6;MCM3;MCM4
Negative epigenetic regulation of rRNA expression R-HSA-5250941	0.00279080745168146	3.38528543313423	9/80	0.066727954745609	POLR2K;POLR2L;H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3
RHO GTPases activate PKNs R-HSA-5625740	0.00279080745168146	3.38528543313423	9/80	0.066727954745609	YWHAB;H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3;YWHAQ
Global Genome Nucleotide Excision Repair (GG-NER) R-HSA-5696399	0.00298177008044844	4.80152959365392	6/39	0.0700320158717713	RPA3;POLE3;POLE;SUMO1;POLD2;PCNA
trans-Golgi Network Vesicle Budding R-HSA-199992	0.00298177008044844	4.80152959365392	6/39	0.0700320158717713	HSPA8;AP1M1;VAMP8;CLTA;VAMP7;RAB5C
Pre-NOTCH Transcription and Translation R-HSA-1912408	0.00304085240482329	3.33742293572736	9/81	0.0707931779157984	TFDP1;E2F1;H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3
Clathrin-mediated endocytosis R-HSA-8856828	0.00330828820446708	3.29087082402798	9/82	0.0756913525401347	HSPA8;CD3D;VAMP8;CLTA;ARPC5;ARPC3;VAMP7;NEDD8;RAB5C
Post-translational protein modification R-HSA-597592	0.00329623502733577	1.75547945126833	38/659	0.0756913525401347	CCNA2;HSPA8;TUBB4B;DYNLL1;H2BC17;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3;SEC13;CTSC;SEC23A;UBA3;UBE2F;SEC22B;DDOST;SUMO1;COPB1;TRAPPC3;RAB1A;B4GALT2;TMED2;CNIH1;ALG5;PCNA;MYC;NEDD8;TOP2A;H2AC12;HCFC1;H2AC13;RAB5C;USP10;DTL;SNX3;HNRNPK;SAE1
RHO GTPase Effectors R-HSA-195258	0.00337965649620882	2.3435075469232	16/202	0.076663319153318	YWHAB;TUBB4B;DYNLL1;H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3;YWHAQ;MAPK1;SEC13;ZWINT;ARPC5;ARPC3
HATs acetylate histones R-HSA-3214847	0.00340856261021093	3.04277727290502	10/98	0.0766637726059306	H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3;H2AC12;HCFC1;H2AC13
Meiotic recombination R-HSA-912446	0.00360545676813268	3.54613164085263	8/68	0.0804107753161692	H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3;RPA3
Cleavage of the damaged purine R-HSA-110331	0.00386296221771931	4.52532220711225	6/41	0.0832045807411703	H2BC17;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3
Depurination R-HSA-73927	0.00386296221771931	4.52532220711225	6/41	0.0832045807411703	H2BC17;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3
Packaging Of Telomere Ends R-HSA-171306	0.00386296221771931	4.52532220711225	6/41	0.0832045807411703	H2BC17;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3
Recognition and association of DNA glycosylase with site containing an affected purine R-HSA-110330	0.00386296221771931	4.52532220711225	6/41	0.0832045807411703	H2BC17;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3
SUMOylation of DNA replication proteins R-HSA-4615885	0.0038874785274699	7.47538614751585	4/18	0.0832045807411703	SEC13;SUMO1;PCNA;TOP2A
CDC6 association with the ORC:origin complex R-HSA-68689	0.00410721287257918	51.6939057896131	2/3	0.0872043437106011	MCM8;CDC6
RNA Polymerase I Promoter Clearance R-HSA-73854	0.00456867510909973	3.11675984102472	9/86	0.0962322519011959	POLR2K;POLR2L;H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3
Base-Excision Repair, AP Site Formation R-HSA-73929	0.00492400093990799	4.27872765617685	6/43	0.0999959731898287	H2BC17;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3
Cleavage of the damaged pyrimidine  R-HSA-110329	0.00492400093990799	4.27872765617685	6/43	0.0999959731898287	H2BC17;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3
Depyrimidination R-HSA-73928	0.00492400093990799	4.27872765617685	6/43	0.0999959731898287	H2BC17;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3
RNA Polymerase I Transcription R-HSA-73864	0.00493574698111061	3.07602113124377	9/87	0.0999959731898287	POLR2K;POLR2L;H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3
Recognition and association of DNA glycosylase with site containing an affected pyrimidine R-HSA-110328	0.00492400093990799	4.27872765617685	6/43	0.0999959731898287	H2BC17;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3
DNA methylation R-HSA-5334118	0.00502988712859024	3.7069201679058	7/57	0.100370830370515	H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3
RNA Polymerase I Promoter Opening R-HSA-73728	0.00502988712859024	3.7069201679058	7/57	0.100370830370515	H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3
Inhibition of replication initiation of damaged DNA by RB1/E2F1 R-HSA-113501	0.00514249985184935	11.1535468356575	3/10	0.10113848535705	TFDP1;E2F1;POLA2
Neutrophil degranulation R-HSA-6798695	0.00514457254076933	2.2974238839847	15/192	0.10113848535705	PPIA;HSPA8;TUBB4B;DYNLL1;MAPK1;CTSC;AP1M1;VAMP8;DDOST;LAMTOR1;COPB1;CCT8;CCT2;ARPC5;RAB5C
Positive epigenetic regulation of rRNA expression R-HSA-5250913	0.00532538193159702	3.03631339196838	9/88	0.103923262106312	POLR2K;POLR2L;H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3
Assembly of the ORC complex at the origin of replication R-HSA-68616	0.005543976566584	3.63350260469291	7/58	0.106621114548652	H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3
SIRT1 negatively regulates rRNA expression R-HSA-427359	0.005543976566584	3.63350260469291	7/58	0.106621114548652	H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3
RAB GEFs exchange GTP for GDP on RABs R-HSA-8876198	0.00580535812421125	6.53995202440332	4/20	0.11084475152271	TRAPPC3;RAB1A;ULK1;RAB5C
Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 R-HSA-5625886	0.0066892447211011	3.49487560337187	7/60	0.125909613402853	H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3
Chromatin modifications during the maternal to zygotic transition (MZT) R-HSA-9821002	0.0066892447211011	3.49487560337187	7/60	0.125909613402853	H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3
Oxidative Stress Induced Senescence R-HSA-2559580	0.00776429728546437	2.66941753692349	10/110	0.145115809828327	TFDP1;E2F1;H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3;MAPK1
Binding and entry of HIV virion R-HSA-173107	0.00801180617038651	25.8511703320749	2/4	0.146643679835902	PPIA;CCR5
G2/M DNA damage checkpoint R-HSA-69473	0.00800206800855522	3.36611418211319	7/62	0.146643679835902	YWHAB;H2BC17;H2BC12;H2BC14;H2BC3;RPA3;YWHAQ
SUMO is conjugated to E1 (UBA2:SAE1) R-HSA-3065676	0.00801180617038651	25.8511703320749	2/4	0.146643679835902	SUMO1;SAE1
Rab regulation of trafficking R-HSA-9007101	0.00809142419979687	4.52739226909941	5/34	0.147063959688535	TRAPPC3;RAB1A;ULK1;RAB5C;TBC1D14
Ub-specific processing proteases R-HSA-5689880	0.0081455923414524	2.40306521412782	12/146	0.147063959688535	CCNA2;H2BC17;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3;MYC;H2AC12;H2AC13;USP10;SNX3
Deposition of new CENPA-containing nucleosomes at the centromere R-HSA-606279	0.00849679935721156	3.76520018075447	6/48	0.151345674456641	H2BC17;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3
Nucleosome assembly R-HSA-774815	0.00849679935721156	3.76520018075447	6/48	0.151345674456641	H2BC17;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3
Deubiquitination R-HSA-5688426	0.00856844726062403	2.22062434178365	14/184	0.151604393531308	CCNA2;H2BC17;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3;MYC;NEDD8;H2AC12;HCFC1;H2AC13;USP10;SNX3
Activation of HOX genes during differentiation R-HSA-5619507	0.00876202300251781	2.7842043177567	9/95	0.151759821122841	POLR2K;POLR2L;H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3
Activation of anterior HOX genes in hindbrain development during early embryogenesis R-HSA-5617472	0.00876202300251781	2.7842043177567	9/95	0.151759821122841	POLR2K;POLR2L;H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3
Condensation of Prophase Chromosomes R-HSA-2299718	0.00872560655519384	3.30517986671763	7/63	0.151759821122841	H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3
Interconversion of nucleotide di- and triphosphates R-HSA-499943	0.00892032106072464	8.67464392552404	3/12	0.151759821122841	GUK1;NME1;CMPK1
Postmitotic nuclear pore complex (NPC) reformation R-HSA-9615933	0.00892032106072464	8.67464392552404	3/12	0.151759821122841	SEC13;SUMO1;RAN
Rev-mediated nuclear export of HIV RNA R-HSA-165054	0.00892032106072464	8.67464392552404	3/12	0.151759821122841	SEC13;RAN;RANBP1
HIV Life Cycle R-HSA-162587	0.00898567116577048	2.98847901943644	8/79	0.151897906203534	PPIA;SUPT4H1;POLR2K;POLR2L;SEC13;CCR5;RAN;RANBP1
Estrogen-dependent gene expression R-HSA-9018519	0.0100990290061003	2.4305281705988	11/132	0.169638120140444	POLR2K;POLR2L;H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3;KPNA2;MYC
Formation of the beta-catenin:TCF transactivating complex R-HSA-201722	0.0104009084741866	2.90513444009854	8/81	0.171453485034107	H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3;MYC
Meiosis R-HSA-1500620	0.0104009084741866	2.90513444009854	8/81	0.171453485034107	H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3;RPA3
PRC2 methylates histones and DNA R-HSA-212300	0.0103154891948615	3.18961079885016	7/65	0.171453485034107	H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3
MHC class II antigen presentation R-HSA-2132295	0.0111852254596107	3.13477550484404	7/66	0.183244372653128	TUBB4B;DYNLL1;SEC13;CTSC;AP1M1;SEC23A;CLTA
Metalloprotease DUBs R-HSA-5689901	0.0113310910234564	5.2284097465077	4/24	0.183370216928374	H2AC7;H2AC8;H2AC12;H2AC13
Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy R-HSA-9857377	0.0112807933079022	7.80718395687427	3/13	0.183370216928374	ATP6V1G1;ATP6V1A;ATP6V0B
TP53 Regulates Transcription of Cell Cycle Genes R-HSA-6791312	0.0115822444977085	4.10017127132999	5/37	0.186298647860111	CCNA2;TFDP1;E2F1;PCNA;E2F4
DNA Damage/Telomere Stress Induced Senescence R-HSA-2559586	0.0121070628183493	3.08175953300016	7/67	0.193567136866862	CCNA2;H2BC17;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3
Activation of NOXA and translocation to mitochondria R-HSA-111448	0.0130246338695517	17.24170972242	2/5	0.1998114352011	TFDP1;E2F1
Formyl peptide receptors bind formyl peptides and many other ligands R-HSA-444473	0.0130246338695517	17.24170972242	2/5	0.1998114352011	FPR3;ANXA1
G2 Phase R-HSA-68911	0.0130246338695517	17.24170972242	2/5	0.1998114352011	CCNA2;E2F1
Interleukin-12 family signaling R-HSA-447115	0.0129428383006475	3.97506818057765	5/38	0.1998114352011	PPIA;STAT1;TCP1;VAMP7;HSPA9
OAS antiviral response R-HSA-8983711	0.0130246338695517	17.24170972242	2/5	0.1998114352011	OAS1;OAS2
Regulation of HSF1-mediated heat shock response R-HSA-3371453	0.0129428383006475	3.97506818057765	5/38	0.1998114352011	HSPA8;RPA3;MAPK1;SEC13;HSPA9
SUMO is transferred from E1 to E2 (UBE2I, UBC9) R-HSA-3065678	0.0130246338695517	17.24170972242	2/5	0.1998114352011	SUMO1;SAE1
GPCR ligand binding R-HSA-500792	0.0132048858281389	2.44328850487005	10/119	0.201412453953337	ADORA3;CCR5;CCL20;CCL4;CXCR3;CXCL9;CXCL11;CXCL10;FPR3;ANXA1
Interactions of Rev with host cellular proteins R-HSA-177243	0.0139673270447612	7.0950668308511	3/14	0.210620943049979	SEC13;RAN;RANBP1
Regulation of IFNG signaling R-HSA-877312	0.0139673270447612	7.0950668308511	3/14	0.210620943049979	STAT1;SUMO1;IFNGR1
ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression R-HSA-427389	0.0141136415621677	2.98085629469242	7/69	0.211624885344594	H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3
Diseases of programmed cell death R-HSA-9645723	0.0146580533689541	2.7154646111715	8/86	0.218553222703394	H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3;POLA2
Late Phase of HIV Life Cycle R-HSA-162599	0.015201625198257	2.93280614094437	7/70	0.225391694280302	PPIA;SUPT4H1;POLR2K;POLR2L;SEC13;RAN;RANBP1
Amino acids regulate mTORC1 R-HSA-9639288	0.0159800659093237	3.74643731698818	5/40	0.234315441565443	SEC13;LAMTOR1;ATP6V1G1;ATP6V1A;ATP6V0B
E3 ubiquitin ligases ubiquitinate target proteins R-HSA-8866654	0.0159800659093237	3.74643731698818	5/40	0.234315441565443	H2BC17;H2BC12;H2BC14;H2BC3;PCNA
Meiotic synapsis R-HSA-1221632	0.0161940044714959	3.22146011233659	6/55	0.236147735534891	H2BC17;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3
TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest R-HSA-6804114	0.0169857332494447	6.50277939340326	3/15	0.245000739369708	TFDP1;PCNA;E2F4
Transferrin endocytosis and recycling R-HSA-917977	0.0169857332494447	6.50277939340326	3/15	0.245000739369708	ATP6V1G1;ATP6V1A;ATP6V0B
Senescence-Associated Secretory Phenotype (SASP) R-HSA-2559582	0.0172658781229518	2.46147695645817	9/106	0.247695354261157	CCNA2;H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3;MAPK1
Translation R-HSA-72766	0.0175010905191177	2.07253918093827	13/181	0.249719861493217	EIF2S2;SEC61G;DDOST;RPL17;SRPRB;SEC11A;MRPL52;SSR2;TRAM1;MRPL43;AURKAIP1;MRPL34;MRPL36
ESR-mediated signaling R-HSA-8939211	0.0182471506986315	2.05982118061134	13/182	0.258972930236193	GNAI3;POLR2K;POLR2L;H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3;KPNA2;MAPK1;MYC
Reproduction R-HSA-1474165	0.0188839940661632	2.58055562530452	8/90	0.266585746019134	H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3;RPA3
Processing and activation of SUMO R-HSA-3215018	0.0190579610922719	12.9307331121793	2/6	0.267618141475606	SUMO1;SAE1
Interleukin-12 signaling R-HSA-9020591	0.0194424936975665	4.35269450436216	4/28	0.271580938280745	PPIA;TCP1;VAMP7;HSPA9
Antiviral mechanism by IFN-stimulated genes R-HSA-1169410	0.0203834657841402	2.3858098587861	9/109	0.278854217479939	EIF2S2;HSPA8;TUBB4B;KPNA2;SEC13;STAT1;OAS1;SUMO1;OAS2
Insulin receptor recycling R-HSA-77387	0.0203397100162045	6.00083747806967	3/16	0.278854217479939	ATP6V1G1;ATP6V1A;ATP6V0B
ROS and RNS production in phagocytes R-HSA-1222556	0.0203397100162045	6.00083747806967	3/16	0.278854217479939	ATP6V1G1;ATP6V1A;ATP6V0B
TBC/RABGAPs R-HSA-8854214	0.0203397100162045	6.00083747806967	3/16	0.278854217479939	ULK1;RAB5C;TBC1D14
Interferon gamma signaling R-HSA-877300	0.0222745258698272	2.97539237613062	6/59	0.303162008505238	MAPK1;STAT1;OAS1;SUMO1;OAS2;IFNGR1
Orc1 removal from chromatin R-HSA-68949	0.0240062237752412	2.91956794980352	6/60	0.325063866834133	CCNA2;MCM6;MCM8;CDC6;MCM3;MCM4
Epigenetic regulation of gene expression R-HSA-212165	0.0244061178163117	2.19423759369527	10/131	0.328801201444118	POLR2K;POLR2L;H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3;HCFC1
RNA Polymerase II Transcription Termination R-HSA-73856	0.0245624038935873	4.01615394886134	4/30	0.329235454210004	SNRPG;SNRPD3;SNRPB;SLBP
Activation of PUMA and translocation to mitochondria R-HSA-139915	0.0260290090096377	10.3476820146618	2/7	0.341749518604645	TFDP1;E2F1
DNA Double Strand Break Response R-HSA-5693606	0.0258261187809857	2.86577253765704	6/61	0.341749518604645	H2BC17;H2BC12;H2BC14;H2BC3;KPNA2;SUMO1
Frs2-mediated activation R-HSA-170968	0.0260290090096377	10.3476820146618	2/7	0.341749518604645	YWHAB;MAPK1
RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function R-HSA-8936459	0.0261398463740554	2.59723382870027	7/78	0.341749518604645	H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3
Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) R-HSA-400511	0.0260290090096377	10.3476820146618	2/7	0.341749518604645	SEC11A;DPP4
Cilium Assembly R-HSA-5617833	0.0267637465880591	2.4007332505314	8/96	0.3481910953172	TUBB4B;DYNLL1;CCT8;CCT3;CCT5;CCT2;TCP1;CCT4
Iron uptake and transport R-HSA-917937	0.027400011845952	3.86666877052085	4/31	0.354729909459301	ATP6V1G1;ATP6V1A;ATP6V0B;NEDD8
Processing of DNA double-strand break ends R-HSA-5693607	0.0277358385066032	2.81389738823353	6/62	0.35733454075983	CCNA2;H2BC17;H2BC12;H2BC14;H2BC3;RPA3
MicroRNA (miRNA) biogenesis R-HSA-203927	0.0280597466257442	5.19992980660224	3/18	0.358031574734255	POLR2K;POLR2L;RAN
PIWI-interacting RNA (piRNA) biogenesis R-HSA-5601884	0.0280597466257442	5.19992980660224	3/18	0.358031574734255	POLR2K;POLR2L;PLD6
GPCR downstream signalling R-HSA-388396	0.0288275087248106	1.87243675757363	14/214	0.366067981605968	GNAI3;KPNA2;MAPK1;ADORA3;CCR5;CCL20;CCL4;CXCR3;CXCL9;CXCL11;CXCL10;FPR3;ANXA1;CCL4L2
Abortive elongation of HIV-1 transcript in the absence of Tat R-HSA-167242	0.0324243090054484	4.87287283784927	3/19	0.409781505240286	SUPT4H1;POLR2K;POLR2L
Golgi Cisternae Pericentriolar Stack Reorganization R-HSA-162658	0.0338597101401639	8.62356477158805	2/8	0.417970561451139	MAPK1;RAB1A
IFNG signaling activates MAPKs R-HSA-9732724	0.0338597101401639	8.62356477158805	2/8	0.417970561451139	MAPK1;IFNGR1
Prolonged ERK activation events R-HSA-169893	0.0338597101401639	8.62356477158805	2/8	0.417970561451139	YWHAB;MAPK1
RNA Polymerase III Chain Elongation R-HSA-73780	0.0338597101401639	8.62356477158805	2/8	0.417970561451139	POLR2K;POLR2L
SARS-CoV-2-host interactions R-HSA-9705683	0.0334807699980204	2.07034233413494	10/138	0.417970561451139	YWHAB;YWHAQ;KPNA2;SEC13;SEC23A;STAT1;SNRPD1;SNRPG;SNRPD3;SNRPB
Protein ubiquitination R-HSA-8852135	0.0354141131645225	2.97329525143672	5/49	0.435134520086309	H2BC17;H2BC12;H2BC14;H2BC3;PCNA
Coenzyme A biosynthesis R-HSA-196783	0.0375865479723048	Inf	1/1	0.439448010213643	PPCS
Ketone body metabolism R-HSA-74182	0.0375865479723048	Inf	1/1	0.439448010213643	ACSS3
Minus-strand DNA synthesis R-HSA-164516	0.0375865479723048	Inf	1/1	0.439448010213643	PPIA
Plus-strand DNA synthesis R-HSA-164525	0.0375865479723048	Inf	1/1	0.439448010213643	PPIA
Replacement of protamines by nucleosomes in the male pronucleus R-HSA-9821993	0.0370480680396877	3.47734040092257	4/34	0.439448010213643	H2BC17;H2BC12;H2BC14;H2BC3
Respiratory syncytial virus genome transcription R-HSA-9828642	0.0375865479723048	Inf	1/1	0.439448010213643	HSPA8
Reverse Transcription of HIV RNA R-HSA-162589	0.0375865479723048	Inf	1/1	0.439448010213643	PPIA
SARS-CoV-2 Infection R-HSA-9694516	0.0367222093042432	1.89963666250656	12/180	0.439448010213643	YWHAB;YWHAQ;KPNA2;SEC13;SEC23A;DDOST;STAT1;SUMO1;SNRPD1;SNRPG;SNRPD3;SNRPB
Synthesis of Ketone Bodies R-HSA-77111	0.0375865479723048	Inf	1/1	0.439448010213643	ACSS3
Synthesis of dolichyl-phosphate-glucose R-HSA-480985	0.0375865479723048	Inf	1/1	0.439448010213643	ALG5
Uncoating of the HIV Virion R-HSA-162585	0.0375865479723048	Inf	1/1	0.439448010213643	PPIA
Organelle biogenesis and maintenance R-HSA-1852241	0.038319618188137	1.94577731181199	11/161	0.446053801189981	TUBB4B;DYNLL1;CCT8;CCT3;CCT5;CCT2;TCP1;CCT4;HSPA9;HCFC1;TFB2M
Amyloid fiber formation R-HSA-977225	0.0393450709683668	2.35982224036767	7/85	0.455990473144303	H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3
Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer R-HSA-2173793	0.0411153704282886	2.84262684050542	5/51	0.474435622246426	TFDP1;MAPK1;STAT1;MYC;E2F4
Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation R-HSA-8950505	0.0421479099086705	4.33019668745038	3/21	0.484244817738578	PPIA;TCP1;HSPA9
Interleukin-10 signaling R-HSA-6783783	0.0444370069440986	3.25844797088613	4/36	0.506162302273123	CCR5;CCL20;CCL4;CXCL10
SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription R-HSA-2173796	0.0444370069440986	3.25844797088613	4/36	0.506162302273123	TFDP1;MAPK1;MYC;E2F4
Immune System R-HSA-168256	0.0447479812686986	1.38415730198934	47/998	0.507526249090282	EIF2S2;PPIA;YWHAB;HSPA8;TUBB4B;DYNLL1;POLR2K;POLR2L;H3C1;KPNA2;MAPK1;SEC13;CTSC;AP1M1;SEC23A;SEC61G;UBA3;CD3D;UBE2F;VAMP8;SEC22B;CLTA;DDOST;LAMTOR1;ATP6V1G1;ATP6V1A;ATP6V0B;STAT1;OAS1;SUMO1;OAS2;COPB1;CCT8;CCT2;TCP1;ARPC5;ARPC3;MYC;CCR5;VAMP7;HSPA9;CCL20;CCL4;CXCL10;ANXA1;RAB5C;IFNGR1
Maternal to zygotic transition (MZT) R-HSA-9816359	0.0461419113732076	2.27075948786044	7/88	0.521109075678693	H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3
Formation of the Early Elongation Complex R-HSA-113418	0.0474973677736217	4.10146566987795	3/22	0.525241725296633	SUPT4H1;POLR2K;POLR2L
Formation of the HIV-1 Early Elongation Complex R-HSA-167158	0.0474973677736217	4.10146566987795	3/22	0.525241725296633	SUPT4H1;POLR2K;POLR2L
Mitochondrial translation termination R-HSA-5419276	0.0473431598714788	2.72284293752065	5/53	0.525241725296633	MRPL52;MRPL43;AURKAIP1;MRPL34;MRPL36
Pausing and recovery of Tat-mediated HIV elongation R-HSA-167238	0.0474973677736217	4.10146566987795	3/22	0.525241725296633	SUPT4H1;POLR2K;POLR2L
Tat-mediated HIV elongation arrest and recovery R-HSA-167243	0.0474973677736217	4.10146566987795	3/22	0.525241725296633	SUPT4H1;POLR2K;POLR2L
Cyclin E associated events during G1/S transition  R-HSA-69202	0.0520605491774505	2.38154885597024	6/72	0.548288482210133	CCNA2;TFDP1;E2F1;MYC;E2F4;CKS1B
Early Phase of HIV Life Cycle R-HSA-162594	0.0518099686067722	6.46610240508958	2/10	0.548288482210133	PPIA;CCR5
Golgi-to-ER retrograde transport R-HSA-8856688	0.0520605491774505	2.38154885597024	6/72	0.548288482210133	TUBB4B;DYNLL1;SEC22B;COPB1;RAB1A;TMED2
Mitochondrial translation elongation R-HSA-5389840	0.0506561578148268	2.66661790973506	5/54	0.548288482210133	MRPL52;MRPL43;AURKAIP1;MRPL34;MRPL36
Mitochondrial translation initiation R-HSA-5368286	0.0506561578148268	2.66661790973506	5/54	0.548288482210133	MRPL52;MRPL43;AURKAIP1;MRPL34;MRPL36
RAB geranylgeranylation R-HSA-8873719	0.0518099686067722	6.46610240508958	2/10	0.548288482210133	RAB1A;RAB5C
Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) R-HSA-381771	0.0518099686067722	6.46610240508958	2/10	0.548288482210133	SEC11A;DPP4
TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest R-HSA-6804116	0.0518099686067722	6.46610240508958	2/10	0.548288482210133	CCNA2;E2F1
Translesion Synthesis by POLH R-HSA-110320	0.0518099686067722	6.46610240508958	2/10	0.548288482210133	RPA3;PCNA
Translesion synthesis by POLI R-HSA-5656121	0.0518099686067722	6.46610240508958	2/10	0.548288482210133	RPA3;PCNA
Translesion synthesis by POLK R-HSA-5655862	0.0518099686067722	6.46610240508958	2/10	0.548288482210133	RPA3;PCNA
Translesion synthesis by REV1 R-HSA-110312	0.0518099686067722	6.46610240508958	2/10	0.548288482210133	RPA3;PCNA
Viral Messenger RNA Synthesis R-HSA-168325	0.0531637763618991	3.89571043683574	3/23	0.557694318041424	POLR2K;POLR2L;SEC13
COPI-dependent Golgi-to-ER retrograde traffic R-HSA-6811434	0.0541023731491598	2.6126789513363	5/55	0.560889446632305	TUBB4B;SEC22B;COPB1;RAB1A;TMED2
Cellular response to heat stress R-HSA-3371556	0.0541023731491598	2.6126789513363	5/55	0.560889446632305	HSPA8;RPA3;MAPK1;SEC13;HSPA9
Mitochondrial translation R-HSA-5368287	0.0541023731491598	2.6126789513363	5/55	0.560889446632305	MRPL52;MRPL43;AURKAIP1;MRPL34;MRPL36
Signaling by Nuclear Receptors R-HSA-9006931	0.0553549860301899	1.72617903137278	13/213	0.571642540560794	GNAI3;POLR2K;POLR2L;H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3;KPNA2;MAPK1;MYC
M Phase R-HSA-68886	0.0569901789775858	1.65112647345863	15/257	0.586247810102763	TUBB4B;DYNLL1;H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3;MAPK1;SEC13;ZWINT;SUMO1;RAB1A;RAN
Cyclin A:Cdk2-associated events at S phase entry R-HSA-69656	0.0581148816699515	2.31018755576601	6/74	0.595509250780121	CCNA2;TFDP1;E2F1;MYC;E2F4;CKS1B
Cellular Senescence R-HSA-2559583	0.059083197231502	1.79586429391745	11/173	0.596795537283861	CCNA2;TFDP1;E2F1;H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3;MAPK1
HIV elongation arrest and recovery R-HSA-167287	0.0591398742673909	3.7088386463848	3/24	0.596795537283861	SUPT4H1;POLR2K;POLR2L
Pausing and recovery of HIV elongation R-HSA-167290	0.0591398742673909	3.7088386463848	3/24	0.596795537283861	SUPT4H1;POLR2K;POLR2L
SUMOylation of RNA binding proteins R-HSA-4570464	0.0591398742673909	3.7088386463848	3/24	0.596795537283861	SEC13;SUMO1;HNRNPK
Advanced glycosylation endproduct receptor signaling R-HSA-879415	0.061794899397502	5.74668906140256	2/11	0.606113306083635	MAPK1;DDOST
Azathioprine ADME R-HSA-9748787	0.061794899397502	5.74668906140256	2/11	0.606113306083635	GUK1;NME1
Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex R-HSA-75035	0.061794899397502	5.74668906140256	2/11	0.606113306083635	YWHAB;YWHAQ
Incretin synthesis, secretion, and inactivation R-HSA-400508	0.061794899397502	5.74668906140256	2/11	0.606113306083635	SEC11A;DPP4
NEP/NS2 Interacts with the Cellular Export Machinery R-HSA-168333	0.061794899397502	5.74668906140256	2/11	0.606113306083635	SEC13;RAN
SRP-dependent cotranslational protein targeting to membrane R-HSA-1799339	0.0618902433868369	2.11082590248613	7/94	0.606113306083635	SEC61G;DDOST;RPL17;SRPRB;SEC11A;SSR2;TRAM1
Synthesis, secretion, and deacylation of Ghrelin R-HSA-422085	0.061794899397502	5.74668906140256	2/11	0.606113306083635	SEC11A;PLA2G7
mRNA decay by 5' to 3' exoribonuclease R-HSA-430039	0.061794899397502	5.74668906140256	2/11	0.606113306083635	LSM2;LSM5
Signaling by NOTCH R-HSA-157118	0.0650219218093525	1.71723703307724	12/197	0.634441840007432	TFDP1;E2F1;H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3;STAT1;TMED2;MYC
RHO GTPases Activate WASPs and WAVEs R-HSA-5663213	0.0654176151065115	3.53977098896032	3/25	0.635964653819346	MAPK1;ARPC5;ARPC3
Signaling by GPCR R-HSA-372790	0.0668133380894842	1.63768398127425	14/241	0.647162771129529	GNAI3;KPNA2;MAPK1;ADORA3;CCR5;CCL20;CCL4;CXCR3;CXCL9;CXCL11;CXCL10;FPR3;ANXA1;CCL4L2
Adenosine P1 receptors R-HSA-417973	0.0737692946228639	25.6868794816242	1/2	0.652612359763603	ADORA3
Cargo recognition for clathrin-mediated endocytosis R-HSA-8856825	0.0692188534417646	2.41667658727546	5/59	0.652612359763603	CD3D;VAMP8;CLTA;VAMP7;NEDD8
Disease R-HSA-1643685	0.0706736619713659	1.32178099085174	49/1079	0.652612359763603	GNAI3;PPIA;YWHAB;HSPA8;TUBB4B;DYNLL1;TFDP1;E2F1;SUPT4H1;POLR2K;POLR2L;H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3;RPA3;YWHAQ;KPNA2;MAPK1;POLA2;SEC13;AP1M1;SEC23A;CLTA;DDOST;STAT1;SUMO1;OAS2;ARPC5;ARPC3;RPL17;MYC;CCR5;RAN;H2AC12;H2AC13;RAB5C;IFNGR1;RAD51AP1;HNRNPK;SNRPD1;RANBP1;SEC11A;SNRPG;SNRPD3;SNRPB
Entry of Influenza Virion into Host Cell via Endocytosis R-HSA-168275	0.0737692946228639	25.6868794816242	1/2	0.652612359763603	CLTA
Export of Viral Ribonucleoproteins from Nucleus R-HSA-168274	0.0723698150648576	5.17184411018501	2/12	0.652612359763603	SEC13;RAN
Formation of HIV-1 elongation complex containing HIV-1 Tat R-HSA-167200	0.0719882678341519	3.38508950916444	3/26	0.652612359763603	SUPT4H1;POLR2K;POLR2L
HIV Transcription Elongation R-HSA-167169	0.0719882678341519	3.38508950916444	3/26	0.652612359763603	SUPT4H1;POLR2K;POLR2L
Mitochondrial transcription initiation R-HSA-163282	0.0737692946228639	25.6868794816242	1/2	0.652612359763603	TFB2M
Nuclear import of Rev protein R-HSA-180746	0.0723698150648576	5.17184411018501	2/12	0.652612359763603	SEC13;RAN
Oncogene Induced Senescence R-HSA-2559585	0.0719882678341519	3.38508950916444	3/26	0.652612359763603	TFDP1;E2F1;MAPK1
RMTs methylate histone arginines R-HSA-3214858	0.0733290925023577	2.37215209799119	5/60	0.652612359763603	H3C1;H2AC7;H2AC8;H2AC12;H2AC13
RNA Polymerase III Transcription Initiation From Type 3 Promoter R-HSA-76071	0.0723698150648576	5.17184411018501	2/12	0.652612359763603	POLR2K;POLR2L
RNA Polymerase III Transcription Termination R-HSA-73980	0.0723698150648576	5.17184411018501	2/12	0.652612359763603	POLR2K;POLR2L
Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks R-HSA-5693565	0.0733290925023577	2.37215209799119	5/60	0.652612359763603	H2BC17;H2BC12;H2BC14;H2BC3;SUMO1
Regulation of localization of FOXO transcription factors R-HSA-9614399	0.0723698150648576	5.17184411018501	2/12	0.652612359763603	YWHAB;YWHAQ
SARS-CoV-2 modulates host translation machinery R-HSA-9754678	0.0711757804491261	2.74000659841362	4/42	0.652612359763603	SNRPD1;SNRPG;SNRPD3;SNRPB
SARS-CoV-2 targets host intracellular signalling and regulatory pathways R-HSA-9755779	0.0723698150648576	5.17184411018501	2/12	0.652612359763603	YWHAB;YWHAQ
SUMOylation of SUMOylation proteins R-HSA-4085377	0.0723698150648576	5.17184411018501	2/12	0.652612359763603	SEC13;SUMO1
SUMOylation of nuclear envelope proteins R-HSA-9793242	0.0737692946228639	25.6868794816242	1/2	0.652612359763603	SUMO1
Signaling by MAP2K mutants R-HSA-9652169	0.0737692946228639	25.6868794816242	1/2	0.652612359763603	MAPK1
Signaling by MAPK mutants R-HSA-9652817	0.0737692946228639	25.6868794816242	1/2	0.652612359763603	MAPK1
Tat-mediated elongation of the HIV-1 transcript R-HSA-167246	0.0719882678341519	3.38508950916444	3/26	0.652612359763603	SUPT4H1;POLR2K;POLR2L
Telomere C-strand synthesis initiation R-HSA-174430	0.0737692946228639	25.6868794816242	1/2	0.652612359763603	POLA2
Transcription from mitochondrial promoters R-HSA-75944	0.0737692946228639	25.6868794816242	1/2	0.652612359763603	TFB2M
Transcriptional Regulation by E2F6 R-HSA-8953750	0.0719882678341519	3.38508950916444	3/26	0.652612359763603	TFDP1;E2F1;CDC7
phospho-PLA2 pathway R-HSA-111995	0.0737692946228639	25.6868794816242	1/2	0.652612359763603	MAPK1
Cyclin D associated events in G1 R-HSA-69231	0.0762838672294744	2.66910491123253	4/43	0.668176183587541	TFDP1;E2F1;E2F4;CKS1B
G1 Phase R-HSA-69236	0.0762838672294744	2.66910491123253	4/43	0.668176183587541	TFDP1;E2F1;E2F4;CKS1B
Nuclear Envelope (NE) Reassembly R-HSA-2995410	0.0762838672294744	2.66910491123253	4/43	0.668176183587541	TUBB4B;SEC13;SUMO1;RAN
Interferon Signaling R-HSA-913531	0.0788337677384669	1.69732425986092	11/182	0.685983015009479	EIF2S2;HSPA8;TUBB4B;KPNA2;MAPK1;SEC13;STAT1;OAS1;SUMO1;OAS2;IFNGR1
UCH proteinases R-HSA-5689603	0.0787181126427575	2.1197640901543	6/80	0.685983015009479	H2AC7;H2AC8;NEDD8;H2AC12;HCFC1;H2AC13
Signaling by Insulin receptor R-HSA-74752	0.0815719371475031	2.60181908712322	4/44	0.70748993852769	MAPK1;ATP6V1G1;ATP6V1A;ATP6V0B
Switching of origins to a post-replicative state R-HSA-69052	0.0825069601186015	2.0909206478572	6/81	0.713268638940614	CCNA2;MCM6;MCM8;CDC6;MCM3;MCM4
Transport of the SLBP Dependant Mature mRNA R-HSA-159230	0.0834769099297585	4.70041872606317	2/13	0.719310775823308	SEC13;SLBP
Transcriptional Regulation by TP53 R-HSA-3700989	0.0849604108192506	1.59926161609599	13/228	0.729724693573757	CCNA2;YWHAB;TFDP1;E2F1;SUPT4H1;POLR2K;POLR2L;RPA3;YWHAQ;LAMTOR1;PCNA;E2F4;PRELID1
Formation of HIV elongation complex in the absence of HIV Tat R-HSA-167152	0.0859705114911027	3.11284217824773	3/28	0.736018508056086	SUPT4H1;POLR2K;POLR2L
Macroautophagy R-HSA-1632852	0.090385578719555	2.03562124136106	6/83	0.771329022256267	HSPA8;TUBB4B;DYNLL1;LAMTOR1;ULK1;ATG101
Activation of BAD and translocation to mitochondria  R-HSA-111447	0.0950618404105915	4.30799944020108	2/14	0.800933728411777	YWHAB;YWHAQ
NS1 Mediated Effects on Host Pathways R-HSA-168276	0.0950618404105915	4.30799944020108	2/14	0.800933728411777	KPNA2;SEC13
RHOBTB2 GTPase cycle R-HSA-9013418	0.0950618404105915	4.30799944020108	2/14	0.800933728411777	CCT2;CCT6A
RNA Polymerase III Transcription Initiation From Type 2 Promoter R-HSA-76066	0.0950618404105915	4.30799944020108	2/14	0.800933728411777	POLR2K;POLR2L
G-protein mediated events R-HSA-112040	0.101006419469372	2.88091967719847	3/30	0.848326067315548	GNAI3;KPNA2;MAPK1
HIV Infection R-HSA-162906	0.102960244995564	1.69901583842798	9/148	0.862007855578003	PPIA;SUPT4H1;POLR2K;POLR2L;SEC13;AP1M1;CCR5;RAN;RANBP1
Activation of BIM and translocation to mitochondria  R-HSA-111446	0.108600335498006	12.8522723403568	1/3	0.870771270126006	DYNLL1
N-Glycan antennae elongation R-HSA-975577	0.108600335498006	12.8522723403568	1/3	0.870771270126006	B4GALT2
Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes R-HSA-170145	0.108600335498006	12.8522723403568	1/3	0.870771270126006	CCNA2
RNA Polymerase I Transcription Termination R-HSA-73863	0.107073549204614	3.97598561323549	2/15	0.870771270126006	POLR2K;POLR2L
RNA Polymerase III Transcription Initiation From Type 1 Promoter R-HSA-76061	0.107073549204614	3.97598561323549	2/15	0.870771270126006	POLR2K;POLR2L
Recycling of eIF2:GDP R-HSA-72731	0.108600335498006	12.8522723403568	1/3	0.870771270126006	EIF2S2
Respiratory syncytial virus (RSV) genome replication, transcription and translation R-HSA-9820965	0.107073549204614	3.97598561323549	2/15	0.870771270126006	HSPA8;SEC11A
SARS-CoV Infections R-HSA-9679506	0.107987886366744	1.50340310412227	14/260	0.870771270126006	PPIA;YWHAB;YWHAQ;KPNA2;SEC13;SEC23A;DDOST;STAT1;SUMO1;IFNGR1;SNRPD1;SNRPG;SNRPD3;SNRPB
SUMOylation of ubiquitinylation proteins R-HSA-3232142	0.107073549204614	3.97598561323549	2/15	0.870771270126006	SEC13;SUMO1
Signaling by Rho GTPases R-HSA-194315	0.105487607873945	1.42319201700109	19/374	0.870771270126006	YWHAB;TUBB4B;DYNLL1;H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3;YWHAQ;MAPK1;SEC13;LAMTOR1;ZWINT;CCT2;CCT6A;ARPC5;ARPC3
Signaling by TGF-beta Receptor Complex R-HSA-170834	0.107327088758273	1.93312733838565	6/87	0.870771270126006	TFDP1;MAPK1;STAT1;MYC;NEDD8;E2F4
Suppression of apoptosis R-HSA-9635465	0.108600335498006	12.8522723403568	1/3	0.870771270126006	MAPK1
Synthesis of PG R-HSA-1483148	0.108600335498006	12.8522723403568	1/3	0.870771270126006	PLD6
Synthesis of PI R-HSA-1483226	0.108600335498006	12.8522723403568	1/3	0.870771270126006	CDIPT
Signaling by Rho GTPases, Miro GTPases and RHOBTB3 R-HSA-9716542	0.111775567055265	1.41007339144551	19/377	0.89353118965263	YWHAB;TUBB4B;DYNLL1;H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3;YWHAQ;MAPK1;SEC13;LAMTOR1;ZWINT;CCT2;CCT6A;ARPC5;ARPC3
COPI-mediated anterograde transport R-HSA-6807878	0.116069691253756	2.03394520828981	5/69	0.925071953716121	TUBB4B;DYNLL1;COPB1;RAB1A;TMED2
Formation of TC-NER Pre-Incision Complex R-HSA-6781823	0.117010099778153	2.68097533219411	3/32	0.92699941734692	POLR2K;POLR2L;PRPF19
Nonhomologous End-Joining (NHEJ) R-HSA-5693571	0.116892314022199	2.25909153761931	4/50	0.92699941734692	H2BC17;H2BC12;H2BC14;H2BC3
Defective homologous recombination repair (HRR) due to BRCA2 loss of function R-HSA-9701190	0.119464097660101	3.69084069955096	2/16	0.935273496135422	RPA3;RAD51AP1
Diseases of DNA Double-Strand Break Repair R-HSA-9675136	0.119464097660101	3.69084069955096	2/16	0.935273496135422	RPA3;RAD51AP1
SARS-CoV-1 targets host intracellular signalling and regulatory pathways R-HSA-9735871	0.119464097660101	3.69084069955096	2/16	0.935273496135422	YWHAB;YWHAQ
Transport of Mature mRNAs Derived from Intronless Transcripts R-HSA-159234	0.119464097660101	3.69084069955096	2/16	0.935273496135422	SEC13;SLBP
Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal R-HSA-141444	0.125346969350116	2.59110180061504	3/33	0.975574359692692	DYNLL1;SEC13;ZWINT
Amplification of signal from the kinetochores R-HSA-141424	0.125346969350116	2.59110180061504	3/33	0.975574359692692	DYNLL1;SEC13;ZWINT
2-LTR circle formation R-HSA-164843	1	0	0/5	1	
5-Phosphoribose 1-diphosphate biosynthesis R-HSA-73843	1	0	0/0	1	
A tetrasaccharide linker sequence is required for GAG synthesis R-HSA-1971475	1	0	0/10	1	
ABC transporter disorders R-HSA-5619084	1	0	0/63	1	
ABC transporters in lipid homeostasis R-HSA-1369062	1	0	0/10	1	
ABC-family proteins mediated transport R-HSA-382556	0.949135177746886	0.332577059397564	1/77	1	EIF2S2
ABO blood group biosynthesis R-HSA-9033807	1	0	0/2	1	
ADORA2B mediated anti-inflammatory cytokines production R-HSA-9660821	0.553612977356495	1.28202882811191	1/21	1	GNAI3
ADP signalling through P2Y purinoceptor 1 R-HSA-418592	1	0	0/14	1	
ADP signalling through P2Y purinoceptor 12 R-HSA-392170	0.344236190036209	2.57008458248319	1/11	1	GNAI3
AKT phosphorylates targets in the cytosol R-HSA-198323	1	0	0/12	1	
AKT phosphorylates targets in the nucleus R-HSA-198693	1	0	0/10	1	
AKT-mediated inactivation of FOXO1A R-HSA-211163	1	0	0/4	1	
ALK mutants bind TKIs R-HSA-9700645	1	0	0/3	1	
ALKBH2 mediated reversal of alkylation damage R-HSA-112122	1	0	0/0	1	
ALKBH3 mediated reversal of alkylation damage R-HSA-112126	1	0	0/0	1	
AMPK inhibits chREBP transcriptional activation activity R-HSA-163680	1	0	0/6	1	
APC truncation mutants are not K63 polyubiquitinated R-HSA-5467333	1	0	0/1	1	
APC truncation mutants have impaired AXIN binding R-HSA-5467337	1	0	0/10	1	
APC-Cdc20 mediated degradation of Nek2A R-HSA-179409	1	0	0/22	1	
APC/C-mediated degradation of cell cycle proteins R-HSA-174143	0.954762201117562	0.319697148679627	1/80	1	CCNA2
APC/C:Cdc20 mediated degradation of Cyclin B R-HSA-174048	1	0	0/23	1	
APC/C:Cdc20 mediated degradation of Securin R-HSA-174154	1	0	0/66	1	
APC/C:Cdc20 mediated degradation of mitotic proteins R-HSA-176409	0.935711693844916	0.361648547173489	1/71	1	CCNA2
APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 R-HSA-174178	1	0	0/71	1	
APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint R-HSA-179419	0.930497248440735	0.372478991567458	1/69	1	CCNA2
APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway R-HSA-5649702	1	0	0/2	1	
APOBEC3G mediated resistance to HIV-1 infection R-HSA-180689	0.174406148124961	6.42991121082952	1/5	1	PPIA
ARL13B-mediated ciliary trafficking of INPP5E R-HSA-5624958	1	0	0/0	1	
ARMS-mediated activation R-HSA-170984	0.142129845273879	8.57316652446317	1/4	1	YWHAB
ASP-3026-resistant ALK mutants R-HSA-9717264	1	0	0/0	1	
ATF4 activates genes in response to endoplasmic reticulum  stress R-HSA-380994	1	0	0/24	1	
ATF6 (ATF6-alpha) activates chaperone genes R-HSA-381183	1	0	0/9	1	
ATF6 (ATF6-alpha) activates chaperones R-HSA-381033	1	0	0/11	1	
ATF6B (ATF6-beta) activates chaperones R-HSA-8874177	1	0	0/4	1	
ATP sensitive Potassium channels R-HSA-1296025	1	0	0/1	1	
AUF1 (hnRNP D0) binds and destabilizes mRNA R-HSA-450408	0.870479581049987	0.489103881449791	1/53	1	HSPA8
AURKA Activation by TPX2 R-HSA-8854518	0.408107159969482	1.46914349975516	2/37	1	TUBB4B;DYNLL1
AXIN missense mutants destabilize the destruction complex R-HSA-5467340	1	0	0/10	1	
Abacavir ADME R-HSA-2161522	1	0	0/3	1	
Abacavir metabolism R-HSA-2161541	1	0	0/1	1	
Abacavir transmembrane transport R-HSA-2161517	1	0	0/2	1	
Abasic sugar-phosphate removal via the single-nucleotide replacement pathway R-HSA-73930	1	0	0/1	1	
Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects R-HSA-9659787	0.132188505977977	3.44430718189997	2/17	1	TFDP1;E2F1
Aberrant regulation of mitotic cell cycle due to RB1 defects R-HSA-9687139	0.381222220846868	1.55895902004401	2/35	1	TFDP1;E2F1
Aberrant regulation of mitotic exit in cancer due to RB1 defects R-HSA-9687136	1	0	0/19	1	
Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate R-HSA-2978092	1	0	0/0	1	
Acetylation R-HSA-156582	1	0	0/2	1	
Acetylcholine Neurotransmitter Release Cycle R-HSA-264642	1	0	0/5	1	
Acetylcholine binding and downstream events R-HSA-181431	1	0	0/5	1	
Acetylcholine inhibits contraction of outer hair cells R-HSA-9667769	1	0	0/1	1	
Acetylcholine regulates insulin secretion R-HSA-399997	1	0	0/4	1	
Acrosome Reaction and Sperm:Oocyte Membrane Binding R-HSA-1300645	1	0	0/1	1	
Activated NOTCH1 Transmits Signal to the Nucleus R-HSA-2122948	1	0	0/15	1	
Activated NTRK2 signals through CDK5 R-HSA-9032845	1	0	0/5	1	
Activated NTRK2 signals through FRS2 and FRS3 R-HSA-9028731	1	0	0/7	1	
Activated NTRK2 signals through FYN R-HSA-9032500	1	0	0/4	1	
Activated NTRK2 signals through PI3K R-HSA-9028335	1	0	0/5	1	
Activated NTRK2 signals through PLCG1 R-HSA-9026527	1	0	0/2	1	
Activated NTRK2 signals through RAS R-HSA-9026519	1	0	0/6	1	
Activated NTRK3 signals through PI3K R-HSA-9603381	1	0	0/4	1	
Activated NTRK3 signals through PLCG1 R-HSA-9034793	1	0	0/1	1	
Activated NTRK3 signals through RAS R-HSA-9034864	1	0	0/5	1	
Activated point mutants of FGFR2 R-HSA-2033519	1	0	0/4	1	
Activation and oligomerization of BAK protein R-HSA-111452	1	0	0/1	1	
Activation of AKT2 R-HSA-165158	1	0	0/3	1	
Activation of AMPA receptors R-HSA-399710	1	0	0/0	1	
Activation of AMPK downstream of NMDARs R-HSA-9619483	0.631841499343673	1.02437078713227	1/26	1	TUBB4B
Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins R-HSA-176814	0.938171251492933	0.356462116080611	1/72	1	CCNA2
Activation of BMF and translocation to mitochondria R-HSA-139910	1	0	0/1	1	
Activation of C3 and C5 R-HSA-174577	1	0	0/5	1	
Activation of Ca-permeable Kainate Receptor R-HSA-451308	1	0	0/4	1	
Activation of G protein gated Potassium channels R-HSA-1296041	1	0	0/11	1	
Activation of GABAB receptors R-HSA-991365	0.498966544921479	1.50933201594162	1/18	1	GNAI3
Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) R-HSA-936964	1	0	0/14	1	
Activation of Matrix Metalloproteinases R-HSA-1592389	1	0	0/12	1	
Activation of NF-kappaB in B cells R-HSA-1169091	1	0	0/66	1	
Activation of NIMA Kinases NEK9, NEK6, NEK7 R-HSA-2980767	1	0	0/4	1	
Activation of NMDA receptors and postsynaptic events R-HSA-442755	0.383458603753469	1.37905292543158	3/59	1	TUBB4B;KPNA2;MAPK1
Activation of Na-permeable kainate receptors R-HSA-451307	1	0	0/0	1	
Activation of PPARGC1A (PGC-1alpha) by phosphorylation R-HSA-2151209	1	0	0/7	1	
Activation of RAC1 R-HSA-428540	1	0	0/10	1	
Activation of RAC1 downstream of NMDARs R-HSA-9619229	1	0	0/5	1	
Activation of RAS in B cells R-HSA-1169092	1	0	0/5	1	
Activation of SMO R-HSA-5635838	1	0	0/7	1	
Activation of TRKA receptors R-HSA-187015	1	0	0/3	1	
Activation of caspases through apoptosome-mediated cleavage R-HSA-111459	1	0	0/2	1	
Activation of gene expression by SREBF (SREBP) R-HSA-2426168	1	0	0/24	1	
Activation of kainate receptors upon glutamate binding R-HSA-451326	1	0	0/12	1	
Activation of the AP-1 family of transcription factors R-HSA-450341	0.318559709069054	2.85600744758908	1/10	1	MAPK1
Activation of the TFAP2 (AP-2) family of transcription factors R-HSA-8866907	1	0	0/6	1	
Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S R-HSA-72662	0.848731099233435	0.530409771183194	1/49	1	EIF2S2
Activation of the phototransduction cascade R-HSA-2485179	1	0	0/6	1	
Activation, myristolyation of BID and translocation to mitochondria R-HSA-75108	1	0	0/3	1	
Activation, translocation and oligomerization of BAX R-HSA-114294	1	0	0/2	1	
Acyl chain remodeling of CL R-HSA-1482798	1	0	0/4	1	
Acyl chain remodeling of DAG and TAG R-HSA-1482883	1	0	0/3	1	
Acyl chain remodelling of PC R-HSA-1482788	1	0	0/10	1	
Acyl chain remodelling of PE R-HSA-1482839	1	0	0/9	1	
Acyl chain remodelling of PG R-HSA-1482925	1	0	0/6	1	
Acyl chain remodelling of PI R-HSA-1482922	1	0	0/7	1	
Acyl chain remodelling of PS R-HSA-1482801	1	0	0/6	1	
Adaptive Immune System R-HSA-1280218	0.516299577019383	1.01784007885116	15/393	1	PPIA;YWHAB;TUBB4B;DYNLL1;SEC13;CTSC;AP1M1;SEC23A;SEC61G;UBA3;CD3D;UBE2F;VAMP8;SEC22B;CLTA
Adenylate cyclase activating pathway R-HSA-170660	1	0	0/5	1	
Adenylate cyclase inhibitory pathway R-HSA-170670	0.235383581618475	4.2860969528668	1/7	1	GNAI3
Adherens junctions interactions R-HSA-418990	1	0	0/23	1	
Adipogenesis R-HSA-9843745	1	0	0/68	1	
Adrenaline signalling through Alpha-2 adrenergic receptor R-HSA-392023	1	0	0/2	1	
Adrenaline,noradrenaline inhibits insulin secretion R-HSA-400042	1	0	0/13	1	
Adrenoceptors R-HSA-390696	1	0	0/3	1	
Aerobic respiration and respiratory electron transport R-HSA-1428517	1	0	0/109	1	
Aflatoxin activation and detoxification R-HSA-5423646	1	0	0/6	1	
Aggrephagy R-HSA-9646399	0.353841739128265	1.66037147168254	2/33	1	TUBB4B;DYNLL1
Agmatine biosynthesis R-HSA-351143	1	0	0/0	1	
Alanine metabolism R-HSA-8964540	1	0	0/0	1	
Alpha-defensins R-HSA-1462054	1	0	0/3	1	
Alpha-oxidation of phytanate R-HSA-389599	1	0	0/3	1	
Alpha-protein kinase 1 signaling pathway R-HSA-9645460	1	0	0/9	1	
Alternative Lengthening of Telomeres (ALT) R-HSA-9006821	1	0	0/1	1	
Alternative complement activation R-HSA-173736	1	0	0/2	1	
Amine Oxidase reactions R-HSA-140179	1	0	0/1	1	
Amine ligand-binding receptors R-HSA-375280	1	0	0/3	1	
Amino Acid conjugation R-HSA-156587	1	0	0/4	1	
Amino acid transport across the plasma membrane R-HSA-352230	1	0	0/10	1	
Anchoring fibril formation R-HSA-2214320	1	0	0/13	1	
Anchoring of the basal body to the plasma membrane R-HSA-5620912	0.509370491253451	1.19343025904594	2/45	1	TUBB4B;DYNLL1
Androgen biosynthesis R-HSA-193048	1	0	0/2	1	
Antagonism of Activin by Follistatin R-HSA-2473224	1	0	0/2	1	
Anti-inflammatory response favouring Leishmania parasite infection R-HSA-9662851	0.801594271869943	0.622085984281075	1/42	1	GNAI3
Antigen Presentation: Folding, assembly and peptide loading of class I MHC R-HSA-983170	0.171956326043045	2.86838050873959	2/20	1	SEC13;SEC23A
Antigen activates B Cell Receptor (BCR) leading to generation of second messengers R-HSA-983695	1	0	0/16	1	
Antigen processing-Cross presentation R-HSA-1236975	0.634391275446562	0.924007968574745	3/86	1	SEC61G;VAMP8;SEC22B
Antigen processing: Ubiquitination & Proteasome degradation R-HSA-983168	0.981056601106455	0.332679961663373	2/152	1	UBA3;UBE2F
Antimicrobial peptides R-HSA-6803157	1	0	0/16	1	
Apoptosis R-HSA-109581	0.363221350536757	1.2487076741987	6/130	1	YWHAB;DYNLL1;TFDP1;E2F1;YWHAQ;MAPK1
Apoptosis induced DNA fragmentation R-HSA-140342	1	0	0/10	1	
Apoptotic cleavage of cell adhesion  proteins R-HSA-351906	1	0	0/4	1	
Apoptotic cleavage of cellular proteins R-HSA-111465	1	0	0/20	1	
Apoptotic execution phase R-HSA-75153	1	0	0/31	1	
Apoptotic factor-mediated response R-HSA-111471	0.291884735022825	3.21357144757802	1/9	1	MAPK1
Aquaporin-mediated transport R-HSA-445717	1	0	0/21	1	
Arachidonate production from DAG R-HSA-426048	1	0	0/4	1	
Arachidonic acid metabolism R-HSA-2142753	1	0	0/21	1	
Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2 R-HSA-211957	1	0	0/0	1	
Aryl hydrocarbon receptor signalling R-HSA-8937144	1	0	0/6	1	
Aspartate and asparagine metabolism R-HSA-8963693	1	0	0/4	1	
Aspirin ADME R-HSA-9749641	1	0	0/12	1	
Assembly Of The HIV Virion R-HSA-175474	0.291884735022825	3.21357144757802	1/9	1	PPIA
Assembly and cell surface presentation of NMDA receptors R-HSA-9609736	0.696434865498924	0.852568679258093	1/31	1	TUBB4B
Assembly and release of respiratory syncytial virus (RSV) virions R-HSA-9820962	1	0	0/2	1	
Assembly of Viral Components at the Budding Site R-HSA-168316	1	0	0/2	1	
Assembly of active LPL and LIPC lipase complexes R-HSA-8963889	1	0	0/9	1	
Assembly of collagen fibrils and other multimeric structures R-HSA-2022090	1	0	0/38	1	
Astrocytic Glutamate-Glutamine Uptake And Metabolism R-HSA-210455	1	0	0/2	1	
Asymmetric localization of PCP proteins R-HSA-4608870	1	0	0/58	1	
Atorvastatin ADME R-HSA-9754706	1	0	0/3	1	
Attachment and Entry R-HSA-9678110	1	0	0/1	1	
Attachment and Entry R-HSA-9694614	1	0	0/7	1	
Attachment of GPI anchor to uPAR R-HSA-162791	1	0	0/2	1	
Attenuation phase R-HSA-3371568	0.517882860165378	1.4251445251651	1/19	1	HSPA8
Autodegradation of Cdh1 by Cdh1:APC/C R-HSA-174084	1	0	0/63	1	
Autodegradation of the E3 ubiquitin ligase COP1 R-HSA-349425	1	0	0/51	1	
Autointegration results in viral DNA circles R-HSA-177539	1	0	0/3	1	
Autophagy R-HSA-9612973	0.13064460350818	1.81829699607462	6/92	1	HSPA8;TUBB4B;DYNLL1;LAMTOR1;ULK1;ATG101
Axon guidance R-HSA-422475	0.978863878580027	0.510985564585476	7/343	1	HSPA8;TUBB4B;MAPK1;CLTA;ARPC5;ARPC3;RPL17
Axonal growth inhibition (RHOA activation) R-HSA-193634	1	0	0/2	1	
Axonal growth stimulation R-HSA-209563	1	0	0/2	1	
BDNF activates NTRK2 (TRKB) signaling R-HSA-9024909	1	0	0/1	1	
BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members R-HSA-111453	1	0	0/8	1	
BMAL1:CLOCK,NPAS2 activates circadian gene expression R-HSA-1368108	1	0	0/20	1	
Bacterial Infection Pathways R-HSA-9824439	0.793763144714459	0.63780152469564	1/41	1	MAPK1
Basigin interactions R-HSA-210991	0.344236190036209	2.57008458248319	1/11	1	PPIA
Beta defensins R-HSA-1461957	1	0	0/6	1	
Beta oxidation of butanoyl-CoA to acetyl-CoA R-HSA-77352	1	0	0/5	1	
Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA R-HSA-77346	1	0	0/2	1	
Beta oxidation of hexanoyl-CoA to butanoyl-CoA R-HSA-77350	1	0	0/3	1	
Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA R-HSA-77310	1	0	0/3	1	
Beta oxidation of myristoyl-CoA to lauroyl-CoA R-HSA-77285	1	0	0/1	1	
Beta oxidation of octanoyl-CoA to hexanoyl-CoA R-HSA-77348	1	0	0/2	1	
Beta oxidation of palmitoyl-CoA to myristoyl-CoA R-HSA-77305	1	0	0/0	1	
Beta-catenin independent WNT signaling R-HSA-3858494	0.91153333485459	0.49053636385935	2/105	1	CLTA;MYC
Beta-catenin phosphorylation cascade R-HSA-196299	1	0	0/11	1	
Beta-oxidation of pristanoyl-CoA R-HSA-389887	1	0	0/3	1	
Beta-oxidation of very long chain fatty acids R-HSA-390247	1	0	0/4	1	
Bicarbonate transporters R-HSA-425381	1	0	0/3	1	
Bile acid and bile salt metabolism R-HSA-194068	1	0	0/13	1	
Binding and Uptake of Ligands by Scavenger Receptors R-HSA-2173782	1	0	0/20	1	
Binding of TCF/LEF:CTNNB1 to target gene promoters R-HSA-4411364	0.264172706115377	3.67308504447128	1/8	1	MYC
Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB R-HSA-141333	1	0	0/1	1	
Biological oxidations R-HSA-211859	0.942813390288604	0.346515497629378	1/74	1	BPNT2
Biosynthesis of A2E, implicated in retinal degradation R-HSA-2466712	1	0	0/0	1	
Biosynthesis of D-series resolvins R-HSA-9018676	1	0	0/2	1	
Biosynthesis of DHA-derived SPMs R-HSA-9018677	1	0	0/5	1	
Biosynthesis of DHA-derived sulfido conjugates R-HSA-9026395	1	0	0/0	1	
Biosynthesis of DPA-derived SPMs R-HSA-9018683	1	0	0/3	1	
Biosynthesis of DPAn-3 SPMs R-HSA-9025094	1	0	0/3	1	
Biosynthesis of DPAn-3-derived 13-series resolvins R-HSA-9026403	1	0	0/1	1	
Biosynthesis of DPAn-3-derived maresins R-HSA-9026290	1	0	0/1	1	
Biosynthesis of DPAn-3-derived protectins and resolvins R-HSA-9026286	1	0	0/2	1	
Biosynthesis of DPAn-6 SPMs R-HSA-9025106	1	0	0/1	1	
Biosynthesis of E-series 18(R)-resolvins R-HSA-9023661	1	0	0/3	1	
Biosynthesis of E-series 18(S)-resolvins R-HSA-9018896	1	0	0/3	1	
Biosynthesis of EPA-derived SPMs R-HSA-9018679	1	0	0/4	1	
Biosynthesis of aspirin-triggered D-series resolvins R-HSA-9020265	1	0	0/2	1	
Biosynthesis of electrophilic ω-3 PUFA oxo-derivatives R-HSA-9027604	1	0	0/2	1	
Biosynthesis of maresin conjugates in tissue regeneration (MCTR) R-HSA-9026762	1	0	0/0	1	
Biosynthesis of maresin-like SPMs R-HSA-9027307	1	0	0/0	1	
Biosynthesis of maresins R-HSA-9018682	1	0	0/2	1	
Biosynthesis of protectin and resolvin conjugates in tissue regeneration (PCTR and RCTR) R-HSA-9026766	1	0	0/0	1	
Biosynthesis of protectins R-HSA-9018681	1	0	0/1	1	
Biosynthesis of specialized proresolving mediators (SPMs) R-HSA-9018678	1	0	0/6	1	
Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein R-HSA-446193	0.553612977356495	1.28202882811191	1/21	1	ALG5
Biotin transport and metabolism R-HSA-196780	1	0	0/6	1	
Blockage of phagosome acidification R-HSA-9636467	1	0	0/0	1	
Blood group systems biosynthesis R-HSA-9033658	1	0	0/4	1	
Branched-chain amino acid catabolism R-HSA-70895	1	0	0/10	1	
Breakdown of the nuclear lamina R-HSA-352238	1	0	0/1	1	
Budding and maturation of HIV virion R-HSA-162588	0.458894009609797	1.71140093295747	1/16	1	PPIA
Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA R-HSA-450385	0.437679640112941	1.83398057876147	1/15	1	YWHAB
Butyrophilin (BTN) family interactions R-HSA-8851680	1	0	0/4	1	
C-type lectin receptors (CLRs) R-HSA-5621481	0.98983419438835	0.213719043732607	1/118	1	UBA3
C6 deamination of adenosine R-HSA-75102	1	0	0/0	1	
CASP8 activity is inhibited R-HSA-5218900	1	0	0/10	1	
CD163 mediating an anti-inflammatory response R-HSA-9662834	1	0	0/6	1	
CD209 (DC-SIGN) signaling R-HSA-5621575	1	0	0/21	1	
CD22 mediated BCR regulation R-HSA-5690714	1	0	0/4	1	
CD28 co-stimulation R-HSA-389356	1	0	0/26	1	
CD28 dependent PI3K/Akt signaling R-HSA-389357	1	0	0/17	1	
CD28 dependent Vav1 pathway R-HSA-389359	1	0	0/9	1	
CDC42 GTPase cycle R-HSA-9013148	0.933154963720485	0.366985295333829	1/70	1	LAMTOR1
CDH11 homotypic and heterotypic interactions R-HSA-9833576	1	0	0/5	1	
CDK-mediated phosphorylation and removal of Cdc6 R-HSA-69017	0.761083100835686	0.728044476773648	2/72	1	CCNA2;CDC6
CHL1 interactions R-HSA-447041	0.174406148124961	6.42991121082952	1/5	1	HSPA8
CLEC7A (Dectin-1) induces NFAT activation R-HSA-5607763	1	0	0/9	1	
CLEC7A (Dectin-1) signaling R-HSA-5607764	0.970591527530416	0.279816591125833	1/91	1	UBA3
CLEC7A/inflammasome pathway R-HSA-5660668	1	0	0/6	1	
COPI-independent Golgi-to-ER retrograde traffic R-HSA-6811436	0.394731717852687	1.51272901639371	2/36	1	TUBB4B;DYNLL1
COX reactions R-HSA-140180	1	0	0/1	1	
CREB phosphorylation R-HSA-199920	1	0	0/7	1	
CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling R-HSA-442742	0.553612977356495	1.28202882811191	1/21	1	MAPK1
CREB1 phosphorylation through the activation of Adenylate Cyclase R-HSA-442720	1	0	0/7	1	
CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde R-HSA-442729	0.205475785531498	5.14414324267236	1/6	1	KPNA2
CREB3 factors activate genes R-HSA-8874211	1	0	0/4	1	
CRMPs in Sema3A signaling R-HSA-399956	1	0	0/8	1	
CS/DS degradation R-HSA-2024101	1	0	0/6	1	
CTLA4 inhibitory signaling R-HSA-389513	1	0	0/15	1	
CTNNB1 S33 mutants aren't phosphorylated R-HSA-5358747	1	0	0/11	1	
CTNNB1 S37 mutants aren't phosphorylated R-HSA-5358749	1	0	0/11	1	
CTNNB1 S45 mutants aren't phosphorylated R-HSA-5358751	1	0	0/11	1	
CTNNB1 T41 mutants aren't phosphorylated R-HSA-5358752	1	0	0/11	1	
CYP2E1 reactions R-HSA-211999	1	0	0/3	1	
Ca-dependent events R-HSA-111996	0.213363040881783	2.45690336361357	2/23	1	KPNA2;MAPK1
Ca2+ activated K+ channels R-HSA-1296052	1	0	0/2	1	
Ca2+ pathway R-HSA-4086398	0.718998322784487	0.798879056196462	1/33	1	MYC
CaM pathway R-HSA-111997	0.553612977356495	1.28202882811191	1/21	1	KPNA2
CaMK IV-mediated phosphorylation of CREB R-HSA-111932	0.264172706115377	3.67308504447128	1/8	1	KPNA2
Calcineurin activates NFAT R-HSA-2025928	0.291884735022825	3.21357144757802	1/9	1	PPIA
Calcitonin-like ligand receptors R-HSA-419812	1	0	0/5	1	
Calmodulin induced events R-HSA-111933	0.553612977356495	1.28202882811191	1/21	1	KPNA2
Calnexin/calreticulin cycle R-HSA-901042	1	0	0/14	1	
Cam-PDE 1 activation R-HSA-111957	1	0	0/2	1	
Cap-dependent Translation Initiation R-HSA-72737	0.886494642509068	0.532964063475686	2/97	1	EIF2S2;RPL17
Carboxyterminal post-translational modifications of tubulin R-HSA-8955332	0.586711236520839	1.16491237093854	1/23	1	TUBB4B
Cardiac conduction R-HSA-5576891	1	0	0/51	1	
Cardiogenesis R-HSA-9733709	1	0	0/18	1	
Carnitine metabolism R-HSA-200425	1	0	0/8	1	
Carnitine synthesis R-HSA-71262	1	0	0/1	1	
Caspase activation via Death Receptors in the presence of ligand R-HSA-140534	1	0	0/13	1	
Caspase activation via Dependence Receptors in the absence of ligand R-HSA-418889	1	0	0/3	1	
Caspase activation via extrinsic apoptotic signalling pathway R-HSA-5357769	1	0	0/16	1	
Caspase-mediated cleavage of cytoskeletal proteins R-HSA-264870	1	0	0/7	1	
Catecholamine biosynthesis R-HSA-209905	1	0	0/1	1	
Cation-coupled Chloride cotransporters R-HSA-426117	1	0	0/4	1	
Cdc20:Phospho-APC/C mediated degradation of Cyclin A R-HSA-174184	0.930497248440735	0.372478991567458	1/69	1	CCNA2
Cell death signalling via NRAGE, NRIF and NADE R-HSA-204998	1	0	0/41	1	
Cell junction organization R-HSA-446728	1	0	0/46	1	
Cell recruitment (pro-inflammatory response) R-HSA-9664424	1	0	0/24	1	
Cell surface interactions at the vascular wall R-HSA-202733	0.921877801787475	0.389974199096113	1/66	1	PPIA
Cell-Cell communication R-HSA-1500931	1	0	0/70	1	
Cell-cell junction organization R-HSA-421270	1	0	0/29	1	
Cell-extracellular matrix interactions R-HSA-446353	1	0	0/13	1	
Cellular hexose transport R-HSA-189200	1	0	0/5	1	
Cellular response to chemical stress R-HSA-9711123	0.998660808292702	0.146832322422746	1/169	1	MYC
Cellular response to hypoxia R-HSA-1234174	1	0	0/66	1	
Cellular response to mitochondrial stress R-HSA-9840373	0.235383581618475	4.2860969528668	1/7	1	EIF2S2
Cellular response to starvation R-HSA-9711097	0.226615342106865	1.45466593976665	7/132	1	EIF2S2;SEC13;LAMTOR1;ATP6V1G1;ATP6V1A;ATP6V0B;RPL17
Cellular responses to stimuli R-HSA-8953897	0.383205344272703	1.09078080816677	25/620	1	EIF2S2;CCNA2;HSPA8;TUBB4B;DYNLL1;TFDP1;E2F1;H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3;RPA3;MAPK1;SEC13;LAMTOR1;ATP6V1G1;ATP6V1A;ATP6V0B;RPL17;MYC;HSPA9;SRPRB
Cellular responses to stress R-HSA-2262752	0.383205344272703	1.09078080816677	25/620	1	EIF2S2;CCNA2;HSPA8;TUBB4B;DYNLL1;TFDP1;E2F1;H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3;RPA3;MAPK1;SEC13;LAMTOR1;ATP6V1G1;ATP6V1A;ATP6V0B;RPL17;MYC;HSPA9;SRPRB
Centrosome maturation R-HSA-380287	0.460100610410333	1.31716129245694	2/41	1	TUBB4B;DYNLL1
Ceramide signalling R-HSA-193681	1	0	0/2	1	
ChREBP activates metabolic gene expression R-HSA-163765	1	0	0/3	1	
Chaperone Mediated Autophagy R-HSA-9613829	0.437679640112941	1.83398057876147	1/15	1	HSPA8
Cholesterol biosynthesis R-HSA-191273	1	0	0/6	1	
Cholesterol biosynthesis via desmosterol R-HSA-6807047	1	0	0/0	1	
Cholesterol biosynthesis via lathosterol R-HSA-6807062	1	0	0/0	1	
Choline catabolism R-HSA-6798163	1	0	0/2	1	
Chondroitin sulfate biosynthesis R-HSA-2022870	1	0	0/10	1	
Chondroitin sulfate/dermatan sulfate metabolism R-HSA-1793185	1	0	0/21	1	
Chromatin modifying enzymes R-HSA-3247509	0.137575072231593	1.54162374420622	10/180	1	H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3;H2AC12;HCFC1;H2AC13
Chromatin organization R-HSA-4839726	0.137575072231593	1.54162374420622	10/180	1	H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3;H2AC12;HCFC1;H2AC13
Chylomicron assembly R-HSA-8963888	1	0	0/5	1	
Chylomicron clearance R-HSA-8964026	1	0	0/1	1	
Chylomicron remodeling R-HSA-8963901	1	0	0/6	1	
Ciprofloxacin ADME R-HSA-9793528	1	0	0/2	1	
Circadian Clock R-HSA-400253	1	0	0/52	1	
Citric acid cycle (TCA cycle) R-HSA-71403	1	0	0/12	1	
Class B/2 (Secretin family receptors) R-HSA-373080	1	0	0/38	1	
Class C/3 (Metabotropic glutamate/pheromone receptors) R-HSA-420499	1	0	0/1	1	
Class I MHC mediated antigen processing & presentation R-HSA-983169	0.62269937792928	0.935452952298306	7/198	1	SEC13;SEC23A;SEC61G;UBA3;UBE2F;VAMP8;SEC22B
Class I peroxisomal membrane protein import R-HSA-9603798	1	0	0/8	1	
Classical Kir channels R-HSA-1296053	1	0	0/1	1	
Classical antibody-mediated complement activation R-HSA-173623	1	0	0/3	1	
Cobalamin (Cbl) metabolism R-HSA-9759218	1	0	0/4	1	
Cobalamin (Cbl, vitamin B12) transport and metabolism R-HSA-196741	1	0	0/7	1	
Cohesin Loading onto Chromatin R-HSA-2470946	1	0	0/10	1	
Collagen biosynthesis and modifying enzymes R-HSA-1650814	1	0	0/31	1	
Collagen chain trimerization R-HSA-8948216	1	0	0/22	1	
Collagen degradation R-HSA-1442490	1	0	0/34	1	
Collagen formation R-HSA-1474290	1	0	0/45	1	
Common Pathway of Fibrin Clot Formation R-HSA-140875	1	0	0/11	1	
Competing endogenous RNAs (ceRNAs) regulate PTEN translation R-HSA-8948700	1	0	0/1	1	
Complement cascade R-HSA-166658	1	0	0/25	1	
Complex I biogenesis R-HSA-6799198	1	0	0/41	1	
Condensation of Prometaphase Chromosomes R-HSA-2514853	1	0	0/6	1	
Conjugation of benzoate with glycine R-HSA-177135	1	0	0/2	1	
Conjugation of carboxylic acids R-HSA-159424	1	0	0/4	1	
Conjugation of phenylacetate with glutamine R-HSA-177162	1	0	0/1	1	
Conjugation of salicylate with glycine R-HSA-177128	1	0	0/4	1	
Constitutive Signaling by AKT1 E17K in Cancer R-HSA-5674400	1	0	0/25	1	
Constitutive Signaling by Aberrant PI3K in Cancer R-HSA-2219530	1	0	0/43	1	
Constitutive Signaling by EGFRvIII R-HSA-5637810	1	0	0/13	1	
Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants R-HSA-1236382	1	0	0/17	1	
Constitutive Signaling by NOTCH1 HD Domain Mutants R-HSA-2691232	1	0	0/9	1	
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants R-HSA-2894862	0.854486511728183	0.519451139120248	1/50	1	MYC
Constitutive Signaling by NOTCH1 PEST Domain Mutants R-HSA-2644606	0.854486511728183	0.519451139120248	1/50	1	MYC
Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant R-HSA-2660826	1	0	0/4	1	
Constitutive Signaling by Overexpressed ERBB2 R-HSA-9634285	1	0	0/7	1	
Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase R-HSA-176407	1	0	0/18	1	
Costimulation by the CD28 family R-HSA-388841	0.860024331011437	0.508930802430352	1/51	1	CD3D
Creatine metabolism R-HSA-71288	1	0	0/1	1	
Creation of C4 and C2 activators R-HSA-166786	1	0	0/7	1	
Cristae formation R-HSA-8949613	0.617370309248053	1.06727882366375	1/25	1	HSPA9
Cross-presentation of particulate exogenous antigens (phagosomes) R-HSA-1236973	1	0	0/5	1	
Cross-presentation of soluble exogenous antigens (endosomes) R-HSA-1236978	1	0	0/45	1	
Crosslinking of collagen fibrils R-HSA-2243919	1	0	0/14	1	
Cyclin A/B1/B2 associated events during G2/M transition R-HSA-69273	0.437679640112941	1.83398057876147	1/15	1	CCNA2
Cysteine formation from homocysteine R-HSA-1614603	1	0	0/1	1	
Cytochrome P450 - arranged by substrate type R-HSA-211897	1	0	0/16	1	
Cytochrome c-mediated apoptotic response R-HSA-111461	0.174406148124961	6.42991121082952	1/5	1	MAPK1
Cytokine Signaling in Immune system R-HSA-1280215	0.289463473207276	1.1638431695289	23/540	1	EIF2S2;PPIA;HSPA8;TUBB4B;H3C1;KPNA2;MAPK1;SEC13;UBA3;STAT1;OAS1;SUMO1;OAS2;TCP1;MYC;CCR5;VAMP7;HSPA9;CCL20;CCL4;CXCL10;ANXA1;IFNGR1
Cytoprotection by HMOX1 R-HSA-9707564	1	0	0/50	1	
Cytosolic iron-sulfur cluster assembly R-HSA-2564830	1	0	0/2	1	
Cytosolic sensors of pathogen-associated DNA  R-HSA-1834949	0.485096978421095	1.25227862068696	2/43	1	POLR2K;POLR2L
Cytosolic sulfonation of small molecules R-HSA-156584	0.344236190036209	2.57008458248319	1/11	1	BPNT2
Cytosolic tRNA aminoacylation R-HSA-379716	1	0	0/7	1	
DAG and IP3 signaling R-HSA-1489509	0.617370309248053	1.06727882366375	1/25	1	KPNA2
DAP12 interactions R-HSA-2172127	1	0	0/23	1	
DAP12 signaling R-HSA-2424491	1	0	0/21	1	
DARPP-32 events R-HSA-180024	1	0	0/14	1	
DCC mediated attractive signaling R-HSA-418885	1	0	0/9	1	
DDX58/IFIH1-mediated induction of interferon-alpha/beta R-HSA-168928	1	0	0/68	1	
DEx/H-box helicases activate type I IFN and inflammatory cytokines production  R-HSA-3134963	1	0	0/7	1	
DNA Damage Recognition in GG-NER R-HSA-5696394	1	0	0/18	1	
DNA Damage Reversal R-HSA-73942	1	0	0/0	1	
DSCAM interactions R-HSA-376172	1	0	0/1	1	
Dasatinib-resistant KIT mutants R-HSA-9669914	1	0	0/1	1	
Deactivation of the beta-catenin transactivating complex R-HSA-3769402	1	0	0/29	1	
Deadenylation of mRNA R-HSA-429947	1	0	0/18	1	
Deadenylation-dependent mRNA decay R-HSA-429914	0.434420671639942	1.38904125234144	2/39	1	LSM2;LSM5
Death Receptor Signaling R-HSA-73887	0.97172233648953	0.276669139813744	1/92	1	ULK1
Dectin-1 mediated noncanonical NF-kB signaling R-HSA-5607761	0.897413111399592	0.437833860624597	1/59	1	UBA3
Dectin-2 family R-HSA-5621480	1	0	0/12	1	
Defective ABCA1 causes TGD R-HSA-5682113	1	0	0/2	1	
Defective ABCA12 causes ARCI4B R-HSA-5682294	1	0	0/1	1	
Defective ABCA3 causes SMDP3 R-HSA-5683678	1	0	0/0	1	
Defective ABCA3 causes SMDP3 R-HSA-5688399	1	0	0/0	1	
Defective ABCB11 causes PFIC2 and BRIC2 R-HSA-5678520	1	0	0/1	1	
Defective ABCB4 causes PFIC3, ICP3 and GBD1 R-HSA-5678771	1	0	0/0	1	
Defective ABCB6 causes MCOPCB7 R-HSA-5683371	1	0	0/0	1	
Defective ABCC2 causes DJS R-HSA-5679001	1	0	0/0	1	
Defective ABCC6 causes PXE R-HSA-5690338	1	0	0/0	1	
Defective ABCC8 can cause hypo- and hyper-glycemias R-HSA-5683177	1	0	0/0	1	
Defective ABCC9 causes CMD10, ATFB12 and Cantu syndrome R-HSA-5678420	1	0	0/1	1	
Defective ABCD1 causes ALD R-HSA-5684045	1	0	0/0	1	
Defective ABCD4 causes MAHCJ R-HSA-5683329	1	0	0/2	1	
Defective ABCG5 causes sitosterolemia R-HSA-5679096	1	0	0/0	1	
Defective ABCG8 causes GBD4 and sitosterolemia R-HSA-5679090	1	0	0/0	1	
Defective ACTH causes obesity and POMCD R-HSA-5579031	1	0	0/1	1	
Defective ACY1 causes encephalopathy R-HSA-5579007	1	0	0/0	1	
Defective ADA disrupts (deoxy)adenosine deamination R-HSA-9734735	1	0	0/0	1	
Defective AHCY causes HMAHCHD R-HSA-5578997	1	0	0/1	1	
Defective ALG1 causes CDG-1k R-HSA-4549380	1	0	0/0	1	
Defective ALG11 causes CDG-1p R-HSA-4551295	1	0	0/0	1	
Defective ALG12 causes CDG-1g R-HSA-4720489	1	0	0/0	1	
Defective ALG14 causes ALG14-CMS R-HSA-5633231	1	0	0/0	1	
Defective ALG2 causes CDG-1i R-HSA-4549349	1	0	0/0	1	
Defective ALG3 causes CDG-1d R-HSA-4720475	1	0	0/1	1	
Defective ALG6 causes CDG-1c R-HSA-4724289	1	0	0/0	1	
Defective ALG8 causes CDG-1h R-HSA-4724325	1	0	0/0	1	
Defective ALG9 causes CDG-1l R-HSA-4720454	1	0	0/0	1	
Defective AMN causes MGA1 R-HSA-3359462	1	0	0/0	1	
Defective APRT disrupts adenine salvage R-HSA-9734195	1	0	0/1	1	
Defective AVP does not bind AVPR1A,B and causes neurohypophyseal diabetes insipidus (NDI) R-HSA-5619099	1	0	0/0	1	
Defective AVP does not bind AVPR2 and causes neurohypophyseal diabetes insipidus (NDI) R-HSA-9036092	1	0	0/1	1	
Defective B3GALT6 causes EDSP2 and SEMDJL1 R-HSA-4420332	1	0	0/7	1	
Defective B3GALTL causes PpS R-HSA-5083635	1	0	0/14	1	
Defective B3GAT3 causes JDSSDHD R-HSA-3560801	1	0	0/8	1	
Defective B4GALT1 causes B4GALT1-CDG (CDG-2d) R-HSA-3656244	1	0	0/4	1	
Defective B4GALT1 causes CDG-2d R-HSA-4793953	1	0	0/0	1	
Defective B4GALT7 causes EDS, progeroid type R-HSA-3560783	1	0	0/7	1	
Defective BTD causes biotidinase deficiency R-HSA-3371598	1	0	0/1	1	
Defective Base Excision Repair Associated with MUTYH R-HSA-9605310	1	0	0/0	1	
Defective Base Excision Repair Associated with NEIL1 R-HSA-9616334	1	0	0/1	1	
Defective Base Excision Repair Associated with NEIL3 R-HSA-9629232	1	0	0/0	1	
Defective Base Excision Repair Associated with NTHL1 R-HSA-9616333	1	0	0/0	1	
Defective Base Excision Repair Associated with OGG1 R-HSA-9656249	1	0	0/0	1	
Defective C1GALT1C1 causes TNPS R-HSA-5083632	1	0	0/10	1	
Defective CBLIF causes IFD R-HSA-3359457	1	0	0/0	1	
Defective CD320 causes MMATC R-HSA-3359485	1	0	0/0	1	
Defective CFTR causes cystic fibrosis R-HSA-5678895	1	0	0/56	1	
Defective CHST14 causes EDS, musculocontractural type R-HSA-3595174	1	0	0/3	1	
Defective CHST3 causes SEDCJD R-HSA-3595172	1	0	0/4	1	
Defective CHST6 causes MCDC1 R-HSA-3656225	1	0	0/4	1	
Defective CHSY1 causes TPBS R-HSA-3595177	1	0	0/3	1	
Defective CP causes aceruloplasminemia (ACERULOP) R-HSA-5619060	1	0	0/1	1	
Defective CSF2RA causes SMDP4 R-HSA-5688890	1	0	0/2	1	
Defective CSF2RB causes SMDP5 R-HSA-5688849	1	0	0/2	1	
Defective CUBN causes MGA1 R-HSA-3359463	1	0	0/0	1	
Defective CYP11A1 causes AICSR R-HSA-5579026	1	0	0/0	1	
Defective CYP11B1 causes AH4 R-HSA-5579017	1	0	0/0	1	
Defective CYP11B2 causes CMO-1 deficiency R-HSA-5579009	1	0	0/0	1	
Defective CYP17A1 causes AH5 R-HSA-5579028	1	0	0/0	1	
Defective CYP19A1 causes AEXS R-HSA-5579030	1	0	0/0	1	
Defective CYP1B1 causes Glaucoma R-HSA-5579000	1	0	0/0	1	
Defective CYP21A2 causes AH3 R-HSA-5579021	1	0	0/0	1	
Defective CYP24A1 causes HCAI R-HSA-5579010	1	0	0/0	1	
Defective CYP26B1 causes RHFCA R-HSA-5579015	1	0	0/0	1	
Defective CYP26C1 causes FFDD4 R-HSA-5579004	1	0	0/0	1	
Defective CYP27A1 causes CTX R-HSA-5578996	1	0	0/1	1	
Defective CYP27B1 causes VDDR1A R-HSA-5579014	1	0	0/0	1	
Defective CYP27B1 causes VDDR1B R-HSA-5579027	1	0	0/0	1	
Defective CYP2U1 causes SPG56 R-HSA-5579011	1	0	0/1	1	
Defective CYP4F22 causes ARCI5 R-HSA-5579005	1	0	0/0	1	
Defective CYP7B1 causes SPG5A and CBAS3 R-HSA-5579013	1	0	0/0	1	
Defective DHDDS causes RP59 R-HSA-4755609	1	0	0/0	1	
Defective DNA double strand break response due to BARD1 loss of function R-HSA-9699150	1	0	0/1	1	
Defective DNA double strand break response due to BRCA1 loss of function R-HSA-9663199	1	0	0/1	1	
Defective DOLK causes DOLK-CDG R-HSA-4755583	1	0	0/0	1	
Defective DPAGT1 causes CDG-1j, CMSTA2 R-HSA-4549356	1	0	0/1	1	
Defective DPM1 causes DPM1-CDG R-HSA-4717374	1	0	0/2	1	
Defective DPM2 causes DPM2-CDG R-HSA-4719377	1	0	0/2	1	
Defective DPM3 causes DPM3-CDG R-HSA-4719360	1	0	0/2	1	
Defective EXT1 causes exostoses 1, TRPS2 and CHDS R-HSA-3656253	1	0	0/4	1	
Defective EXT2 causes exostoses 2 R-HSA-3656237	1	0	0/4	1	
Defective F8 accelerates dissociation of the A2 domain R-HSA-9672387	1	0	0/1	1	
Defective F8 binding to the cell membrane R-HSA-9672395	1	0	0/1	1	
Defective F8 binding to von Willebrand factor R-HSA-9672393	1	0	0/2	1	
Defective F8 cleavage by thrombin R-HSA-9672391	1	0	0/3	1	
Defective F8 secretion R-HSA-9672397	1	0	0/1	1	
Defective F8 sulfation at Y1699 R-HSA-9674519	1	0	0/1	1	
Defective F9 activation R-HSA-9673221	1	0	0/2	1	
Defective F9 secretion R-HSA-9673218	1	0	0/0	1	
Defective F9 variant does not activate FX R-HSA-9673202	1	0	0/1	1	
Defective FMO3 causes TMAU R-HSA-5579019	1	0	0/0	1	
Defective GALE causes EDG R-HSA-5609977	1	0	0/0	1	
Defective GALK1 causes GALCT2 R-HSA-5609976	1	0	0/0	1	
Defective GALNT12 causes CRCS1 R-HSA-5083636	1	0	0/8	1	
Defective GALNT3 causes HFTC R-HSA-5083625	1	0	0/8	1	
Defective GALT can cause GALCT R-HSA-5609978	1	0	0/0	1	
Defective GCK causes maturity-onset diabetes of the young 2 (MODY2) R-HSA-5619073	1	0	0/0	1	
Defective GCLC causes HAGGSD R-HSA-5578999	1	0	0/2	1	
Defective GFPT1 causes CMSTA1 R-HSA-4085023	1	0	0/0	1	
Defective GGT1 causes GLUTH R-HSA-5579022	1	0	0/0	1	
Defective GGT1 in aflatoxin detoxification causes GLUTH R-HSA-9035968	1	0	0/0	1	
Defective GNE causes sialuria, NK and IBM2 R-HSA-4085011	1	0	0/1	1	
Defective GSS causes GSS deficiency R-HSA-5579006	1	0	0/1	1	
Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function R-HSA-9704331	0.415639234052386	1.97560356752423	1/14	1	RAD51AP1
Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function R-HSA-9704646	0.415639234052386	1.97560356752423	1/14	1	RAD51AP1
Defective HEXA causes GM2G1 R-HSA-3656234	1	0	0/1	1	
Defective HEXB causes GM2G2 R-HSA-3656248	1	0	0/1	1	
Defective HK1 causes hexokinase deficiency (HK deficiency) R-HSA-5619056	1	0	0/1	1	
Defective HLCS causes multiple carboxylase deficiency R-HSA-3371599	1	0	0/3	1	
Defective HPRT1 disrupts guanine and hypoxanthine salvage R-HSA-9734281	1	0	0/0	1	
Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations R-HSA-9670615	1	0	0/1	1	
Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations R-HSA-9670613	1	0	0/1	1	
Defective Inhibition of DNA Recombination at Telomere R-HSA-9670621	1	0	0/1	1	
Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function R-HSA-9645722	1	0	0/2	1	
Defective Intrinsic Pathway for Apoptosis R-HSA-9734009	1	0	0/16	1	
Defective LARGE causes MDDGA6 and MDDGB6 R-HSA-5083627	1	0	0/0	1	
Defective LFNG causes SCDO3 R-HSA-5083630	1	0	0/5	1	
Defective MAN1B1 causes MRT15 R-HSA-4793950	1	0	0/0	1	
Defective MAOA causes BRUNS R-HSA-5579012	1	0	0/1	1	
Defective MAT1A causes MATD R-HSA-5579024	1	0	0/1	1	
Defective MGAT2 causes CDG-2a R-HSA-4793952	1	0	0/0	1	
Defective MMAA causes MMA, cblA type R-HSA-3359475	1	0	0/2	1	
Defective MMAB causes MMA, cblB type R-HSA-3359471	1	0	0/0	1	
Defective MMACHC causes MAHCC R-HSA-3359474	1	0	0/1	1	
Defective MMADHC causes MMAHCD R-HSA-3359473	1	0	0/1	1	
Defective MOGS causes CDG-2b R-HSA-4793954	1	0	0/0	1	
Defective MPDU1 causes CDG-1f R-HSA-4687000	1	0	0/0	1	
Defective MPI causes MPI-CDG R-HSA-4043916	1	0	0/0	1	
Defective MTR causes HMAG R-HSA-3359469	1	0	0/1	1	
Defective MTRR causes HMAE R-HSA-3359467	1	0	0/1	1	
Defective MUT causes MMAM R-HSA-3359478	1	0	0/2	1	
Defective MUTYH substrate binding R-HSA-9608287	1	0	0/0	1	
Defective MUTYH substrate processing R-HSA-9608290	1	0	0/0	1	
Defective Mismatch Repair Associated With MLH1 R-HSA-5545483	1	0	0/0	1	
Defective Mismatch Repair Associated With MSH2 R-HSA-5632928	1	0	0/1	1	
Defective Mismatch Repair Associated With MSH3 R-HSA-5632927	1	0	0/0	1	
Defective Mismatch Repair Associated With MSH6 R-HSA-5632968	1	0	0/1	1	
Defective Mismatch Repair Associated With PMS2 R-HSA-5632987	1	0	0/0	1	
Defective NEU1 causes sialidosis R-HSA-4341670	1	0	0/2	1	
Defective NTHL1 substrate binding R-HSA-9630222	1	0	0/0	1	
Defective NTHL1 substrate processing R-HSA-9630221	1	0	0/0	1	
Defective OGG1 Localization R-HSA-9657050	1	0	0/0	1	
Defective OGG1 Substrate Binding R-HSA-9656255	1	0	0/0	1	
Defective OGG1 Substrate Processing R-HSA-9656256	1	0	0/0	1	
Defective OPLAH causes OPLAHD R-HSA-5578998	1	0	0/1	1	
Defective PAPSS2 causes SEMD-PA R-HSA-3560796	1	0	0/0	1	
Defective PGM1 causes PGM1-CDG R-HSA-5609974	1	0	0/1	1	
Defective PMM2 causes PMM2-CDG R-HSA-4043911	1	0	0/1	1	
Defective PNP disrupts phosphorolysis of (deoxy)guanosine and (deoxy)inosine R-HSA-9735763	1	0	0/1	1	
Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3 R-HSA-5083628	1	0	0/0	1	
Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1 R-HSA-5083633	1	0	0/1	1	
Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2 R-HSA-5083629	1	0	0/1	1	
Defective RFT1 causes CDG-1n R-HSA-4570571	1	0	0/0	1	
Defective RHAG causes regulator type Rh-null hemolytic anemia (RHN) R-HSA-5619042	1	0	0/0	1	
Defective RIPK1-mediated regulated necrosis R-HSA-9693928	1	0	0/7	1	
Defective SERPING1 causes hereditary angioedema R-HSA-9657689	1	0	0/3	1	
Defective SFTPA2 causes IPF R-HSA-5687868	1	0	0/0	1	
Defective SLC11A2 causes hypochromic microcytic anemia, with iron overload 1 (AHMIO1) R-HSA-5619048	1	0	0/1	1	
Defective SLC12A1 causes Bartter syndrome 1 (BS1) R-HSA-5619104	1	0	0/1	1	
Defective SLC12A3 causes Gitelman syndrome (GS) R-HSA-5619087	1	0	0/0	1	
Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN) R-HSA-5619039	1	0	0/1	1	
Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT) R-HSA-5619070	1	0	0/2	1	
Defective SLC17A5 causes Salla disease (SD) and ISSD R-HSA-5619035	1	0	0/1	1	
Defective SLC17A8 causes autosomal dominant deafness 25 (DFNA25) R-HSA-5619076	1	0	0/0	1	
Defective SLC1A1 is implicated in schizophrenia 18 (SCZD18) and dicarboxylic aminoaciduria (DCBXA) R-HSA-5619067	1	0	0/0	1	
Defective SLC1A3 causes episodic ataxia 6 (EA6) R-HSA-5619062	1	0	0/1	1	
Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) R-HSA-5619111	1	0	0/1	1	
Defective SLC22A12 causes renal hypouricemia 1 (RHUC1) R-HSA-5619071	1	0	0/0	1	
Defective SLC22A18 causes lung cancer (LNCR) and embryonal rhabdomyosarcoma 1 (RMSE1) R-HSA-5619066	1	0	0/0	1	
Defective SLC22A5 causes systemic primary carnitine deficiency (CDSP) R-HSA-5619053	1	0	0/1	1	
Defective SLC24A1 causes congenital stationary night blindness 1D (CSNB1D) R-HSA-5619077	1	0	0/1	1	
Defective SLC24A4 causes hypomineralized amelogenesis imperfecta (AI) R-HSA-5619055	1	0	0/0	1	
Defective SLC24A5 causes oculocutaneous albinism 6 (OCA6) R-HSA-5619036	1	0	0/0	1	
Defective SLC26A2 causes chondrodysplasias R-HSA-3560792	1	0	0/1	1	
Defective SLC26A3 causes congenital secretory chloride diarrhea 1 (DIAR1) R-HSA-5619085	1	0	0/0	1	
Defective SLC26A4 causes Pendred syndrome (PDS) R-HSA-5619046	1	0	0/0	1	
Defective SLC27A4 causes ichthyosis prematurity syndrome (IPS) R-HSA-5619108	1	0	0/1	1	
Defective SLC29A3 causes histiocytosis-lymphadenopathy plus syndrome (HLAS) R-HSA-5619063	1	0	0/0	1	
Defective SLC2A1 causes GLUT1 deficiency syndrome 1 (GLUT1DS1) R-HSA-5619043	1	0	0/0	1	
Defective SLC2A10 causes arterial tortuosity syndrome (ATS) R-HSA-5619068	1	0	0/0	1	
Defective SLC2A2 causes Fanconi-Bickel syndrome (FBS) R-HSA-5619098	1	0	0/0	1	
Defective SLC2A9 causes hypouricemia renal 2 (RHUC2) R-HSA-5619047	1	0	0/0	1	
Defective SLC33A1 causes spastic paraplegia 42 (SPG42) R-HSA-5619061	1	0	0/0	1	
Defective SLC34A1 causes hypophosphatemic nephrolithiasis/osteoporosis 1 (NPHLOP1) R-HSA-5619040	1	0	0/1	1	
Defective SLC34A2 causes PALM R-HSA-5687583	1	0	0/0	1	
Defective SLC34A2 causes pulmonary alveolar microlithiasis (PALM) R-HSA-5619045	1	0	0/0	1	
Defective SLC34A3 causes Hereditary hypophosphatemic rickets with hypercalciuria (HHRH) R-HSA-5619097	1	0	0/0	1	
Defective SLC35A1 causes congenital disorder of glycosylation 2F (CDG2F) R-HSA-5619037	1	0	0/1	1	
Defective SLC35A1 causes congenital disorder of glycosylation 2F (CDG2F) R-HSA-5663020	1	0	0/1	1	
Defective SLC35A2 causes congenital disorder of glycosylation 2M (CDG2M) R-HSA-5619072	1	0	0/1	1	
Defective SLC35A3 causes arthrogryposis, mental retardation, and seizures (AMRS) R-HSA-5619083	1	0	0/0	1	
Defective SLC35C1 causes congenital disorder of glycosylation 2C (CDG2C) R-HSA-5619078	1	0	0/0	1	
Defective SLC35D1 causes SCHBCKD R-HSA-5579020	1	0	0/0	1	
Defective SLC36A2 causes iminoglycinuria (IG) and hyperglycinuria (HG) R-HSA-5619041	1	0	0/0	1	
Defective SLC39A4 causes acrodermatitis enteropathica, zinc-deficiency type (AEZ) R-HSA-5619088	1	0	0/0	1	
Defective SLC3A1 causes cystinuria (CSNU) R-HSA-5619113	1	0	0/1	1	
Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum) R-HSA-5655799	1	0	0/2	1	
Defective SLC40A1 causes hemochromatosis 4 (HFE4) (macrophages) R-HSA-5619049	1	0	0/1	1	
Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4),  distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) R-HSA-5619050	1	0	0/1	1	
Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) R-HSA-5619054	1	0	0/0	1	
Defective SLC5A1 causes congenital glucose/galactose malabsorption (GGM) R-HSA-5656364	1	0	0/1	1	
Defective SLC5A2 causes renal glucosuria (GLYS1) R-HSA-5658208	1	0	0/0	1	
Defective SLC5A5 causes thyroid dyshormonogenesis 1 (TDH1) R-HSA-5619096	1	0	0/1	1	
Defective SLC5A7 causes distal hereditary motor neuronopathy 7A (HMN7A) R-HSA-5619114	1	0	0/0	1	
Defective SLC5A7 causes distal hereditary motor neuronopathy 7A (HMN7A) R-HSA-5658471	1	0	0/0	1	
Defective SLC6A18 may confer susceptibility to iminoglycinuria and/or hyperglycinuria R-HSA-5619079	1	0	0/0	1	
Defective SLC6A18 may confer susceptibility to iminoglycinuria and/or hyperglycinuria R-HSA-5659729	1	0	0/0	1	
Defective SLC6A19 causes Hartnup disorder (HND) R-HSA-5619044	1	0	0/0	1	
Defective SLC6A19 causes Hartnup disorder (HND) R-HSA-5659735	1	0	0/0	1	
Defective SLC6A2 causes orthostatic intolerance (OI) R-HSA-5619109	1	0	0/0	1	
Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) R-HSA-5619081	1	0	0/0	1	
Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) R-HSA-5660724	1	0	0/0	1	
Defective SLC6A5 causes hyperekplexia 3 (HKPX3) R-HSA-5619089	1	0	0/0	1	
Defective SLC7A7 causes lysinuric protein intolerance (LPI) R-HSA-5660862	1	0	0/1	1	
Defective SLC7A9 causes cystinuria (CSNU) R-HSA-5660883	1	0	0/1	1	
Defective SLC9A6 causes  X-linked, syndromic mental retardation,, Christianson type (MRXSCH) R-HSA-5619092	1	0	0/1	1	
Defective SLC9A9 causes autism 16 (AUTS16) R-HSA-5619052	1	0	0/1	1	
Defective SLCO1B1 causes hyperbilirubinemia, Rotor type (HBLRR) R-HSA-5619110	1	0	0/0	1	
Defective SLCO1B3 causes hyperbilirubinemia, Rotor type (HBLRR) R-HSA-5619058	1	0	0/0	1	
Defective SLCO2A1 causes primary, autosomal recessive hypertrophic osteoarthropathy 2 (PHOAR2) R-HSA-5619095	1	0	0/0	1	
Defective SRD5A3 causes SRD5A3-CDG, KHRZ R-HSA-4755579	1	0	0/1	1	
Defective ST3GAL3 causes MCT12 and EIEE15 R-HSA-3656243	1	0	0/5	1	
Defective TBXAS1 causes GHDD R-HSA-5579032	1	0	0/0	1	
Defective TCN2 causes TCN2 deficiency R-HSA-3359454	1	0	0/0	1	
Defective TPMT causes TPMT deficiency R-HSA-5578995	1	0	0/1	1	
Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) R-HSA-5619107	0.318559709069054	2.85600744758908	1/10	1	SEC13
Defective UGT1A1 causes hyperbilirubinemia R-HSA-5579002	1	0	0/0	1	
Defective UGT1A4 causes hyperbilirubinemia R-HSA-5579016	1	0	0/0	1	
Defective VWF binding to collagen type I  R-HSA-9845622	1	0	0/3	1	
Defective VWF cleavage by ADAMTS13 variant R-HSA-9845621	1	0	0/4	1	
Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) R-HSA-9661069	0.132188505977977	3.44430718189997	2/17	1	TFDP1;E2F1
Defective binding of VWF variant to GPIb:IX:V R-HSA-9846298	1	0	0/4	1	
Defective cofactor function of FVIIIa variant R-HSA-9672396	1	0	0/1	1	
Defective factor IX causes hemophilia B R-HSA-9668250	1	0	0/4	1	
Defective factor IX causes thrombophilia R-HSA-9672383	1	0	0/1	1	
Defective factor VIII causes hemophilia A R-HSA-9662001	1	0	0/3	1	
Defective factor XII causes hereditary angioedema R-HSA-9657688	1	0	0/3	1	
Defective gamma-carboxylation of F9 R-HSA-9673240	1	0	0/1	1	
Defective homologous recombination repair (HRR) due to BRCA1 loss of function R-HSA-9701192	0.415639234052386	1.97560356752423	1/14	1	RAD51AP1
Defective homologous recombination repair (HRR) due to PALB2 loss of function R-HSA-9701193	0.415639234052386	1.97560356752423	1/14	1	RAD51AP1
Defective pro-SFTPB causes SMDP1 and RDS R-HSA-5688031	1	0	0/1	1	
Defective pro-SFTPC causes SMDP2 and RDS R-HSA-5688354	1	0	0/0	1	
Defective regulation of TLR7 by endogenous ligand R-HSA-9824856	1	0	0/1	1	
Defective translocation of RB1 mutants to the nucleus R-HSA-9661070	1	0	0/1	1	
Defects in biotin (Btn) metabolism R-HSA-3323169	1	0	0/4	1	
Defects in cobalamin (B12) metabolism R-HSA-3296469	1	0	0/6	1	
Defects in vitamin and cofactor metabolism R-HSA-3296482	1	0	0/10	1	
Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) R-HSA-9651496	1	0	0/9	1	
Defects of platelet adhesion to exposed collagen R-HSA-9823587	1	0	0/5	1	
Defensins R-HSA-1461973	1	0	0/9	1	
Degradation of AXIN R-HSA-4641257	1	0	0/52	1	
Degradation of DVL R-HSA-4641258	1	0	0/52	1	
Degradation of GABA R-HSA-916853	1	0	0/1	1	
Degradation of GLI1 by the proteasome R-HSA-5610780	1	0	0/58	1	
Degradation of GLI2 by the proteasome R-HSA-5610783	1	0	0/59	1	
Degradation of beta-catenin by the destruction complex R-HSA-195253	0.949135177746886	0.332577059397564	1/77	1	MYC
Degradation of cysteine and homocysteine R-HSA-1614558	1	0	0/5	1	
Degradation of the extracellular matrix R-HSA-1474228	1	0	0/60	1	
Deletions in the AMER1 gene destabilize the destruction complex R-HSA-5467343	1	0	0/1	1	
Deletions in the AXIN1 gene destabilize the destruction complex R-HSA-5467345	1	0	0/1	1	
Depolymerization of the Nuclear Lamina R-HSA-4419969	1	0	0/7	1	
Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models R-HSA-8862803	1	0	0/13	1	
Dermatan sulfate biosynthesis R-HSA-2022923	1	0	0/4	1	
Detoxification of Reactive Oxygen Species R-HSA-3299685	1	0	0/18	1	
Developmental Biology R-HSA-1266738	0.85234598143861	0.803700717760711	22/699	1	HSPA8;TUBB4B;TFDP1;E2F1;POLR2K;POLR2L;H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3;MAPK1;CLTA;ATP6V1G1;ATP6V1A;ATP6V0B;ARPC5;ARPC3;RPL17;MYC
Developmental Cell Lineages R-HSA-9734767	1	0	0/5	1	
Differentiation of keratinocytes in interfollicular epidermis in mammalian skin R-HSA-9725554	1	0	0/5	1	
Digestion R-HSA-8935690	1	0	0/2	1	
Digestion and absorption R-HSA-8963743	1	0	0/4	1	
Digestion of dietary carbohydrate R-HSA-189085	1	0	0/1	1	
Digestion of dietary lipid R-HSA-192456	1	0	0/1	1	
Dimerization of procaspase-8 R-HSA-69416	1	0	0/10	1	
Disassembly of the destruction complex and recruitment of AXIN to the membrane R-HSA-4641262	1	0	0/20	1	
Diseases associated with N-glycosylation of proteins R-HSA-3781860	1	0	0/4	1	
Diseases associated with O-glycosylation of proteins R-HSA-3906995	1	0	0/30	1	
Diseases associated with glycosaminoglycan metabolism R-HSA-3560782	1	0	0/17	1	
Diseases associated with glycosylation precursor biosynthesis R-HSA-5609975	1	0	0/6	1	
Diseases associated with surfactant metabolism R-HSA-5687613	1	0	0/2	1	
Diseases associated with the TLR signaling cascade R-HSA-5602358	1	0	0/24	1	
Diseases associated with visual transduction R-HSA-2474795	1	0	0/1	1	
Diseases of Base Excision Repair R-HSA-9605308	1	0	0/1	1	
Diseases of Cellular Senescence R-HSA-9630747	1	0	0/3	1	
Diseases of DNA repair R-HSA-9675135	0.145204600897006	3.22833101189847	2/18	1	RPA3;RAD51AP1
Diseases of Immune System R-HSA-5260271	1	0	0/24	1	
Diseases of Mismatch Repair (MMR) R-HSA-5423599	1	0	0/1	1	
Diseases of Telomere Maintenance R-HSA-9673013	1	0	0/1	1	
Diseases of carbohydrate metabolism R-HSA-5663084	1	0	0/17	1	
Diseases of cellular response to stress R-HSA-9675132	1	0	0/3	1	
Diseases of glycosylation R-HSA-3781865	1	0	0/57	1	
Diseases of hemostasis R-HSA-9671793	1	0	0/12	1	
Diseases of metabolism R-HSA-5668914	1	0	0/99	1	
Diseases of mitochondrial beta oxidation R-HSA-9759774	1	0	0/2	1	
Diseases of mitotic cell cycle R-HSA-9675126	0.394731717852687	1.51272901639371	2/36	1	TFDP1;E2F1
Diseases of nucleotide metabolism R-HSA-9735804	1	0	0/2	1	
Diseases of propionyl-CoA catabolism R-HSA-9759785	1	0	0/2	1	
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202	0.983180019773558	0.474922245511569	6/316	1	YWHAB;POLR2K;POLR2L;MAPK1;STAT1;MYC
Diseases of the neuronal system R-HSA-9675143	1	0	0/1	1	
Disinhibition of SNARE formation R-HSA-114516	1	0	0/4	1	
Disorders of Developmental Biology R-HSA-9675151	1	0	0/10	1	
Disorders of Nervous System Development R-HSA-9697154	1	0	0/10	1	
Disorders of transmembrane transporters R-HSA-5619115	0.979343650675899	0.253778431796595	1/100	1	SEC13
Displacement of DNA glycosylase by APEX1 R-HSA-110357	1	0	0/2	1	
Dissolution of Fibrin Clot R-HSA-75205	1	0	0/10	1	
Dopamine Neurotransmitter Release Cycle R-HSA-212676	1	0	0/5	1	
Dopamine clearance from the synaptic cleft R-HSA-379401	1	0	0/1	1	
Dopamine receptors R-HSA-390651	1	0	0/0	1	
Downregulation of ERBB2 signaling R-HSA-8863795	1	0	0/19	1	
Downregulation of ERBB2:ERBB3 signaling R-HSA-1358803	1	0	0/8	1	
Downregulation of ERBB4 signaling R-HSA-1253288	1	0	0/8	1	
Downregulation of SMAD2/3:SMAD4 transcriptional activity R-HSA-2173795	0.326057104295125	1.77576003048232	2/31	1	MAPK1;STAT1
Downregulation of TGF-beta receptor signaling R-HSA-2173788	1	0	0/26	1	
Downstream TCR signaling R-HSA-202424	0.97280993893224	0.273590106438006	1/93	1	CD3D
Downstream signal transduction R-HSA-186763	0.67207250610081	0.91392634390264	1/29	1	STAT1
Downstream signaling events of B Cell Receptor (BCR) R-HSA-1168372	0.954762201117562	0.319697148679627	1/80	1	PPIA
Downstream signaling of activated FGFR1 R-HSA-5654687	1	0	0/12	1	
Downstream signaling of activated FGFR2 R-HSA-5654696	1	0	0/14	1	
Downstream signaling of activated FGFR3 R-HSA-5654708	1	0	0/12	1	
Downstream signaling of activated FGFR4 R-HSA-5654716	1	0	0/12	1	
Drug ADME R-HSA-9748784	0.421339530883202	1.42797982983662	2/38	1	GUK1;NME1
Drug resistance in ERBB2 KD mutants R-HSA-9665230	1	0	0/2	1	
Drug resistance in ERBB2 TMD/JMD mutants R-HSA-9665737	1	0	0/2	1	
Drug resistance of ALK mutants R-HSA-9700649	1	0	0/0	1	
Drug resistance of FLT3 mutants R-HSA-9702506	1	0	0/0	1	
Drug resistance of KIT mutants R-HSA-9669937	1	0	0/1	1	
Drug resistance of PDGFR mutants R-HSA-9674415	1	0	0/1	1	
Drug-mediated inhibition of CDK4/CDK6 activity R-HSA-9754119	1	0	0/5	1	
Drug-mediated inhibition of ERBB2 signaling R-HSA-9652282	1	0	0/2	1	
Drug-mediated inhibition of MET activation R-HSA-9734091	1	0	0/1	1	
E2F-enabled inhibition of pre-replication complex formation R-HSA-113507	0.142129845273879	8.57316652446317	1/4	1	MCM8
ECM proteoglycans R-HSA-3000178	1	0	0/40	1	
EGFR Transactivation by Gastrin R-HSA-2179392	1	0	0/9	1	
EGFR downregulation R-HSA-182971	1	0	0/24	1	
EGFR interacts with phospholipase C-gamma R-HSA-212718	1	0	0/9	1	
EGR2 and SOX10-mediated initiation of Schwann cell myelination R-HSA-9619665	1	0	0/13	1	
EML4 and NUDC in mitotic spindle formation R-HSA-9648025	0.136682178735679	2.11912724021154	4/53	1	TUBB4B;DYNLL1;SEC13;ZWINT
EPH-Ephrin signaling R-HSA-2682334	0.341894219772855	1.48663805722902	3/55	1	CLTA;ARPC5;ARPC3
EPH-ephrin mediated repulsion of cells R-HSA-3928665	0.617370309248053	1.06727882366375	1/25	1	CLTA
EPHA-mediated growth cone collapse R-HSA-3928663	1	0	0/14	1	
EPHB-mediated forward signaling R-HSA-3928662	0.283865776727722	1.98210611793963	2/28	1	ARPC5;ARPC3
ER Quality Control Compartment (ERQC) R-HSA-901032	1	0	0/10	1	
ER-Phagosome pathway R-HSA-1236974	0.593420379625518	0.984515873383842	3/81	1	SEC61G;VAMP8;SEC22B
ERBB2 Activates PTK6 Signaling R-HSA-8847993	1	0	0/8	1	
ERBB2 Regulates Cell Motility R-HSA-6785631	1	0	0/9	1	
ERK/MAPK targets R-HSA-198753	0.458894009609797	1.71140093295747	1/16	1	MAPK1
ERKs are inactivated R-HSA-202670	0.235383581618475	4.2860969528668	1/7	1	MAPK1
Early SARS-CoV-2 Infection Events R-HSA-9772572	1	0	0/16	1	
Effects of PIP2 hydrolysis R-HSA-114508	1	0	0/12	1	
Eicosanoid ligand-binding receptors R-HSA-391903	1	0	0/1	1	
Eicosanoids R-HSA-211979	1	0	0/3	1	
Elastic fibre formation R-HSA-1566948	1	0	0/22	1	
Electric Transmission Across Gap Junctions R-HSA-112303	1	0	0/1	1	
Electron transport from NADPH to Ferredoxin R-HSA-2395516	1	0	0/0	1	
Elevation of cytosolic Ca2+ levels R-HSA-139853	1	0	0/5	1	
Endogenous sterols R-HSA-211976	1	0	0/8	1	
Endosomal Sorting Complex Required For Transport (ESCRT) R-HSA-917729	1	0	0/17	1	
Endosomal/Vacuolar pathway R-HSA-1236977	1	0	0/7	1	
Energy dependent regulation of mTOR by LKB1-AMPK R-HSA-380972	0.602334189032362	1.11399051059428	1/24	1	LAMTOR1
Enhanced binding of GP1BA variant to VWF multimer:collagen  R-HSA-9845620	1	0	0/4	1	
Enhanced cleavage of VWF variant by ADAMTS13 R-HSA-9845619	1	0	0/4	1	
Enzymatic degradation of Dopamine by monoamine oxidase R-HSA-379398	1	0	0/1	1	
Enzymatic degradation of dopamine by COMT R-HSA-379397	1	0	0/1	1	
Ephrin signaling R-HSA-3928664	1	0	0/11	1	
Epithelial-Mesenchymal Transition (EMT) during gastrulation R-HSA-9758919	1	0	0/3	1	
Erythrocytes take up carbon dioxide and release oxygen R-HSA-1237044	1	0	0/7	1	
Erythrocytes take up oxygen and release carbon dioxide R-HSA-1247673	1	0	0/7	1	
Erythropoietin activates Phosphoinositide-3-kinase (PI3K) R-HSA-9027276	1	0	0/9	1	
Erythropoietin activates Phospholipase C gamma (PLCG) R-HSA-9027277	1	0	0/4	1	
Erythropoietin activates RAS R-HSA-9027284	1	0	0/10	1	
Erythropoietin activates STAT5 R-HSA-9027283	1	0	0/5	1	
Essential fructosuria R-HSA-5657562	1	0	0/1	1	
Essential pentosuria R-HSA-5662853	1	0	0/0	1	
Establishment of Sister Chromatid Cohesion R-HSA-2468052	1	0	0/9	1	
Estrogen biosynthesis R-HSA-193144	1	0	0/0	1	
Estrogen-dependent nuclear events downstream of ESR-membrane signaling R-HSA-9634638	0.602334189032362	1.11399051059428	1/24	1	MAPK1
Estrogen-stimulated signaling through PRKCZ R-HSA-9634635	0.205475785531498	5.14414324267236	1/6	1	MAPK1
Ethanol oxidation R-HSA-71384	1	0	0/4	1	
Eukaryotic Translation Elongation R-HSA-156842	0.959770364975441	0.307759594824728	1/83	1	RPL17
Eukaryotic Translation Initiation R-HSA-72613	0.886494642509068	0.532964063475686	2/97	1	EIF2S2;RPL17
Eukaryotic Translation Termination R-HSA-72764	0.956496849308816	0.315618492633763	1/81	1	RPL17
Evasion by RSV of host interferon responses R-HSA-9833109	1	0	0/34	1	
Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 R-HSA-9630791	1	0	0/2	1	
Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 R-HSA-9630794	1	0	0/3	1	
Evasion of Oncogene Induced Senescence Due to p14ARF Defects R-HSA-9646303	1	0	0/1	1	
Evasion of Oncogene Induced Senescence Due to p16INK4A Defects R-HSA-9630750	1	0	0/3	1	
Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 R-HSA-9632697	1	0	0/2	1	
Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 R-HSA-9632700	1	0	0/3	1	
Evasion of Oxidative Stress Induced Senescence Due to p14ARF Defects R-HSA-9646304	1	0	0/1	1	
Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects R-HSA-9632693	1	0	0/3	1	
Events associated with phagocytolytic activity of PMN cells R-HSA-8941413	1	0	0/0	1	
Expression and Processing of Neurotrophins R-HSA-9036866	1	0	0/2	1	
Expression and translocation of olfactory receptors R-HSA-9752946	1	0	0/1	1	
Extra-nuclear estrogen signaling R-HSA-9009391	0.638682226120279	0.930197483218581	2/57	1	GNAI3;MAPK1
Extracellular matrix organization R-HSA-1474244	1	0	0/133	1	
Extrinsic Pathway of Fibrin Clot Formation R-HSA-140834	1	0	0/3	1	
FASTK family proteins regulate processing and stability of mitochondrial RNAs R-HSA-9837092	1	0	0/0	1	
FBXL7 down-regulates AURKA during mitotic entry and in early mitosis R-HSA-8854050	1	0	0/53	1	
FBXW7 Mutants and NOTCH1 in Cancer R-HSA-2644605	1	0	0/5	1	
FCERI mediated Ca+2 mobilization R-HSA-2871809	1	0	0/19	1	
FCERI mediated MAPK activation R-HSA-2871796	0.586711236520839	1.16491237093854	1/23	1	MAPK1
FCERI mediated NF-kB activation R-HSA-2871837	1	0	0/75	1	
FCGR activation R-HSA-2029481	1	0	0/10	1	
FCGR3A-mediated IL10 synthesis R-HSA-9664323	1	0	0/25	1	
FCGR3A-mediated phagocytosis R-HSA-9664422	0.151560771747948	2.3537364605182	3/36	1	MAPK1;ARPC5;ARPC3
FGFR1 ligand binding and activation R-HSA-190242	1	0	0/3	1	
FGFR1 mutant receptor activation R-HSA-1839124	0.536089519856027	1.34983084155226	1/20	1	STAT1
FGFR1b ligand binding and activation R-HSA-190370	1	0	0/2	1	
FGFR1c and Klotho ligand binding and activation R-HSA-190374	1	0	0/0	1	
FGFR1c ligand binding and activation R-HSA-190373	1	0	0/3	1	
FGFR2 alternative splicing R-HSA-6803529	0.171956326043045	2.86838050873959	2/20	1	POLR2K;POLR2L
FGFR2 ligand binding and activation R-HSA-190241	1	0	0/4	1	
FGFR2 mutant receptor activation R-HSA-1839126	0.158472870531307	3.037775775203	2/19	1	POLR2K;POLR2L
FGFR2b ligand binding and activation R-HSA-190377	1	0	0/3	1	
FGFR2c ligand binding and activation R-HSA-190375	1	0	0/3	1	
FGFR3 ligand binding and activation R-HSA-190239	1	0	0/2	1	
FGFR3 mutant receptor activation R-HSA-2033514	1	0	0/2	1	
FGFR3b ligand binding and activation R-HSA-190371	1	0	0/0	1	
FGFR3c ligand binding and activation R-HSA-190372	1	0	0/2	1	
FGFR4 ligand binding and activation R-HSA-190322	1	0	0/2	1	
FGFR4 mutant receptor activation R-HSA-1839128	1	0	0/1	1	
FGFRL1 modulation of FGFR1 signaling R-HSA-5658623	1	0	0/4	1	
FLT3 Signaling R-HSA-9607240	1	0	0/30	1	
FLT3 mutants bind TKIs R-HSA-9702509	1	0	0/0	1	
FLT3 signaling by CBL mutants R-HSA-9706377	1	0	0/5	1	
FLT3 signaling in disease R-HSA-9682385	1	0	0/22	1	
FLT3 signaling through SRC family kinases R-HSA-9706374	1	0	0/4	1	
FMO oxidises nucleophiles R-HSA-217271	1	0	0/0	1	
FOXO-mediated transcription R-HSA-9614085	0.555637766010393	1.09074085300898	2/49	1	YWHAB;YWHAQ
FOXO-mediated transcription of cell cycle genes R-HSA-9617828	1	0	0/11	1	
FOXO-mediated transcription of cell death genes R-HSA-9614657	1	0	0/14	1	
FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes R-HSA-9615017	1	0	0/21	1	
FRS-mediated FGFR1 signaling R-HSA-5654693	1	0	0/8	1	
FRS-mediated FGFR2 signaling R-HSA-5654700	1	0	0/10	1	
FRS-mediated FGFR3 signaling R-HSA-5654706	1	0	0/8	1	
FRS-mediated FGFR4 signaling R-HSA-5654712	1	0	0/8	1	
Factors involved in megakaryocyte development and platelet production R-HSA-983231	0.893304179584843	0.521701123783596	2/99	1	TUBB4B;H3C1
Fanconi Anemia Pathway R-HSA-6783310	0.586711236520839	1.16491237093854	1/23	1	RPA3
FasL/ CD95L signaling R-HSA-75157	1	0	0/4	1	
Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion R-HSA-434316	1	0	0/3	1	
Fatty acid metabolism R-HSA-8978868	1	0	0/74	1	
Fatty acids R-HSA-211935	1	0	0/5	1	
Fatty acyl-CoA biosynthesis R-HSA-75105	1	0	0/14	1	
Fc epsilon receptor (FCERI) signaling R-HSA-2454202	0.988096055852444	0.221518281522899	1/114	1	MAPK1
Fcgamma receptor (FCGR) dependent phagocytosis R-HSA-2029480	0.331458946640772	1.51616775687301	3/54	1	MAPK1;ARPC5;ARPC3
Fertilization R-HSA-1187000	1	0	0/4	1	
Fibronectin matrix formation R-HSA-1566977	1	0	0/3	1	
Ficolins bind to repetitive carbohydrate structures on the target cell surface R-HSA-2855086	1	0	0/3	1	
Formation of ATP by chemiosmotic coupling R-HSA-163210	1	0	0/15	1	
Formation of Fibrin Clot (Clotting Cascade) R-HSA-140877	1	0	0/22	1	
Formation of Incision Complex in GG-NER R-HSA-5696395	0.185620369846663	2.71680916381686	2/21	1	RPA3;SUMO1
Formation of RNA Pol II elongation complex  R-HSA-112382	0.133892024315642	2.50672042818043	3/34	1	SUPT4H1;POLR2K;POLR2L
Formation of Senescence-Associated Heterochromatin Foci (SAHF) R-HSA-2559584	1	0	0/16	1	
Formation of WDR5-containing histone-modifying complexes R-HSA-9772755	0.631841499343673	1.02437078713227	1/26	1	HCFC1
Formation of a pool of free 40S subunits R-HSA-72689	0.966922478791855	0.289693043298967	1/88	1	RPL17
Formation of annular gap junctions R-HSA-196025	0.291884735022825	3.21357144757802	1/9	1	CLTA
Formation of apoptosome R-HSA-111458	0.174406148124961	6.42991121082952	1/5	1	MAPK1
Formation of axial mesoderm R-HSA-9796292	1	0	0/11	1	
Formation of definitive endoderm R-HSA-9823730	1	0	0/10	1	
Formation of editosomes by ADAR proteins R-HSA-77042	1	0	0/0	1	
Formation of intermediate mesoderm R-HSA-9761174	1	0	0/3	1	
Formation of lateral plate mesoderm R-HSA-9758920	1	0	0/1	1	
Formation of paraxial mesoderm R-HSA-9793380	1	0	0/58	1	
Formation of the Editosome R-HSA-75094	1	0	0/0	1	
Formation of the active cofactor, UDP-glucuronate R-HSA-173599	1	0	0/0	1	
Formation of the anterior neural plate R-HSA-9823739	1	0	0/4	1	
Formation of the cornified envelope R-HSA-6809371	1	0	0/11	1	
Formation of the nephric duct R-HSA-9830364	1	0	0/9	1	
Formation of the posterior neural plate R-HSA-9832991	1	0	0/5	1	
Formation of the ternary complex, and subsequently, the 43S complex R-HSA-72695	0.809129921713963	0.607118697929812	1/43	1	EIF2S2
Formation of the ureteric bud R-HSA-9830674	1	0	0/8	1	
Formation of xylulose-5-phosphate R-HSA-5661270	1	0	0/1	1	
Free fatty acid receptors R-HSA-444209	1	0	0/0	1	
Free fatty acids regulate insulin secretion R-HSA-400451	1	0	0/4	1	
Fructose biosynthesis R-HSA-5652227	1	0	0/1	1	
Fructose catabolism R-HSA-70350	1	0	0/2	1	
Fructose metabolism R-HSA-5652084	1	0	0/3	1	
G alpha (12/13) signalling events R-HSA-416482	1	0	0/38	1	
G alpha (q) signalling events R-HSA-416476	0.79906664241781	0.669522338745299	2/78	1	MAPK1;ANXA1
G alpha (s) signalling events R-HSA-418555	0.830072735737981	0.566207597994036	1/46	1	GNAI3
G alpha (z) signalling events R-HSA-418597	0.617370309248053	1.06727882366375	1/25	1	GNAI3
G beta:gamma signalling through BTK R-HSA-8964315	1	0	0/9	1	
G beta:gamma signalling through CDC42 R-HSA-8964616	1	0	0/11	1	
G beta:gamma signalling through PI3Kgamma R-HSA-392451	1	0	0/15	1	
G beta:gamma signalling through PLC beta R-HSA-418217	1	0	0/8	1	
G protein gated Potassium channels R-HSA-1296059	1	0	0/11	1	
G-protein activation R-HSA-202040	1	0	0/13	1	
G-protein beta:gamma signalling R-HSA-397795	1	0	0/19	1	
G1/S DNA Damage Checkpoints R-HSA-69615	0.915549723680259	0.402563247203239	1/64	1	CCNA2
G2/M DNA replication checkpoint R-HSA-69478	1	0	0/2	1	
G2/M Transition R-HSA-69275	0.884172347197209	0.582699308606494	3/133	1	CCNA2;TUBB4B;DYNLL1
GAB1 signalosome R-HSA-180292	1	0	0/15	1	
GABA B receptor activation R-HSA-977444	0.498966544921479	1.50933201594162	1/18	1	GNAI3
GABA receptor activation R-HSA-977443	0.498966544921479	1.50933201594162	1/18	1	GNAI3
GABA synthesis R-HSA-888568	1	0	0/0	1	
GABA synthesis, release, reuptake and degradation R-HSA-888590	0.205475785531498	5.14414324267236	1/6	1	HSPA8
GDP-fucose biosynthesis R-HSA-6787639	1	0	0/1	1	
GLI proteins bind promoters of Hh responsive genes to promote transcription R-HSA-5635851	1	0	0/7	1	
GLI3 is processed to GLI3R by the proteasome R-HSA-5610785	1	0	0/59	1	
GP1b-IX-V activation signalling R-HSA-430116	1	0	0/9	1	
GPER1 signaling R-HSA-9634597	0.570478706275663	1.22068271949632	1/22	1	GNAI3
GPVI-mediated activation cascade R-HSA-114604	1	0	0/26	1	
GRB2 events in EGFR signaling R-HSA-179812	1	0	0/13	1	
GRB2 events in ERBB2 signaling R-HSA-1963640	1	0	0/11	1	
GRB2:SOS provides linkage to MAPK signaling for Integrins  R-HSA-354194	1	0	0/7	1	
GRB7 events in ERBB2 signaling R-HSA-1306955	1	0	0/2	1	
GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 R-HSA-9762114	1	0	0/51	1	
GTP hydrolysis and joining of the 60S ribosomal subunit R-HSA-72706	0.879287411555434	0.54471136619981	2/95	1	EIF2S2;RPL17
Gain-of-function MRAS complexes activate RAF signaling R-HSA-9726842	0.174406148124961	6.42991121082952	1/5	1	YWHAB
Galactose catabolism R-HSA-70370	1	0	0/1	1	
Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation R-HSA-163841	1	0	0/21	1	
Gamma-carboxylation of protein precursors R-HSA-159740	1	0	0/3	1	
Gamma-carboxylation, transport, and amino-terminal cleavage of proteins R-HSA-159854	1	0	0/4	1	
Gap junction assembly R-HSA-190861	0.553612977356495	1.28202882811191	1/21	1	TUBB4B
Gap junction degradation R-HSA-190873	0.291884735022825	3.21357144757802	1/9	1	CLTA
Gap junction trafficking R-HSA-190828	0.297977166269642	1.90826119245548	2/29	1	TUBB4B;CLTA
Gap junction trafficking and regulation R-HSA-157858	0.312046505326805	1.83973407440731	2/30	1	TUBB4B;CLTA
Gastrin-CREB signalling pathway via PKC and MAPK R-HSA-881907	0.458894009609797	1.71140093295747	1/16	1	MAPK1
Gastrulation R-HSA-9758941	1	0	0/87	1	
Gene expression (Transcription) R-HSA-74160	0.178377635041382	1.22519142900273	34/775	1	CCNA2;YWHAB;TFDP1;E2F1;SUPT4H1;POLR2K;POLR2L;H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3;RPA3;CDC7;YWHAQ;MAPK1;SEC13;LAMTOR1;STAT1;SUMO1;PCNA;MYC;RAN;E2F4;HCFC1;SNRPG;SNRPD3;SNRPB;PLD6;PRELID1;TFB2M;SLBP
Generation of second messenger molecules R-HSA-202433	0.602334189032362	1.11399051059428	1/24	1	CD3D
Generic Transcription Pathway R-HSA-212436	0.467460613519128	1.03885720647654	25/645	1	CCNA2;YWHAB;TFDP1;E2F1;SUPT4H1;POLR2K;POLR2L;H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3;RPA3;CDC7;YWHAQ;MAPK1;LAMTOR1;STAT1;SUMO1;PCNA;MYC;E2F4;PRELID1
Germ layer formation at gastrulation R-HSA-9754189	1	0	0/11	1	
Glucagon signaling in metabolic regulation R-HSA-163359	1	0	0/17	1	
Glucagon-like Peptide-1 (GLP1) regulates insulin secretion R-HSA-381676	1	0	0/17	1	
Glucagon-type ligand receptors R-HSA-420092	1	0	0/14	1	
Glucocorticoid biosynthesis R-HSA-194002	1	0	0/1	1	
Gluconeogenesis R-HSA-70263	1	0	0/11	1	
Glucose metabolism R-HSA-70326	0.749756698012414	0.729847371203816	1/36	1	SEC13
Glucuronidation R-HSA-156588	1	0	0/2	1	
Glutamate Neurotransmitter Release Cycle R-HSA-210500	1	0	0/10	1	
Glutamate and glutamine metabolism R-HSA-8964539	1	0	0/4	1	
Glutamate binding, activation of AMPA receptors and synaptic plasticity R-HSA-399721	1	0	0/14	1	
Glutathione conjugation R-HSA-156590	1	0	0/22	1	
Glutathione synthesis and recycling R-HSA-174403	1	0	0/9	1	
Glycerophospholipid biosynthesis R-HSA-1483206	0.447343229673137	1.35215173083541	2/40	1	PLD6;CDIPT
Glycerophospholipid catabolism R-HSA-6814848	1	0	0/0	1	
Glycine degradation R-HSA-6783984	1	0	0/4	1	
Glycogen breakdown (glycogenolysis) R-HSA-70221	1	0	0/7	1	
Glycogen metabolism R-HSA-8982491	1	0	0/12	1	
Glycogen storage disease type 0 (liver GYS2) R-HSA-3858516	1	0	0/0	1	
Glycogen storage disease type 0 (muscle GYS1) R-HSA-3828062	1	0	0/2	1	
Glycogen storage disease type II (GAA) R-HSA-5357609	1	0	0/1	1	
Glycogen storage disease type IV (GBE1) R-HSA-3878781	1	0	0/0	1	
Glycogen storage disease type Ia (G6PC) R-HSA-3274531	1	0	0/0	1	
Glycogen storage disease type Ib (SLC37A4) R-HSA-3229133	1	0	0/1	1	
Glycogen storage disease type XV (GYG1) R-HSA-3814836	1	0	0/2	1	
Glycogen storage diseases R-HSA-3229121	1	0	0/8	1	
Glycogen synthesis R-HSA-3322077	1	0	0/7	1	
Glycolysis R-HSA-70171	0.707932971764601	0.824858095256863	1/32	1	SEC13
Glycoprotein hormones R-HSA-209822	1	0	0/3	1	
Glycosaminoglycan metabolism R-HSA-1630316	0.793763144714459	0.63780152469564	1/41	1	B4GALT2
Glycosphingolipid biosynthesis R-HSA-9840309	1	0	0/5	1	
Glycosphingolipid catabolism R-HSA-9840310	1	0	0/14	1	
Glycosphingolipid metabolism R-HSA-1660662	1	0	0/19	1	
Glycosphingolipid transport R-HSA-9845576	1	0	0/2	1	
Glyoxylate metabolism and glycine degradation R-HSA-389661	1	0	0/8	1	
Growth hormone receptor signaling R-HSA-982772	0.227383328755819	2.34471258236625	2/24	1	MAPK1;STAT1
HCN channels R-HSA-1296061	1	0	0/0	1	
HDL assembly R-HSA-8963896	1	0	0/8	1	
HDL clearance R-HSA-8964011	1	0	0/2	1	
HDL remodeling R-HSA-8964058	1	0	0/7	1	
HDMs demethylate histones R-HSA-3214842	0.759246962958051	0.709393086950025	1/37	1	H3C1
HDR through MMEJ (alt-NHEJ) R-HSA-5685939	1	0	0/6	1	
HDR through Single Strand Annealing (SSA) R-HSA-5685938	0.437679640112941	1.83398057876147	1/15	1	RPA3
HHAT G278V doesn't palmitoylate Hh-Np R-HSA-5658034	1	0	0/2	1	
HIV Transcription Initiation R-HSA-167161	0.297977166269642	1.90826119245548	2/29	1	POLR2K;POLR2L
HS-GAG biosynthesis R-HSA-2022928	1	0	0/4	1	
HS-GAG degradation R-HSA-2024096	1	0	0/8	1	
HSF1 activation R-HSA-3371511	0.536089519856027	1.34983084155226	1/20	1	RPA3
HSF1-dependent transactivation R-HSA-3371571	0.659172666796287	0.948013016938371	1/28	1	HSPA8
HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand R-HSA-3371497	0.248538086298187	1.80186600778957	3/46	1	HSPA8;TUBB4B;DYNLL1
Hedgehog 'off' state R-HSA-5610787	0.970591527530416	0.279816591125833	1/91	1	TUBB4B
Hedgehog 'on' state R-HSA-5632684	1	0	0/69	1	
Hedgehog ligand biogenesis R-HSA-5358346	1	0	0/57	1	
Heme biosynthesis R-HSA-189451	1	0	0/5	1	
Heme degradation R-HSA-189483	1	0	0/9	1	
Heme signaling R-HSA-9707616	1	0	0/44	1	
Hemostasis R-HSA-109582	0.991924588838764	0.407319926718389	5/305	1	GNAI3;PPIA;TUBB4B;H3C1;MAPK1
Heparan sulfate/heparin (HS-GAG) metabolism R-HSA-1638091	1	0	0/14	1	
Hereditary fructose intolerance R-HSA-5657560	1	0	0/0	1	
Hh mutants abrogate ligand secretion R-HSA-5387390	1	0	0/56	1	
Hh mutants are degraded by ERAD R-HSA-5362768	1	0	0/54	1	
Highly calcium permeable nicotinic acetylcholine receptors R-HSA-629597	1	0	0/3	1	
Highly calcium permeable postsynaptic nicotinic acetylcholine receptors R-HSA-629594	1	0	0/3	1	
Highly sodium permeable postsynaptic acetylcholine nicotinic receptors R-HSA-629587	1	0	0/3	1	
Histamine receptors R-HSA-390650	1	0	0/0	1	
Histidine catabolism R-HSA-70921	1	0	0/4	1	
Homologous DNA Pairing and Strand Exchange R-HSA-5693579	0.145204600897006	3.22833101189847	2/18	1	RPA3;RAD51AP1
Hormone ligand-binding receptors R-HSA-375281	1	0	0/2	1	
Host Interactions of HIV factors R-HSA-162909	0.28527415942291	1.43671696747763	5/95	1	PPIA;SEC13;AP1M1;RAN;RANBP1
HuR (ELAVL1) binds and stabilizes mRNA R-HSA-450520	1	0	0/7	1	
Hyaluronan biosynthesis and export R-HSA-2142850	1	0	0/0	1	
Hyaluronan metabolism R-HSA-2142845	1	0	0/4	1	
Hyaluronan uptake and degradation R-HSA-2160916	1	0	0/4	1	
Hydrolysis of LPC R-HSA-1483115	1	0	0/4	1	
Hydrolysis of LPE R-HSA-1483152	1	0	0/0	1	
Hydroxycarboxylic acid-binding receptors R-HSA-3296197	1	0	0/0	1	
Hypusine synthesis from eIF5A-lysine R-HSA-204626	1	0	0/4	1	
IGF1R signaling cascade R-HSA-2428924	1	0	0/27	1	
IKBKB deficiency causes SCID R-HSA-5602636	1	0	0/3	1	
IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) R-HSA-5603027	1	0	0/3	1	
IKK complex recruitment mediated by RIP1 R-HSA-937041	1	0	0/20	1	
IL-6-type cytokine receptor ligand interactions R-HSA-6788467	1	0	0/12	1	
IRAK1 recruits IKK complex R-HSA-937039	1	0	0/11	1	
IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation R-HSA-975144	1	0	0/11	1	
IRAK2 mediated activation of TAK1 complex R-HSA-937042	1	0	0/9	1	
IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation R-HSA-975163	1	0	0/12	1	
IRAK4 deficiency (TLR2/4) R-HSA-5603041	1	0	0/13	1	
IRAK4 deficiency (TLR5) R-HSA-5603037	1	0	0/1	1	
IRE1alpha activates chaperones R-HSA-381070	0.602334189032362	1.11399051059428	1/24	1	SRPRB
IRF3 mediated activation of type 1 IFN R-HSA-1606341	1	0	0/3	1	
IRF3-mediated induction of type I IFN R-HSA-3270619	1	0	0/6	1	
IRS activation R-HSA-74713	1	0	0/4	1	
IRS-mediated signalling R-HSA-112399	1	0	0/25	1	
IRS-related events triggered by IGF1R R-HSA-2428928	1	0	0/27	1	
ISG15 antiviral mechanism R-HSA-1169408	0.179338426883516	2.15595829127317	3/39	1	KPNA2;SEC13;STAT1
IkBA variant leads to EDA-ID R-HSA-5603029	1	0	0/7	1	
Imatinib-resistant KIT mutants R-HSA-9669917	1	0	0/1	1	
Imatinib-resistant PDGFR mutants R-HSA-9674396	1	0	0/1	1	
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell R-HSA-198933	0.823358687344993	0.579224847840795	1/45	1	CD3D
Impaired BRCA2 binding to PALB2 R-HSA-9709603	0.415639234052386	1.97560356752423	1/14	1	RAD51AP1
Impaired BRCA2 binding to RAD51 R-HSA-9709570	0.392740848792258	2.14067558250457	1/13	1	RPA3
Impaired BRCA2 binding to SEM1 (DSS1) R-HSA-9763198	1	0	0/1	1	
Impaired BRCA2 translocation to the nucleus R-HSA-9709275	1	0	0/1	1	
Inactivation of APC/C via direct inhibition of the APC/C complex R-HSA-141430	1	0	0/18	1	
Inactivation of CDC42 and RAC1 R-HSA-428543	1	0	0/5	1	
Inactivation of CSF3 (G-CSF) signaling R-HSA-9705462	0.617370309248053	1.06727882366375	1/25	1	STAT1
Inactivation, recovery and regulation of the phototransduction cascade R-HSA-2514859	1	0	0/9	1	
Induction of Cell-Cell Fusion R-HSA-9733458	1	0	0/4	1	
Infection with Mycobacterium tuberculosis R-HSA-9635486	0.458894009609797	1.71140093295747	1/16	1	MAPK1
Inflammasomes R-HSA-622312	1	0	0/19	1	
Influenza Infection R-HSA-168255	0.158728273537987	1.62905605271341	7/119	1	POLR2K;POLR2L;KPNA2;SEC13;CLTA;RPL17;RAN
Influenza Viral RNA Transcription and Replication R-HSA-168273	0.569652124293991	1.00423866695086	4/106	1	POLR2K;POLR2L;SEC13;RPL17
Influenza Virus Induced Apoptosis R-HSA-168277	1	0	0/1	1	
Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits R-HSA-997272	1	0	0/11	1	
Inhibition of Host mRNA Processing and RNA Silencing R-HSA-168315	1	0	0/0	1	
Inhibition of PKR R-HSA-169131	1	0	0/1	1	
Inhibition of Signaling by Overexpressed EGFR R-HSA-5638303	1	0	0/8	1	
Inhibition of TSC complex formation by PKB R-HSA-165181	1	0	0/3	1	
Inhibition of membrane repair R-HSA-9635644	1	0	0/1	1	
Inhibition of nitric oxide production R-HSA-9636249	1	0	0/3	1	
Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components R-HSA-141405	1	0	0/18	1	
Initial triggering of complement R-HSA-166663	1	0	0/11	1	
Initiation of Nuclear Envelope (NE) Reformation R-HSA-2995383	1	0	0/8	1	
InlA-mediated entry of Listeria monocytogenes into host cells R-HSA-8876493	1	0	0/8	1	
InlB-mediated entry of Listeria monocytogenes into host cell R-HSA-8875360	1	0	0/10	1	
Innate Immune System R-HSA-168249	0.313669089730725	1.14799201507017	22/522	1	PPIA;HSPA8;TUBB4B;DYNLL1;POLR2K;POLR2L;MAPK1;CTSC;AP1M1;UBA3;VAMP8;DDOST;LAMTOR1;ATP6V1G1;ATP6V1A;ATP6V0B;COPB1;CCT8;CCT2;ARPC5;ARPC3;RAB5C
Inositol phosphate metabolism R-HSA-1483249	1	0	0/15	1	
Inositol transporters R-HSA-429593	1	0	0/0	1	
Insertion of tail-anchored proteins into the endoplasmic reticulum membrane R-HSA-9609523	0.392740848792258	2.14067558250457	1/13	1	SEC61G
Insulin effects increased synthesis of Xylulose-5-Phosphate R-HSA-163754	1	0	0/2	1	
Insulin processing R-HSA-264876	1	0	0/8	1	
Insulin receptor signalling cascade R-HSA-74751	0.67207250610081	0.91392634390264	1/29	1	MAPK1
Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA R-HSA-428359	1	0	0/0	1	
Integration of energy metabolism R-HSA-163685	1	0	0/48	1	
Integration of provirus R-HSA-162592	0.235383581618475	4.2860969528668	1/7	1	PPIA
Integration of viral DNA into host genomic DNA R-HSA-175567	1	0	0/3	1	
Integrin cell surface interactions R-HSA-216083	1	0	0/50	1	
Integrin signaling R-HSA-354192	1	0	0/14	1	
Interaction With Cumulus Cells And The Zona Pellucida R-HSA-2534343	1	0	0/3	1	
Interaction between L1 and Ankyrins R-HSA-445095	1	0	0/13	1	
Interaction between PHLDA1 and AURKA R-HSA-8854521	1	0	0/2	1	
Interactions of Tat with host cellular proteins R-HSA-176034	1	0	0/2	1	
Interactions of Vpr with host cellular proteins R-HSA-176033	0.415639234052386	1.97560356752423	1/14	1	SEC13
Interconversion of 2-oxoglutarate and 2-hydroxyglutarate R-HSA-880009	1	0	0/3	1	
Interconversion of polyamines R-HSA-351200	1	0	0/0	1	
Interferon alpha/beta signaling R-HSA-909733	0.383458603753469	1.37905292543158	3/59	1	STAT1;OAS1;OAS2
Interleukin receptor SHC signaling R-HSA-912526	1	0	0/16	1	
Interleukin-1 family signaling R-HSA-446652	1	0	0/116	1	
Interleukin-1 processing R-HSA-448706	1	0	0/8	1	
Interleukin-1 signaling R-HSA-9020702	1	0	0/97	1	
Interleukin-15 signaling R-HSA-8983432	1	0	0/9	1	
Interleukin-17 signaling R-HSA-448424	0.870479581049987	0.489103881449791	1/53	1	MAPK1
Interleukin-18 signaling R-HSA-9012546	1	0	0/4	1	
Interleukin-2 family signaling R-HSA-451927	0.684487195782672	0.882189880788344	1/30	1	STAT1
Interleukin-2 signaling R-HSA-9020558	1	0	0/8	1	
Interleukin-20 family signaling R-HSA-8854691	0.617370309248053	1.06727882366375	1/25	1	STAT1
Interleukin-21 signaling R-HSA-9020958	0.318559709069054	2.85600744758908	1/10	1	STAT1
Interleukin-23 signaling R-HSA-9020933	1	0	0/7	1	
Interleukin-27 signaling R-HSA-9020956	0.344236190036209	2.57008458248319	1/11	1	STAT1
Interleukin-3, Interleukin-5 and GM-CSF signaling R-HSA-512988	1	0	0/35	1	
Interleukin-33 signaling R-HSA-9014843	1	0	0/1	1	
Interleukin-35 Signalling R-HSA-8984722	0.368951315033604	2.33577413093742	1/12	1	STAT1
Interleukin-36 pathway R-HSA-9014826	1	0	0/1	1	
Interleukin-37 signaling R-HSA-9008059	1	0	0/11	1	
Interleukin-38 signaling R-HSA-9007892	1	0	0/2	1	
Interleukin-4 and Interleukin-13 signaling R-HSA-6785807	0.514905628490144	1.08017998516607	4/99	1	HSPA8;STAT1;MYC;ANXA1
Interleukin-6 family signaling R-HSA-6783589	0.517882860165378	1.4251445251651	1/19	1	STAT1
Interleukin-6 signaling R-HSA-1059683	0.344236190036209	2.57008458248319	1/11	1	STAT1
Interleukin-7 signaling R-HSA-1266695	0.718998322784487	0.798879056196462	1/33	1	H3C1
Interleukin-9 signaling R-HSA-8985947	0.291884735022825	3.21357144757802	1/9	1	STAT1
Intestinal absorption R-HSA-8963676	1	0	0/2	1	
Intestinal hexose absorption R-HSA-8981373	1	0	0/2	1	
Intestinal infectious diseases R-HSA-8942233	1	0	0/0	1	
Intestinal lipid absorption R-HSA-8963678	1	0	0/0	1	
Intestinal saccharidase deficiencies R-HSA-5659898	1	0	0/1	1	
Intra-Golgi and retrograde Golgi-to-ER traffic R-HSA-6811442	0.201167312079028	1.5742793266473	6/105	1	TUBB4B;DYNLL1;SEC22B;COPB1;RAB1A;TMED2
Intra-Golgi traffic R-HSA-6811438	1	0	0/25	1	
Intracellular metabolism of fatty acids regulates insulin secretion R-HSA-434313	1	0	0/1	1	
Intracellular oxygen transport R-HSA-8981607	1	0	0/0	1	
Intracellular signaling by second messengers R-HSA-9006925	0.991776008116688	0.337743836789074	3/222	1	KPNA2;MAPK1;LAMTOR1
Intraflagellar transport R-HSA-5620924	0.312046505326805	1.83973407440731	2/30	1	TUBB4B;DYNLL1
Intrinsic Pathway of Fibrin Clot Formation R-HSA-140837	1	0	0/12	1	
Invadopodia formation R-HSA-8941237	1	0	0/3	1	
Inwardly rectifying K+ channels R-HSA-1296065	1	0	0/13	1	
Ion channel transport R-HSA-983712	0.503235744039754	1.13221664352061	3/71	1	ATP6V1G1;ATP6V1A;ATP6V0B
Ion homeostasis R-HSA-5578775	1	0	0/27	1	
Ion influx/efflux at host-pathogen interface R-HSA-6803544	1	0	0/2	1	
Ion transport by P-type ATPases R-HSA-936837	1	0	0/19	1	
Ionotropic activity of kainate receptors R-HSA-451306	1	0	0/4	1	
JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1 R-HSA-450321	1	0	0/21	1	
Josephin domain DUBs R-HSA-5689877	1	0	0/6	1	
KEAP1-NFE2L2 pathway R-HSA-9755511	0.987617252065614	0.223555130861896	1/113	1	MYC
KIT mutants bind TKIs R-HSA-9669921	1	0	0/1	1	
KSRP (KHSRP) binds and destabilizes mRNA R-HSA-450604	1	0	0/16	1	
KW2449-resistant FLT3 mutants R-HSA-9702569	1	0	0/0	1	
Keratan sulfate biosynthesis R-HSA-2022854	0.291884735022825	3.21357144757802	1/9	1	B4GALT2
Keratan sulfate degradation R-HSA-2022857	1	0	0/7	1	
Keratan sulfate/keratin metabolism R-HSA-1638074	0.368951315033604	2.33577413093742	1/12	1	B4GALT2
Keratinization R-HSA-6805567	1	0	0/11	1	
Kidney development R-HSA-9830369	1	0	0/21	1	
Killing mechanisms R-HSA-9664420	1	0	0/6	1	
Kinesins R-HSA-983189	0.659172666796287	0.948013016938371	1/28	1	TUBB4B
L13a-mediated translational silencing of Ceruloplasmin expression R-HSA-156827	0.882941948511839	0.53877523741921	2/96	1	EIF2S2;RPL17
L1CAM interactions R-HSA-373760	0.268384430913466	1.5665158690711	4/70	1	HSPA8;TUBB4B;MAPK1;CLTA
LDL clearance R-HSA-8964038	0.264172706115377	3.67308504447128	1/8	1	CLTA
LDL remodeling R-HSA-8964041	1	0	0/3	1	
LGI-ADAM interactions R-HSA-5682910	1	0	0/1	1	
LGK974 inhibits PORCN R-HSA-5340573	1	0	0/0	1	
LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production R-HSA-3134973	1	0	0/5	1	
LTC4-CYSLTR mediated IL4 production R-HSA-9664535	1	0	0/2	1	
Lactose synthesis R-HSA-5653890	1	0	0/0	1	
Laminin interactions R-HSA-3000157	1	0	0/17	1	
Late SARS-CoV-2 Infection Events R-HSA-9772573	0.353841739128265	1.66037147168254	2/33	1	DDOST;SUMO1
Late endosomal microautophagy R-HSA-9615710	0.458894009609797	1.71140093295747	1/16	1	HSPA8
Latent infection - Other responses of Mtb to phagocytosis R-HSA-1222499	1	0	0/0	1	
Lectin pathway of complement activation R-HSA-166662	1	0	0/4	1	
Leishmania infection R-HSA-9658195	0.514905628490144	1.08017998516607	4/99	1	GNAI3;MAPK1;ARPC5;ARPC3
Leishmania parasite growth and survival R-HSA-9664433	0.801594271869943	0.622085984281075	1/42	1	GNAI3
Leishmania phagocytosis R-HSA-9664417	0.151560771747948	2.3537364605182	3/36	1	MAPK1;ARPC5;ARPC3
Leukotriene receptors R-HSA-391906	1	0	0/1	1	
Lewis blood group biosynthesis R-HSA-9037629	1	0	0/3	1	
Ligand-receptor interactions R-HSA-5632681	1	0	0/5	1	
Linoleic acid (LA) metabolism R-HSA-2046105	1	0	0/3	1	
Lipid particle organization R-HSA-8964572	1	0	0/2	1	
Lipophagy R-HSA-9613354	0.142129845273879	8.57316652446317	1/4	1	HSPA8
Listeria monocytogenes entry into host cells R-HSA-8876384	1	0	0/14	1	
Localization of the PINCH-ILK-PARVIN complex to focal adhesions R-HSA-446343	1	0	0/4	1	
Long-term potentiation R-HSA-9620244	1	0	0/13	1	
Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling R-HSA-2644607	1	0	0/5	1	
Loss of Function of SMAD2/3 in Cancer R-HSA-3304349	1	0	0/7	1	
Loss of Function of SMAD4 in Cancer R-HSA-3304347	1	0	0/3	1	
Loss of Function of TGFBR1 in Cancer R-HSA-3656534	1	0	0/7	1	
Loss of Function of TGFBR2 in Cancer R-HSA-3642278	1	0	0/3	1	
Loss of Function of TP53 in Cancer R-HSA-9723907	1	0	0/1	1	
Loss of MECP2 binding ability to 5hmC-DNA R-HSA-9022534	1	0	0/1	1	
Loss of MECP2 binding ability to 5mC-DNA R-HSA-9022538	1	0	0/3	1	
Loss of MECP2 binding ability to the NCoR/SMRT complex R-HSA-9022537	1	0	0/6	1	
Loss of Nlp from mitotic centrosomes R-HSA-380259	0.394731717852687	1.51272901639371	2/36	1	TUBB4B;DYNLL1
Loss of function of MECP2 in Rett syndrome R-HSA-9005891	1	0	0/10	1	
Loss of function of TP53 in cancer due to loss of tetramerization ability R-HSA-9723905	1	0	0/1	1	
Loss of phosphorylation of MECP2 at T308 R-HSA-9022535	1	0	0/3	1	
Loss of proteins required for interphase microtubule organization from the centrosome R-HSA-380284	0.394731717852687	1.51272901639371	2/36	1	TUBB4B;DYNLL1
Lysine catabolism R-HSA-71064	1	0	0/6	1	
Lysosomal oligosaccharide catabolism R-HSA-8853383	1	0	0/2	1	
Lysosphingolipid and LPA receptors R-HSA-419408	1	0	0/2	1	
M-decay: degradation of maternal mRNAs by maternally stored factors R-HSA-9820841	1	0	0/18	1	
MAP kinase activation R-HSA-450294	0.870479581049987	0.489103881449791	1/53	1	MAPK1
MAP2K and MAPK activation R-HSA-5674135	0.199432670053967	2.58052448405812	2/22	1	YWHAB;MAPK1
MAP3K8 (TPL2)-dependent MAPK1/3 activation R-HSA-5684264	1	0	0/13	1	
MAPK family signaling cascades R-HSA-5683057	0.970575969275716	0.420167233554677	3/181	1	YWHAB;MAPK1;MYC
MAPK targets/ Nuclear events mediated by MAP kinases R-HSA-450282	0.617370309248053	1.06727882366375	1/25	1	MAPK1
MAPK1 (ERK2) activation R-HSA-112411	0.264172706115377	3.67308504447128	1/8	1	MAPK1
MAPK1/MAPK3 signaling R-HSA-5684996	0.983466930591665	0.323693379732986	2/156	1	YWHAB;MAPK1
MAPK3 (ERK1) activation R-HSA-110056	1	0	0/9	1	
MAPK6/MAPK4 signaling R-HSA-5687128	0.942813390288604	0.346515497629378	1/74	1	MYC
MASTL Facilitates Mitotic Progression R-HSA-2465910	1	0	0/10	1	
MDK and PTN in ALK signaling R-HSA-9851151	1	0	0/1	1	
MECP2 regulates neuronal receptors and channels R-HSA-9022699	1	0	0/9	1	
MECP2 regulates transcription factors R-HSA-9022707	1	0	0/4	1	
MECP2 regulates transcription of genes involved in GABA signaling R-HSA-9022927	1	0	0/1	1	
MECP2 regulates transcription of neuronal ligands R-HSA-9022702	1	0	0/5	1	
MET Receptor Activation R-HSA-6806942	1	0	0/1	1	
MET activates PI3K/AKT signaling R-HSA-8851907	1	0	0/5	1	
MET activates PTK2 signaling R-HSA-8874081	1	0	0/19	1	
MET activates PTPN11 R-HSA-8865999	1	0	0/4	1	
MET activates RAP1 and RAC1 R-HSA-8875555	1	0	0/7	1	
MET activates RAS signaling R-HSA-8851805	1	0	0/8	1	
MET activates STAT3 R-HSA-8875791	1	0	0/2	1	
MET interacts with TNS proteins R-HSA-8875513	1	0	0/2	1	
MET promotes cell motility R-HSA-8875878	1	0	0/25	1	
MET receptor recycling R-HSA-8875656	1	0	0/7	1	
MGMT-mediated DNA damage reversal R-HSA-5657655	1	0	0/0	1	
MITF-M-dependent gene expression R-HSA-9856651	0.258769017639945	1.76050723598692	3/47	1	ATP6V1G1;ATP6V1A;ATP6V0B
MITF-M-regulated melanocyte development R-HSA-9730414	0.218922592795521	1.72582294844212	4/64	1	MAPK1;ATP6V1G1;ATP6V1A;ATP6V0B
MPS I - Hurler syndrome R-HSA-2206302	1	0	0/1	1	
MPS II - Hunter syndrome R-HSA-2206296	1	0	0/0	1	
MPS IIIA - Sanfilippo syndrome A R-HSA-2206307	1	0	0/1	1	
MPS IIIB - Sanfilippo syndrome B R-HSA-2206282	1	0	0/1	1	
MPS IIIC - Sanfilippo syndrome C R-HSA-2206291	1	0	0/1	1	
MPS IIID - Sanfilippo syndrome D R-HSA-2206305	1	0	0/1	1	
MPS IV - Morquio syndrome A R-HSA-2206290	1	0	0/0	1	
MPS IV - Morquio syndrome B R-HSA-2206308	1	0	0/0	1	
MPS IX - Natowicz syndrome R-HSA-2206280	1	0	0/0	1	
MPS VI - Maroteaux-Lamy syndrome R-HSA-2206285	1	0	0/0	1	
MPS VII - Sly syndrome R-HSA-2206292	1	0	0/0	1	
MTF1 activates gene expression R-HSA-5660489	1	0	0/0	1	
MTOR signalling R-HSA-165159	0.367588596304054	1.60808174699969	2/34	1	YWHAB;LAMTOR1
Major pathway of rRNA processing in the nucleolus and cytosol R-HSA-6791226	0.655027793859726	0.895706543615511	4/118	1	RPL17;SNU13;RRP9;UTP3
Malate-aspartate shuttle R-HSA-9856872	1	0	0/3	1	
Manipulation of host energy metabolism R-HSA-9636667	1	0	0/2	1	
Masitinib-resistant KIT mutants R-HSA-9669924	1	0	0/1	1	
Maturation of TCA enzymes and regulation of TCA cycle R-HSA-9854311	1	0	0/5	1	
Maturation of hRSV A proteins R-HSA-9828806	0.368951315033604	2.33577413093742	1/12	1	SEC11A
Maturation of nucleoprotein R-HSA-9683610	0.264172706115377	3.67308504447128	1/8	1	SUMO1
Maturation of nucleoprotein R-HSA-9694631	0.318559709069054	2.85600744758908	1/10	1	SUMO1
Maturation of protein 3a R-HSA-9683673	1	0	0/4	1	
Maturation of protein 3a R-HSA-9694719	1	0	0/4	1	
Maturation of protein E R-HSA-9683683	1	0	0/4	1	
Maturation of protein E R-HSA-9694493	1	0	0/4	1	
Maturation of replicase proteins R-HSA-9694301	1	0	0/0	1	
Maturation of spike protein R-HSA-9683686	1	0	0/2	1	
Maturation of spike protein R-HSA-9694548	0.415639234052386	1.97560356752423	1/14	1	DDOST
Melanin biosynthesis R-HSA-5662702	1	0	0/1	1	
Membrane binding and targetting of GAG proteins R-HSA-174490	1	0	0/7	1	
Metabolic disorders of biological oxidation enzymes R-HSA-5579029	1	0	0/10	1	
Metabolism R-HSA-1430728	0.99999518206072	0.34424636553455	14/900	1	SEC13;SEC23A;B4GALT2;RPL17;GUK1;NME1;BPNT2;RAN;PPCS;PLD6;CDIPT;CMPK1;ACSS3;PI4K2A
Metabolism of Angiotensinogen to Angiotensins R-HSA-2022377	1	0	0/7	1	
Metabolism of amine-derived hormones R-HSA-209776	1	0	0/5	1	
Metabolism of amino acids and derivatives R-HSA-71291	0.999798136368008	0.113287435393423	1/216	1	RPL17
Metabolism of carbohydrates R-HSA-71387	0.91693568315785	0.480952694483616	2/107	1	SEC13;B4GALT2
Metabolism of cofactors R-HSA-8978934	1	0	0/6	1	
Metabolism of fat-soluble vitamins R-HSA-6806667	1	0	0/13	1	
Metabolism of folate and pterines R-HSA-196757	1	0	0/9	1	
Metabolism of ingested H2SeO4 and H2SeO3 into H2Se R-HSA-2408550	1	0	0/3	1	
Metabolism of ingested MeSeO2H into MeSeH R-HSA-5263617	1	0	0/1	1	
Metabolism of ingested SeMet, Sec, MeSec into H2Se R-HSA-2408508	1	0	0/4	1	
Metabolism of lipids R-HSA-556833	0.975935900682897	0.499325196997459	6/302	1	SEC23A;RAN;PLD6;CDIPT;ACSS3;PI4K2A
Metabolism of nitric oxide: NOS3 activation and regulation R-HSA-202131	1	0	0/7	1	
Metabolism of nucleotides R-HSA-15869	0.188892069009225	2.09712656422137	3/40	1	GUK1;NME1;CMPK1
Metabolism of polyamines R-HSA-351202	1	0	0/51	1	
Metabolism of porphyrins R-HSA-189445	1	0	0/13	1	
Metabolism of serotonin R-HSA-380612	1	0	0/1	1	
Metabolism of steroid hormones R-HSA-196071	1	0	0/7	1	
Metabolism of steroids R-HSA-8957322	0.588275924800733	1.02453310806237	2/52	1	SEC23A;RAN
Metabolism of vitamin K R-HSA-6806664	1	0	0/0	1	
Metabolism of vitamins and cofactors R-HSA-196854	0.912197296936827	0.409162312971513	1/63	1	PPCS
Metabolism of water-soluble vitamins and cofactors R-HSA-196849	0.816381171876292	0.592847469675796	1/44	1	PPCS
Metal ion SLC transporters R-HSA-425410	1	0	0/3	1	
Metal sequestration by antimicrobial proteins R-HSA-6799990	1	0	0/3	1	
Metallothioneins bind metals R-HSA-5661231	1	0	0/0	1	
Methionine salvage pathway R-HSA-1237112	1	0	0/4	1	
Methylation R-HSA-156581	1	0	0/7	1	
Methylation of MeSeH for excretion R-HSA-2408552	1	0	0/1	1	
Microbial modulation of RIPK1-mediated regulated necrosis R-HSA-9686347	1	0	0/4	1	
Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane R-HSA-190840	0.536089519856027	1.34983084155226	1/20	1	TUBB4B
Mineralocorticoid biosynthesis R-HSA-193993	1	0	0/0	1	
Miro GTPase Cycle R-HSA-9715370	1	0	0/1	1	
Miscellaneous substrates R-HSA-211958	1	0	0/5	1	
Miscellaneous transport and binding events R-HSA-5223345	1	0	0/8	1	
Mitochondrial ABC transporters R-HSA-1369007	1	0	0/3	1	
Mitochondrial Fatty Acid Beta-Oxidation R-HSA-77289	1	0	0/21	1	
Mitochondrial RNA degradation R-HSA-9836573	1	0	0/0	1	
Mitochondrial Uncoupling R-HSA-166187	1	0	0/0	1	
Mitochondrial biogenesis R-HSA-1592230	0.444579251415049	1.2436999094141	3/65	1	HSPA9;HCFC1;TFB2M
Mitochondrial calcium ion transport R-HSA-8949215	1	0	0/13	1	
Mitochondrial iron-sulfur cluster biogenesis R-HSA-1362409	1	0	0/1	1	
Mitochondrial protein degradation R-HSA-9837999	0.566715886990788	1.06772679643527	2/50	1	HSPA9;PRELID1
Mitochondrial protein import R-HSA-1268020	0.631841499343673	1.02437078713227	1/26	1	HSPA9
Mitochondrial tRNA aminoacylation R-HSA-379726	1	0	0/6	1	
Mitochondrial transcription termination R-HSA-163316	1	0	0/0	1	
Mitophagy R-HSA-5205647	0.458894009609797	1.71140093295747	1/16	1	ULK1
Mitotic Anaphase R-HSA-68882	0.472003276728835	1.10132854155188	6/146	1	TUBB4B;DYNLL1;SEC13;ZWINT;SUMO1;RAN
Mitotic G2-G2/M phases R-HSA-453274	0.755389618902291	0.775979539734139	4/135	1	CCNA2;TUBB4B;DYNLL1;E2F1
Mitotic Metaphase and Anaphase R-HSA-2555396	0.472003276728835	1.10132854155188	6/146	1	TUBB4B;DYNLL1;SEC13;ZWINT;SUMO1;RAN
Mitotic Metaphase/Anaphase Transition R-HSA-68881	1	0	0/1	1	
Mitotic Prometaphase R-HSA-68877	0.498693491381302	1.10400322469611	4/97	1	TUBB4B;DYNLL1;SEC13;ZWINT
Mitotic Spindle Checkpoint R-HSA-69618	0.289762862480904	1.64688463938375	3/50	1	DYNLL1;SEC13;ZWINT
Mitotic Telophase/Cytokinesis R-HSA-68884	1	0	0/11	1	
Modulation by Mtb of host immune system R-HSA-9637628	1	0	0/6	1	
Molecules associated with elastic fibres R-HSA-2129379	1	0	0/17	1	
Molybdenum cofactor biosynthesis R-HSA-947581	1	0	0/2	1	
Mtb iron assimilation by chelation R-HSA-1222449	1	0	0/0	1	
Mucopolysaccharidoses R-HSA-2206281	1	0	0/5	1	
Multifunctional anion exchangers R-HSA-427601	1	0	0/2	1	
Muscarinic acetylcholine receptors R-HSA-390648	1	0	0/0	1	
Muscle contraction R-HSA-397014	0.976760175995923	0.261915394003898	1/97	1	ANXA1
MyD88 cascade initiated on plasma membrane R-HSA-975871	0.945002902801483	0.341743791176929	1/75	1	MAPK1
MyD88 deficiency (TLR2/4) R-HSA-5602498	1	0	0/13	1	
MyD88 deficiency (TLR5) R-HSA-5602680	1	0	0/1	1	
MyD88 dependent cascade initiated on endosome R-HSA-975155	0.956496849308816	0.315618492633763	1/81	1	MAPK1
MyD88-independent TLR4 cascade  R-HSA-166166	0.969415807431685	0.283034766427375	1/90	1	MAPK1
MyD88:MAL(TIRAP) cascade initiated on plasma membrane R-HSA-166058	0.968193404783674	0.286326076584362	1/89	1	MAPK1
Myoclonic epilepsy of Lafora R-HSA-3785653	1	0	0/6	1	
Myogenesis R-HSA-525793	1	0	0/18	1	
N-glycan antennae elongation in the medial/trans-Golgi R-HSA-975576	0.174406148124961	6.42991121082952	1/5	1	B4GALT2
N-glycan trimming and elongation in the cis-Golgi R-HSA-964739	1	0	0/0	1	
N-glycan trimming in the ER and Calnexin/Calreticulin cycle R-HSA-532668	1	0	0/19	1	
NADE modulates death signalling R-HSA-205025	1	0	0/4	1	
NADPH regeneration R-HSA-389542	1	0	0/0	1	
NCAM signaling for neurite out-growth R-HSA-375165	0.718998322784487	0.798879056196462	1/33	1	MAPK1
NCAM1 interactions R-HSA-419037	1	0	0/20	1	
NEIL3-mediated resolution of ICLs R-HSA-9636003	1	0	0/0	1	
NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 R-HSA-933543	1	0	0/11	1	
NF-kB is activated and signals survival R-HSA-209560	1	0	0/12	1	
NFE2L2 regulates pentose phosphate pathway genes R-HSA-9818028	1	0	0/8	1	
NFE2L2 regulating ER-stress associated genes R-HSA-9818035	1	0	0/5	1	
NFE2L2 regulating MDR associated enzymes R-HSA-9818032	1	0	0/7	1	
NFE2L2 regulating TCA cycle genes R-HSA-9818025	1	0	0/1	1	
NFE2L2 regulating anti-oxidant/detoxification enzymes R-HSA-9818027	1	0	0/19	1	
NFE2L2 regulating inflammation associated genes R-HSA-9818026	1	0	0/5	1	
NFE2L2 regulating tumorigenic genes R-HSA-9818030	1	0	0/11	1	
NFG and proNGF binds to p75NTR R-HSA-205017	1	0	0/1	1	
NGF processing R-HSA-167060	1	0	0/2	1	
NGF-independant TRKA activation R-HSA-187024	1	0	0/3	1	
NGF-stimulated transcription R-HSA-9031628	1	0	0/36	1	
NIK-->noncanonical NF-kB signaling R-HSA-5676590	0.889118801551791	0.453705432056081	1/57	1	UBA3
NOD1/2 Signaling Pathway R-HSA-168638	1	0	0/31	1	
NOSIP mediated eNOS trafficking R-HSA-203754	1	0	0/0	1	
NOSTRIN mediated eNOS trafficking R-HSA-203641	1	0	0/2	1	
NOTCH1 Intracellular Domain Regulates Transcription R-HSA-2122947	0.842749602637046	0.541834671405377	1/48	1	MYC
NOTCH2 Activation and Transmission of Signal to the Nucleus R-HSA-2979096	1	0	0/13	1	
NOTCH2 intracellular domain regulates transcription R-HSA-2197563	1	0	0/12	1	
NOTCH3 Activation and Transmission of Signal to the Nucleus R-HSA-9013507	1	0	0/16	1	
NOTCH3 Intracellular Domain Regulates Transcription R-HSA-9013508	0.602334189032362	1.11399051059428	1/24	1	STAT1
NOTCH4 Activation and Transmission of Signal to the Nucleus R-HSA-9013700	1	0	0/8	1	
NOTCH4 Intracellular Domain Regulates Transcription R-HSA-9013695	1	0	0/20	1	
NPAS4 regulates expression of target genes R-HSA-9768919	0.392740848792258	2.14067558250457	1/13	1	MAPK1
NR1D1 (REV-ERBA) represses gene expression R-HSA-1368071	1	0	0/3	1	
NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis  R-HSA-9632974	1	0	0/4	1	
NR1H2 & NR1H3 regulate gene expression linked to lipogenesis R-HSA-9029558	1	0	0/5	1	
NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose R-HSA-9031528	1	0	0/3	1	
NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis R-HSA-9623433	1	0	0/6	1	
NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake  R-HSA-9031525	1	0	0/4	1	
NR1H2 and NR1H3-mediated signaling R-HSA-9024446	1	0	0/23	1	
NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux R-HSA-9029569	1	0	0/20	1	
NRAGE signals death through JNK R-HSA-193648	1	0	0/28	1	
NRIF signals cell death from the nucleus R-HSA-205043	1	0	0/12	1	
NTF3 activates NTRK2 (TRKB) signaling R-HSA-9025046	1	0	0/1	1	
NTF3 activates NTRK3 signaling R-HSA-9034013	1	0	0/0	1	
NTF4 activates NTRK2 (TRKB) signaling R-HSA-9026357	1	0	0/1	1	
NTRK2 activates RAC1 R-HSA-9032759	1	0	0/3	1	
NTRK3 as a dependence receptor R-HSA-9603505	1	0	0/1	1	
NVP-TAE684-resistant ALK mutants R-HSA-9717301	1	0	0/0	1	
Na+/Cl- dependent neurotransmitter transporters R-HSA-442660	1	0	0/4	1	
Nectin/Necl  trans heterodimerization R-HSA-420597	1	0	0/2	1	
Neddylation R-HSA-8951664	0.744858505608643	0.788427704835451	4/133	1	UBA3;UBE2F;NEDD8;DTL
Nef Mediated CD4 Down-regulation R-HSA-167590	1	0	0/6	1	
Nef Mediated CD8 Down-regulation R-HSA-182218	1	0	0/4	1	
Nef and signal transduction R-HSA-164944	1	0	0/7	1	
Nef mediated downregulation of CD28 cell surface expression R-HSA-164939	1	0	0/1	1	
Nef mediated downregulation of MHC class I complex cell surface expression R-HSA-164940	0.174406148124961	6.42991121082952	1/5	1	AP1M1
Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters R-HSA-164938	0.368951315033604	2.33577413093742	1/12	1	AP1M1
Negative feedback regulation of MAPK pathway R-HSA-5674499	0.142129845273879	8.57316652446317	1/4	1	MAPK1
Negative regulation of FGFR1 signaling R-HSA-5654726	0.479313103586786	1.60405328615125	1/17	1	MAPK1
Negative regulation of FGFR2 signaling R-HSA-5654727	0.517882860165378	1.4251445251651	1/19	1	MAPK1
Negative regulation of FGFR3 signaling R-HSA-5654732	0.479313103586786	1.60405328615125	1/17	1	MAPK1
Negative regulation of FGFR4 signaling R-HSA-5654733	0.479313103586786	1.60405328615125	1/17	1	MAPK1
Negative regulation of FLT3 R-HSA-9706369	1	0	0/8	1	
Negative regulation of MAPK pathway R-HSA-5675221	0.185620369846663	2.71680916381686	2/21	1	YWHAB;MAPK1
Negative regulation of MET activity R-HSA-6807004	1	0	0/13	1	
Negative regulation of NMDA receptor-mediated neuronal transmission R-HSA-9617324	1	0	0/12	1	
Negative regulation of NOTCH4 signaling R-HSA-9604323	1	0	0/52	1	
Negative regulation of TCF-dependent signaling by DVL-interacting proteins R-HSA-5368598	1	0	0/2	1	
Negative regulation of TCF-dependent signaling by WNT ligand antagonists R-HSA-3772470	1	0	0/6	1	
Negative regulation of activity of TFAP2 (AP-2) family transcription factors R-HSA-8866904	0.205475785531498	5.14414324267236	1/6	1	SUMO1
Negative regulation of the PI3K/AKT network R-HSA-199418	0.915549723680259	0.402563247203239	1/64	1	MAPK1
Negative regulators of DDX58/IFIH1 signaling R-HSA-936440	1	0	0/27	1	
Nephrin family interactions R-HSA-373753	1	0	0/15	1	
Nephron development R-HSA-9831926	1	0	0/7	1	
Nervous system development R-HSA-9675108	0.984676270521209	0.490156301968378	7/356	1	HSPA8;TUBB4B;MAPK1;CLTA;ARPC5;ARPC3;RPL17
Netrin mediated repulsion signals R-HSA-418886	1	0	0/5	1	
Netrin-1 signaling R-HSA-373752	1	0	0/18	1	
Neurexins and neuroligins R-HSA-6794361	1	0	0/16	1	
Neurodegenerative Diseases R-HSA-8863678	1	0	0/13	1	
Neurofascin interactions R-HSA-447043	1	0	0/4	1	
Neuronal System R-HSA-112316	0.611893507265924	0.946597911347547	5/140	1	GNAI3;HSPA8;TUBB4B;KPNA2;MAPK1
Neurophilin interactions with VEGF and VEGFR R-HSA-194306	1	0	0/2	1	
Neurotoxicity of clostridium toxins R-HSA-168799	1	0	0/3	1	
Neurotransmitter clearance R-HSA-112311	1	0	0/2	1	
Neurotransmitter receptors and postsynaptic signal transmission R-HSA-112314	0.465623298568536	1.15482910940333	4/93	1	GNAI3;TUBB4B;KPNA2;MAPK1
Neurotransmitter release cycle R-HSA-112310	0.437679640112941	1.83398057876147	1/15	1	HSPA8
Neurotransmitter uptake and metabolism In glial cells R-HSA-112313	1	0	0/2	1	
Nicotinamide salvaging R-HSA-197264	1	0	0/7	1	
Nicotinate metabolism R-HSA-196807	1	0	0/12	1	
Nilotinib-resistant KIT mutants R-HSA-9669926	1	0	0/1	1	
Nitric oxide stimulates guanylate cyclase R-HSA-392154	1	0	0/7	1	
Non-integrin membrane-ECM interactions R-HSA-3000171	1	0	0/33	1	
Noncanonical activation of NOTCH3 R-HSA-9017802	1	0	0/6	1	
Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) R-HSA-975957	0.97172233648953	0.276669139813744	1/92	1	RPL17
Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) R-HSA-975956	0.961314142941543	0.303972162919671	1/84	1	RPL17
Nonsense-Mediated Decay (NMD) R-HSA-927802	0.97172233648953	0.276669139813744	1/92	1	RPL17
Norepinephrine Neurotransmitter Release Cycle R-HSA-181430	1	0	0/6	1	
Notch-HLH transcription pathway R-HSA-350054	1	0	0/28	1	
NrCAM interactions R-HSA-447038	1	0	0/3	1	
Nuclear Envelope Breakdown R-HSA-2980766	0.517882860165378	1.4251445251651	1/19	1	SEC13
Nuclear Events (kinase and transcription factor activation) R-HSA-198725	0.865352731133215	0.49882298199217	1/52	1	MAPK1
Nuclear Pore Complex (NPC) Disassembly R-HSA-3301854	0.368951315033604	2.33577413093742	1/12	1	SEC13
Nuclear Receptor transcription pathway R-HSA-383280	1	0	0/33	1	
Nuclear events mediated by NFE2L2 R-HSA-9759194	0.970591527530416	0.279816591125833	1/91	1	MYC
Nuclear events stimulated by ALK signaling in cancer R-HSA-9725371	0.645768849293838	0.984720976687612	1/27	1	MAPK1
Nuclear signaling by ERBB4 R-HSA-1251985	1	0	0/22	1	
Nucleotide biosynthesis R-HSA-8956320	1	0	0/5	1	
Nucleotide catabolism R-HSA-8956319	1	0	0/17	1	
Nucleotide catabolism defects R-HSA-9735786	1	0	0/1	1	
Nucleotide salvage R-HSA-8956321	1	0	0/9	1	
Nucleotide salvage defects R-HSA-9734207	1	0	0/1	1	
Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways R-HSA-168643	1	0	0/49	1	
Nucleotide-like (purinergic) receptors R-HSA-418038	0.174406148124961	6.42991121082952	1/5	1	ADORA3
O-glycosylation of TSR domain-containing proteins R-HSA-5173214	1	0	0/15	1	
O-linked glycosylation R-HSA-5173105	1	0	0/38	1	
O-linked glycosylation of mucins R-HSA-913709	1	0	0/22	1	
O2/CO2 exchange in erythrocytes R-HSA-1480926	1	0	0/7	1	
OGDH complex synthesizes succinyl-CoA from 2-OG R-HSA-9853506	1	0	0/2	1	
Oleoyl-phe metabolism R-HSA-9673163	1	0	0/0	1	
Olfactory Signaling Pathway R-HSA-381753	1	0	0/3	1	
Oligomerization of connexins into connexons R-HSA-190704	1	0	0/2	1	
Oncogenic MAPK signaling R-HSA-6802957	0.472686931339616	1.28390911264883	2/42	1	YWHAB;MAPK1
Opioid Signalling R-HSA-111885	0.289762862480904	1.64688463938375	3/50	1	GNAI3;KPNA2;MAPK1
Opsins R-HSA-419771	1	0	0/1	1	
Orexin and neuropeptides FF and QRFP bind to their respective receptors R-HSA-389397	1	0	0/3	1	
Organic anion transport R-HSA-561048	1	0	0/0	1	
Organic anion transporters R-HSA-428643	1	0	0/4	1	
Organic cation transport R-HSA-549127	1	0	0/4	1	
Organic cation/anion/zwitterion transport R-HSA-549132	1	0	0/4	1	
Other interleukin signaling R-HSA-449836	1	0	0/11	1	
Other semaphorin interactions R-HSA-416700	1	0	0/13	1	
Ovarian tumor domain proteases R-HSA-5689896	1	0	0/26	1	
Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha R-HSA-1234176	1	0	0/60	1	
P2Y receptors R-HSA-417957	1	0	0/3	1	
PAOs oxidise polyamines to amines R-HSA-141334	1	0	0/0	1	
PCP/CE pathway R-HSA-4086400	0.947109115644561	0.337099319093361	1/76	1	CLTA
PD-1 signaling R-HSA-389948	0.498966544921479	1.50933201594162	1/18	1	CD3D
PDE3B signalling R-HSA-165160	1	0	0/2	1	
PDGFR mutants bind TKIs R-HSA-9674428	1	0	0/1	1	
PDH complex synthesizes acetyl-CoA from PYR R-HSA-9861559	1	0	0/2	1	
PECAM1 interactions R-HSA-210990	1	0	0/11	1	
PERK regulates gene expression R-HSA-381042	0.659172666796287	0.948013016938371	1/28	1	EIF2S2
PI Metabolism R-HSA-1483255	0.777167989010462	0.671713617611832	1/39	1	PI4K2A
PI and PC transport between ER and Golgi membranes R-HSA-1483196	1	0	0/0	1	
PI-3K cascade:FGFR1 R-HSA-5654689	1	0	0/7	1	
PI-3K cascade:FGFR2 R-HSA-5654695	1	0	0/9	1	
PI-3K cascade:FGFR3 R-HSA-5654710	1	0	0/7	1	
PI-3K cascade:FGFR4 R-HSA-5654720	1	0	0/7	1	
PI3K Cascade R-HSA-109704	1	0	0/21	1	
PI3K events in ERBB2 signaling R-HSA-1963642	1	0	0/11	1	
PI3K events in ERBB4 signaling R-HSA-1250342	1	0	0/6	1	
PI3K/AKT Signaling in Cancer R-HSA-2219528	1	0	0/69	1	
PI3K/AKT activation R-HSA-198203	1	0	0/8	1	
PI5P Regulates TP53 Acetylation R-HSA-6811555	1	0	0/6	1	
PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling R-HSA-6811558	0.897413111399592	0.437833860624597	1/59	1	MAPK1
PINK1-PRKN Mediated Mitophagy R-HSA-5205685	1	0	0/10	1	
PIP3 activates AKT signaling R-HSA-1257604	0.996178966906419	0.251478286206898	2/198	1	MAPK1;LAMTOR1
PKA activation R-HSA-163615	1	0	0/10	1	
PKA activation in glucagon signalling R-HSA-164378	1	0	0/8	1	
PKA-mediated phosphorylation of CREB R-HSA-111931	1	0	0/12	1	
PKA-mediated phosphorylation of key metabolic factors R-HSA-163358	1	0	0/5	1	
PKB-mediated events R-HSA-109703	1	0	0/2	1	
PKMTs methylate histone lysines R-HSA-3214841	0.880158648093307	0.470752534355348	1/55	1	H3C1
PKR-mediated signaling R-HSA-9833482	0.132486190936214	1.94140350221705	5/72	1	EIF2S2;HSPA8;TUBB4B;STAT1;SUMO1
PLC beta mediated events R-HSA-112043	0.283865776727722	1.98210611793963	2/28	1	KPNA2;MAPK1
PLC-gamma1 signalling R-HSA-167021	1	0	0/2	1	
PLCG1 events in ERBB2 signaling R-HSA-1251932	1	0	0/3	1	
POLB-Dependent Long Patch Base Excision Repair R-HSA-110362	1	0	0/2	1	
POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation R-HSA-2892247	1	0	0/6	1	
POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation R-HSA-2892245	1	0	0/4	1	
PP2A-mediated dephosphorylation of key metabolic factors R-HSA-163767	1	0	0/6	1	
PPARA activates gene expression R-HSA-1989781	1	0	0/67	1	
PTEN Loss of Function in Cancer R-HSA-5674404	1	0	0/1	1	
PTEN Regulation R-HSA-6807070	0.943391532786069	0.430262401942163	2/119	1	MAPK1;LAMTOR1
PTK6 Activates STAT3 R-HSA-8849474	1	0	0/3	1	
PTK6 Down-Regulation R-HSA-8849472	1	0	0/2	1	
PTK6 Expression R-HSA-8849473	1	0	0/5	1	
PTK6 Regulates Cell Cycle R-HSA-8849470	1	0	0/6	1	
PTK6 Regulates Proteins Involved in RNA Processing R-HSA-8849468	1	0	0/1	1	
PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases R-HSA-8849471	1	0	0/12	1	
PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 R-HSA-8849469	1	0	0/8	1	
PTK6 promotes HIF1A stabilization R-HSA-8857538	1	0	0/6	1	
Paracetamol ADME R-HSA-9753281	1	0	0/12	1	
Paradoxical activation of RAF signaling by kinase inactive BRAF R-HSA-6802955	0.269730400639392	2.06176929638176	2/27	1	YWHAB;MAPK1
Parasite infection R-HSA-9664407	0.151560771747948	2.3537364605182	3/36	1	MAPK1;ARPC5;ARPC3
Parasitic Infection Pathways R-HSA-9824443	0.514905628490144	1.08017998516607	4/99	1	GNAI3;MAPK1;ARPC5;ARPC3
Passive transport by Aquaporins R-HSA-432047	1	0	0/3	1	
Pentose phosphate pathway R-HSA-71336	1	0	0/9	1	
Pentose phosphate pathway disease R-HSA-6791465	1	0	0/2	1	
Peptide chain elongation R-HSA-156902	0.956496849308816	0.315618492633763	1/81	1	RPL17
Peptide hormone biosynthesis R-HSA-209952	1	0	0/5	1	
Peptide hormone metabolism R-HSA-2980736	0.142633791347627	2.42786207095678	3/35	1	SEC11A;DPP4;PLA2G7
Peroxisomal lipid metabolism R-HSA-390918	1	0	0/10	1	
Peroxisomal protein import R-HSA-9033241	1	0	0/25	1	
Pervasive developmental disorders R-HSA-9005895	1	0	0/10	1	
Pexophagy R-HSA-9664873	1	0	0/9	1	
Phase 0 - rapid depolarisation R-HSA-5576892	1	0	0/16	1	
Phase 1 - inactivation of fast Na+ channels R-HSA-5576894	1	0	0/0	1	
Phase 2 - plateau phase R-HSA-5576893	1	0	0/6	1	
Phase 3 - rapid repolarisation R-HSA-5576890	1	0	0/2	1	
Phase 4 - resting membrane potential R-HSA-5576886	1	0	0/4	1	
Phase I - Functionalization of compounds R-HSA-211945	1	0	0/26	1	
Phase II - Conjugation of compounds R-HSA-156580	0.836533202013075	0.553756244640644	1/47	1	BPNT2
Phenylalanine and tyrosine metabolism R-HSA-8963691	1	0	0/4	1	
Phenylalanine metabolism R-HSA-8964208	1	0	0/3	1	
Phenylketonuria R-HSA-2160456	1	0	0/0	1	
Phosphate bond hydrolysis by NTPDase proteins R-HSA-8850843	1	0	0/3	1	
Phosphate bond hydrolysis by NUDT proteins R-HSA-2393930	1	0	0/3	1	
Phospholipase C-mediated cascade: FGFR1 R-HSA-5654219	1	0	0/3	1	
Phospholipase C-mediated cascade; FGFR2 R-HSA-5654221	1	0	0/5	1	
Phospholipase C-mediated cascade; FGFR3 R-HSA-5654227	1	0	0/3	1	
Phospholipase C-mediated cascade; FGFR4 R-HSA-5654228	1	0	0/3	1	
Phospholipid metabolism R-HSA-1483257	0.576234165223426	1.01094869578119	3/79	1	PLD6;CDIPT;PI4K2A
Phosphorylation of CD3 and TCR zeta chains R-HSA-202427	0.458894009609797	1.71140093295747	1/16	1	CD3D
Phosphorylation of Emi1 R-HSA-176417	1	0	0/4	1	
Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes R-HSA-69200	1	0	0/4	1	
Phosphorylation of the APC/C R-HSA-176412	1	0	0/20	1	
Physiological factors R-HSA-5578768	1	0	0/7	1	
Plasma lipoprotein assembly R-HSA-8963898	1	0	0/14	1	
Plasma lipoprotein assembly, remodeling, and clearance R-HSA-174824	0.801594271869943	0.622085984281075	1/42	1	CLTA
Plasma lipoprotein clearance R-HSA-8964043	0.517882860165378	1.4251445251651	1/19	1	CLTA
Plasma lipoprotein remodeling R-HSA-8963899	1	0	0/18	1	
Plasmalogen biosynthesis R-HSA-75896	1	0	0/0	1	
Platelet Adhesion to exposed collagen R-HSA-75892	1	0	0/10	1	
Platelet Aggregation (Plug Formation) R-HSA-76009	1	0	0/20	1	
Platelet activation, signaling and aggregation R-HSA-76002	0.864166473683452	0.611866670129108	3/127	1	GNAI3;PPIA;MAPK1
Platelet calcium homeostasis R-HSA-418360	1	0	0/12	1	
Platelet degranulation  R-HSA-114608	0.860024331011437	0.508930802430352	1/51	1	PPIA
Platelet homeostasis R-HSA-418346	1	0	0/38	1	
Platelet sensitization by LDL R-HSA-432142	1	0	0/12	1	
Polo-like kinase mediated events R-HSA-156711	1	0	0/6	1	
Post NMDA receptor activation events R-HSA-438064	0.362725530544455	1.43085315386778	3/57	1	TUBB4B;KPNA2;MAPK1
Post-chaperonin tubulin folding pathway R-HSA-389977	0.171956326043045	2.86838050873959	2/20	1	TUBB4B;TBCA
Post-transcriptional silencing by small RNAs R-HSA-426496	1	0	0/1	1	
Post-translational modification: synthesis of GPI-anchored proteins R-HSA-163125	1	0	0/13	1	
Post-translational protein phosphorylation R-HSA-8957275	1	0	0/34	1	
Postsynaptic nicotinic acetylcholine receptors R-HSA-622327	1	0	0/5	1	
Potassium Channels R-HSA-1296071	1	0	0/25	1	
Potassium transport channels R-HSA-1296067	1	0	0/1	1	
Potential therapeutics for SARS R-HSA-9679191	0.918774960363826	0.396170381236054	1/65	1	IFNGR1
Pre-NOTCH Processing in Golgi R-HSA-1912420	0.344236190036209	2.57008458248319	1/11	1	TMED2
Pre-NOTCH Processing in the Endoplasmic Reticulum R-HSA-1912399	1	0	0/5	1	
Prednisone ADME R-HSA-9757110	1	0	0/1	1	
Pregnenolone biosynthesis R-HSA-196108	1	0	0/5	1	
Presynaptic depolarization and calcium channel opening R-HSA-112308	1	0	0/2	1	
Presynaptic function of Kainate receptors R-HSA-500657	1	0	0/8	1	
Presynaptic nicotinic acetylcholine receptors R-HSA-622323	1	0	0/5	1	
Presynaptic phase of homologous DNA pairing and strand exchange R-HSA-5693616	0.458894009609797	1.71140093295747	1/16	1	RPA3
Prevention of phagosomal-lysosomal fusion R-HSA-9636383	1	0	0/5	1	
Processing of Intronless Pre-mRNAs R-HSA-77595	1	0	0/8	1	
Processing of SMDT1 R-HSA-8949664	1	0	0/9	1	
Programmed Cell Death R-HSA-5357801	0.485348710184568	1.08523062075819	6/148	1	YWHAB;DYNLL1;TFDP1;E2F1;YWHAQ;MAPK1
Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2 R-HSA-964827	1	0	0/0	1	
Prolactin receptor signaling R-HSA-1170546	1	0	0/15	1	
Proline catabolism R-HSA-70688	1	0	0/0	1	
Propionyl-CoA catabolism R-HSA-71032	1	0	0/4	1	
Prostacyclin signalling through prostacyclin receptor R-HSA-392851	1	0	0/8	1	
Prostanoid ligand receptors R-HSA-391908	1	0	0/0	1	
Protein hydroxylation R-HSA-9629569	1	0	0/7	1	
Protein lipoylation R-HSA-9857492	1	0	0/3	1	
Protein localization R-HSA-9609507	0.75418385501036	0.738787478538898	2/71	1	SEC61G;HSPA9
Protein methylation R-HSA-8876725	0.264172706115377	3.67308504447128	1/8	1	HSPA8
Protein repair R-HSA-5676934	1	0	0/2	1	
Protein-protein interactions at synapses R-HSA-6794362	1	0	0/20	1	
Proton-coupled monocarboxylate transport R-HSA-433692	1	0	0/2	1	
Proton-coupled neutral amino acid transporters R-HSA-428559	1	0	0/0	1	
Proton/oligopeptide cotransporters R-HSA-427975	1	0	0/0	1	
Purine catabolism R-HSA-74259	1	0	0/9	1	
Purine ribonucleoside monophosphate biosynthesis R-HSA-73817	1	0	0/4	1	
Purine salvage R-HSA-74217	1	0	0/7	1	
Purinergic signaling in leishmaniasis infection R-HSA-9660826	1	0	0/24	1	
Pyrimidine biosynthesis R-HSA-500753	1	0	0/1	1	
Pyrimidine catabolism R-HSA-73621	1	0	0/7	1	
Pyrimidine salvage R-HSA-73614	1	0	0/3	1	
Pyrophosphate hydrolysis R-HSA-71737	1	0	0/2	1	
Pyroptosis R-HSA-5620971	1	0	0/14	1	
Pyruvate metabolism R-HSA-70268	1	0	0/13	1	
RA biosynthesis pathway R-HSA-5365859	1	0	0/5	1	
RAC1 GTPase cycle R-HSA-9013149	0.947109115644561	0.337099319093361	1/76	1	LAMTOR1
RAC2 GTPase cycle R-HSA-9013404	0.793763144714459	0.63780152469564	1/41	1	LAMTOR1
RAC3 GTPase cycle R-HSA-9013423	0.823358687344993	0.579224847840795	1/45	1	LAMTOR1
RAF activation R-HSA-5673000	0.570478706275663	1.22068271949632	1/22	1	YWHAB
RAF-independent MAPK1/3 activation R-HSA-112409	0.368951315033604	2.33577413093742	1/12	1	MAPK1
RAF/MAP kinase cascade R-HSA-5673001	0.979727783123179	0.337355396908839	2/150	1	YWHAB;MAPK1
RAS GTPase cycle mutants R-HSA-9649913	1	0	0/3	1	
RAS processing R-HSA-9648002	1	0	0/13	1	
RAS signaling downstream of NF1 loss-of-function variants R-HSA-6802953	1	0	0/5	1	
RET signaling R-HSA-8853659	1	0	0/22	1	
RHO GTPase cycle R-HSA-9012999	0.987573238609619	0.36032619457363	3/209	1	LAMTOR1;CCT2;CCT6A
RHO GTPases Activate Formins R-HSA-5663220	0.276831198315751	1.54273701213284	4/71	1	TUBB4B;DYNLL1;SEC13;ZWINT
RHO GTPases Activate NADPH Oxidases R-HSA-5668599	0.479313103586786	1.60405328615125	1/17	1	MAPK1
RHO GTPases Activate ROCKs R-HSA-5627117	1	0	0/13	1	
RHO GTPases Activate Rhotekin and Rhophilins R-HSA-5666185	1	0	0/3	1	
RHO GTPases activate CIT R-HSA-5625900	1	0	0/11	1	
RHO GTPases activate IQGAPs R-HSA-5626467	0.696434865498924	0.852568679258093	1/31	1	TUBB4B
RHO GTPases activate KTN1 R-HSA-5625970	1	0	0/6	1	
RHO GTPases activate PAKs R-HSA-5627123	1	0	0/15	1	
RHO GTPases regulate CFTR trafficking R-HSA-5627083	1	0	0/1	1	
RHOA GTPase cycle R-HSA-8980692	1	0	0/66	1	
RHOB GTPase cycle R-HSA-9013026	1	0	0/36	1	
RHOBTB GTPase Cycle R-HSA-9706574	0.199432670053967	2.58052448405812	2/22	1	CCT2;CCT6A
RHOBTB1 GTPase cycle R-HSA-9013422	0.437679640112941	1.83398057876147	1/15	1	CCT2
RHOBTB3 ATPase cycle R-HSA-9706019	1	0	0/4	1	
RHOC GTPase cycle R-HSA-9013106	1	0	0/40	1	
RHOD GTPase cycle R-HSA-9013405	1	0	0/23	1	
RHOF GTPase cycle R-HSA-9035034	1	0	0/18	1	
RHOG GTPase cycle R-HSA-9013408	0.684487195782672	0.882189880788344	1/30	1	LAMTOR1
RHOH GTPase cycle R-HSA-9013407	0.479313103586786	1.60405328615125	1/17	1	LAMTOR1
RHOJ GTPase cycle R-HSA-9013409	0.707932971764601	0.824858095256863	1/32	1	LAMTOR1
RHOQ GTPase cycle R-HSA-9013406	0.67207250610081	0.91392634390264	1/29	1	LAMTOR1
RHOT1 GTPase cycle R-HSA-9013425	1	0	0/1	1	
RHOT2 GTPase cycle R-HSA-9013419	1	0	0/1	1	
RHOU GTPase cycle R-HSA-9013420	1	0	0/26	1	
RHOV GTPase cycle R-HSA-9013424	1	0	0/20	1	
RIP-mediated NFkB activation via ZBP1 R-HSA-1810476	1	0	0/17	1	
RIPK1-mediated regulated necrosis R-HSA-5213460	1	0	0/25	1	
RNA Pol II CTD phosphorylation and interaction with CE R-HSA-77075	0.158472870531307	3.037775775203	2/19	1	POLR2K;POLR2L
RNA Pol II CTD phosphorylation and interaction with CE during HIV infection R-HSA-167160	0.158472870531307	3.037775775203	2/19	1	POLR2K;POLR2L
RNA Polymerase I Transcription Initiation R-HSA-73762	0.297977166269642	1.90826119245548	2/29	1	POLR2K;POLR2L
RNA Polymerase II HIV Promoter Escape R-HSA-167162	0.297977166269642	1.90826119245548	2/29	1	POLR2K;POLR2L
RNA Polymerase II Pre-transcription Events R-HSA-674695	0.248538086298187	1.80186600778957	3/46	1	SUPT4H1;POLR2K;POLR2L
RNA Polymerase II Promoter Escape R-HSA-73776	0.297977166269642	1.90826119245548	2/29	1	POLR2K;POLR2L
RNA Polymerase II Transcription Elongation R-HSA-75955	0.133892024315642	2.50672042818043	3/34	1	SUPT4H1;POLR2K;POLR2L
RNA Polymerase II Transcription Initiation And Promoter Clearance R-HSA-76042	0.297977166269642	1.90826119245548	2/29	1	POLR2K;POLR2L
RNA Polymerase II Transcription Initiation R-HSA-75953	0.297977166269642	1.90826119245548	2/29	1	POLR2K;POLR2L
RNA Polymerase II Transcription Pre-Initiation And Promoter Opening R-HSA-73779	0.297977166269642	1.90826119245548	2/29	1	POLR2K;POLR2L
RNA Polymerase II Transcription R-HSA-73857	0.322044056064843	1.12366951398667	29/704	1	CCNA2;YWHAB;TFDP1;E2F1;SUPT4H1;POLR2K;POLR2L;H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3;RPA3;CDC7;YWHAQ;MAPK1;LAMTOR1;STAT1;SUMO1;PCNA;MYC;E2F4;SNRPG;SNRPD3;SNRPB;PRELID1;SLBP
RNA Polymerase III Abortive And Retractive Initiation R-HSA-749476	0.199432670053967	2.58052448405812	2/22	1	POLR2K;POLR2L
RNA Polymerase III Transcription Initiation R-HSA-76046	0.145204600897006	3.22833101189847	2/18	1	POLR2K;POLR2L
RNA Polymerase III Transcription R-HSA-74158	0.199432670053967	2.58052448405812	2/22	1	POLR2K;POLR2L
RNA polymerase II transcribes snRNA genes R-HSA-6807505	0.269056318219519	1.72095114155427	3/48	1	SUPT4H1;POLR2K;POLR2L
RND1 GTPase cycle R-HSA-9696273	1	0	0/14	1	
RND2 GTPase cycle R-HSA-9696270	1	0	0/15	1	
RND3 GTPase cycle R-HSA-9696264	1	0	0/15	1	
ROBO receptors bind AKAP5 R-HSA-9010642	1	0	0/6	1	
RORA activates gene expression R-HSA-1368082	1	0	0/16	1	
RPIA deficiency: failed conversion of R5P to RU5P R-HSA-5659996	1	0	0/1	1	
RPIA deficiency: failed conversion of RU5P to R5P R-HSA-6791461	1	0	0/1	1	
RSK activation R-HSA-444257	0.205475785531498	5.14414324267236	1/6	1	MAPK1
RSV-host interactions R-HSA-9833110	0.927734586767877	0.378136662723565	1/68	1	OAS2
RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) R-HSA-8877330	1	0	0/5	1	
RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known R-HSA-8939243	1	0	0/28	1	
RUNX1 regulates estrogen receptor mediated transcription R-HSA-8931987	1	0	0/6	1	
RUNX1 regulates expression of components of tight junctions R-HSA-8935964	1	0	0/3	1	
RUNX1 regulates transcription of genes involved in BCR signaling R-HSA-8939245	1	0	0/5	1	
RUNX1 regulates transcription of genes involved in WNT signaling R-HSA-8939256	1	0	0/5	1	
RUNX1 regulates transcription of genes involved in differentiation of HSCs R-HSA-8939236	0.168500472431527	1.5996371653498	7/121	1	H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3
RUNX1 regulates transcription of genes involved in differentiation of keratinocytes R-HSA-8939242	1	0	0/3	1	
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells R-HSA-8939246	1	0	0/6	1	
RUNX1 regulates transcription of genes involved in interleukin signaling R-HSA-8939247	1	0	0/4	1	
RUNX2 regulates bone development R-HSA-8941326	0.602334189032362	1.11399051059428	1/24	1	MAPK1
RUNX2 regulates chondrocyte maturation R-HSA-8941284	1	0	0/5	1	
RUNX2 regulates genes involved in cell migration R-HSA-8941332	1	0	0/7	1	
RUNX2 regulates genes involved in differentiation of myeloid cells R-HSA-8941333	1	0	0/4	1	
RUNX2 regulates osteoblast differentiation R-HSA-8940973	0.517882860165378	1.4251445251651	1/19	1	MAPK1
RUNX3 Regulates Immune Response and Cell Migration R-HSA-8949275	1	0	0/5	1	
RUNX3 regulates BCL2L11 (BIM) transcription R-HSA-8952158	1	0	0/5	1	
RUNX3 regulates CDKN1A transcription R-HSA-8941855	1	0	0/7	1	
RUNX3 regulates NOTCH signaling R-HSA-8941856	1	0	0/14	1	
RUNX3 regulates RUNX1-mediated transcription R-HSA-8951911	1	0	0/3	1	
RUNX3 regulates WNT signaling R-HSA-8951430	0.264172706115377	3.67308504447128	1/8	1	MYC
RUNX3 regulates YAP1-mediated transcription R-HSA-8951671	1	0	0/6	1	
RUNX3 regulates p14-ARF R-HSA-8951936	1	0	0/10	1	
Rap1 signalling R-HSA-392517	0.264172706115377	3.67308504447128	1/8	1	YWHAB
Ras activation upon Ca2+ influx through NMDA receptor R-HSA-442982	1	0	0/14	1	
Reactions specific to the complex N-glycan synthesis pathway R-HSA-975578	1	0	0/2	1	
Reactions specific to the hybrid N-glycan synthesis pathway R-HSA-975574	1	0	0/0	1	
Receptor Mediated Mitophagy R-HSA-8934903	0.264172706115377	3.67308504447128	1/8	1	ULK1
Receptor-type tyrosine-protein phosphatases R-HSA-388844	1	0	0/3	1	
Recruitment of NuMA to mitotic centrosomes R-HSA-380320	0.628999535047443	0.947666360646167	2/56	1	TUBB4B;DYNLL1
Recruitment of mitotic centrosome proteins and complexes R-HSA-380270	0.460100610410333	1.31716129245694	2/41	1	TUBB4B;DYNLL1
Recycling of bile acids and salts R-HSA-159418	1	0	0/7	1	
Recycling pathway of L1 R-HSA-437239	0.151560771747948	2.3537364605182	3/36	1	TUBB4B;MAPK1;CLTA
Reduction of cytosolic Ca++ levels R-HSA-418359	1	0	0/7	1	
Reelin signalling pathway R-HSA-8866376	1	0	0/3	1	
Regorafenib-resistant KIT mutants R-HSA-9669929	1	0	0/1	1	
Regorafenib-resistant PDGFR mutants R-HSA-9674403	1	0	0/1	1	
Regulated Necrosis R-HSA-5218859	1	0	0/39	1	
Regulated proteolysis of p75NTR R-HSA-193692	1	0	0/9	1	
Regulation by TREX1 R-HSA-3248023	1	0	0/0	1	
Regulation by c-FLIP R-HSA-3371378	1	0	0/10	1	
Regulation of APC/C activators between G1/S and early anaphase R-HSA-176408	0.947109115644561	0.337099319093361	1/76	1	CCNA2
Regulation of Apoptosis R-HSA-169911	1	0	0/49	1	
Regulation of BACH1 activity R-HSA-9708530	1	0	0/9	1	
Regulation of CDH11 Expression and Function R-HSA-9759475	1	0	0/12	1	
Regulation of CDH11 function R-HSA-9762292	1	0	0/6	1	
Regulation of CDH11 gene transcription R-HSA-9762293	1	0	0/6	1	
Regulation of CDH11 mRNA translation by microRNAs R-HSA-9759811	1	0	0/2	1	
Regulation of CDH19 Expression and Function R-HSA-9764302	1	0	0/3	1	
Regulation of Complement cascade R-HSA-977606	1	0	0/21	1	
Regulation of Expression and Function of Type II Classical Cadherins R-HSA-9764260	1	0	0/12	1	
Regulation of FOXO transcriptional activity by acetylation R-HSA-9617629	1	0	0/10	1	
Regulation of FZD by ubiquitination R-HSA-4641263	1	0	0/13	1	
Regulation of Glucokinase by Glucokinase Regulatory Protein R-HSA-170822	0.318559709069054	2.85600744758908	1/10	1	SEC13
Regulation of HMOX1 expression and activity R-HSA-9707587	1	0	0/4	1	
Regulation of Homotypic Cell-Cell Adhesion R-HSA-9759476	1	0	0/12	1	
Regulation of IFNA/IFNB signaling R-HSA-912694	0.631841499343673	1.02437078713227	1/26	1	STAT1
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) R-HSA-381426	1	0	0/44	1	
Regulation of KIT signaling R-HSA-1433559	1	0	0/13	1	
Regulation of MECP2 expression and activity R-HSA-9022692	1	0	0/20	1	
Regulation of MITF-M dependent genes involved in invasion R-HSA-9854909	1	0	0/2	1	
Regulation of MITF-M dependent genes involved in metabolism R-HSA-9854907	1	0	0/3	1	
Regulation of MITF-M-dependent genes involved in DNA damage repair and senescence R-HSA-9825895	1	0	0/2	1	
Regulation of MITF-M-dependent genes involved in apoptosis R-HSA-9824594	1	0	0/7	1	
Regulation of MITF-M-dependent genes involved in cell cycle and proliferation R-HSA-9825892	1	0	0/12	1	
Regulation of MITF-M-dependent genes involved in pigmentation R-HSA-9824585	1	0	0/16	1	
Regulation of NF-kappa B signaling R-HSA-9758274	1	0	0/15	1	
Regulation of NFE2L2 gene expression R-HSA-9818749	0.264172706115377	3.67308504447128	1/8	1	MYC
Regulation of NPAS4 gene expression R-HSA-9768759	1	0	0/4	1	
Regulation of NPAS4 gene transcription R-HSA-9768777	1	0	0/3	1	
Regulation of NPAS4 mRNA translation R-HSA-9768778	1	0	0/1	1	
Regulation of PAK-2p34 activity by PS-GAP/RHG10 R-HSA-211728	1	0	0/1	1	
Regulation of PLK1 Activity at G2/M Transition R-HSA-2565942	0.555637766010393	1.09074085300898	2/49	1	TUBB4B;DYNLL1
Regulation of PTEN gene transcription R-HSA-8943724	0.648167032463434	0.91335231310659	2/58	1	MAPK1;LAMTOR1
Regulation of PTEN localization R-HSA-8948747	1	0	0/7	1	
Regulation of PTEN mRNA translation R-HSA-8943723	1	0	0/2	1	
Regulation of PTEN stability and activity R-HSA-8948751	1	0	0/59	1	
Regulation of RAS by GAPs R-HSA-5658442	1	0	0/56	1	
Regulation of RUNX1 Expression and Activity R-HSA-8934593	1	0	0/10	1	
Regulation of RUNX2 expression and activity R-HSA-8939902	0.918774960363826	0.396170381236054	1/65	1	STAT1
Regulation of RUNX3 expression and activity R-HSA-8941858	1	0	0/54	1	
Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7  R-HSA-9824878	1	0	0/11	1	
Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation R-HSA-9828211	1	0	0/10	1	
Regulation of TLR by endogenous ligand R-HSA-5686938	1	0	0/13	1	
Regulation of TNFR1 signaling R-HSA-5357905	0.718998322784487	0.798879056196462	1/33	1	ULK1
Regulation of TP53 Activity R-HSA-5633007	0.882941948511839	0.53877523741921	2/96	1	CCNA2;RPA3
Regulation of TP53 Activity through Acetylation R-HSA-6804758	1	0	0/23	1	
Regulation of TP53 Activity through Association with Co-factors R-HSA-6804759	1	0	0/7	1	
Regulation of TP53 Activity through Methylation R-HSA-6804760	1	0	0/12	1	
Regulation of TP53 Activity through Phosphorylation R-HSA-6804756	0.598756535461105	1.00418216069381	2/53	1	CCNA2;RPA3
Regulation of TP53 Degradation R-HSA-6804757	0.707932971764601	0.824858095256863	1/32	1	CCNA2
Regulation of TP53 Expression R-HSA-6804754	1	0	0/2	1	
Regulation of TP53 Expression and Degradation R-HSA-6806003	0.718998322784487	0.798879056196462	1/33	1	CCNA2
Regulation of actin dynamics for phagocytic cup formation R-HSA-2029482	0.151560771747948	2.3537364605182	3/36	1	MAPK1;ARPC5;ARPC3
Regulation of activated PAK-2p34 by proteasome mediated degradation R-HSA-211733	1	0	0/49	1	
Regulation of beta-cell development R-HSA-186712	1	0	0/21	1	
Regulation of cholesterol biosynthesis by SREBP (SREBF) R-HSA-1655829	0.326057104295125	1.77576003048232	2/31	1	SEC23A;RAN
Regulation of commissural axon pathfinding by SLIT and ROBO R-HSA-428542	1	0	0/5	1	
Regulation of cortical dendrite branching R-HSA-8985801	1	0	0/2	1	
Regulation of cytoskeletal remodeling and cell spreading by IPP complex components R-HSA-446388	1	0	0/5	1	
Regulation of expression of SLITs and ROBOs R-HSA-9010553	0.996223499651391	0.174928353052053	1/143	1	RPL17
Regulation of gap junction activity R-HSA-191650	1	0	0/2	1	
Regulation of gene expression by Hypoxia-inducible Factor R-HSA-1234158	1	0	0/8	1	
Regulation of gene expression in beta cells R-HSA-210745	1	0	0/8	1	
Regulation of gene expression in early pancreatic precursor cells R-HSA-210747	1	0	0/1	1	
Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells R-HSA-210746	1	0	0/0	1	
Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells R-HSA-210744	1	0	0/12	1	
Regulation of glycolysis by fructose 2,6-bisphosphate metabolism R-HSA-9634600	1	0	0/8	1	
Regulation of innate immune responses to cytosolic DNA R-HSA-3134975	1	0	0/9	1	
Regulation of insulin secretion R-HSA-422356	1	0	0/28	1	
Regulation of lipid metabolism by PPARalpha R-HSA-400206	1	0	0/69	1	
Regulation of mRNA stability by proteins that bind AU-rich elements R-HSA-450531	0.815990345817248	0.643594254348742	2/81	1	YWHAB;HSPA8
Regulation of mitotic cell cycle R-HSA-453276	0.954762201117562	0.319697148679627	1/80	1	CCNA2
Regulation of necroptotic cell death R-HSA-5675482	1	0	0/25	1	
Regulation of ornithine decarboxylase (ODC) R-HSA-350562	1	0	0/49	1	
Regulation of pyruvate dehydrogenase (PDH) complex R-HSA-204174	1	0	0/5	1	
Regulation of pyruvate metabolism R-HSA-9861718	1	0	0/10	1	
Regulation of signaling by CBL R-HSA-912631	1	0	0/19	1	
Regulation of signaling by NODAL R-HSA-1433617	1	0	0/2	1	
Regulation of the apoptosome activity R-HSA-9627069	0.174406148124961	6.42991121082952	1/5	1	MAPK1
Regulation of thyroid hormone activity R-HSA-350864	1	0	0/0	1	
Relaxin receptors R-HSA-444821	1	0	0/0	1	
Release of Hh-Np from the secreting cell R-HSA-5362798	1	0	0/3	1	
Release of apoptotic factors from the mitochondria R-HSA-111457	1	0	0/3	1	
Removal of aminoterminal propeptides from gamma-carboxylated proteins R-HSA-159782	1	0	0/3	1	
Replication of the SARS-CoV-1 genome R-HSA-9682706	1	0	0/4	1	
Replication of the SARS-CoV-2 genome R-HSA-9694686	1	0	0/4	1	
Repression of WNT target genes R-HSA-4641265	0.392740848792258	2.14067558250457	1/13	1	MYC
Resistance of ERBB2 KD mutants to AEE788 R-HSA-9665250	1	0	0/2	1	
Resistance of ERBB2 KD mutants to afatinib R-HSA-9665249	1	0	0/2	1	
Resistance of ERBB2 KD mutants to lapatinib R-HSA-9665251	1	0	0/2	1	
Resistance of ERBB2 KD mutants to neratinib R-HSA-9665246	1	0	0/2	1	
Resistance of ERBB2 KD mutants to osimertinib R-HSA-9665247	1	0	0/2	1	
Resistance of ERBB2 KD mutants to sapitinib R-HSA-9665244	1	0	0/2	1	
Resistance of ERBB2 KD mutants to tesevatinib R-HSA-9665245	1	0	0/2	1	
Resistance of ERBB2 KD mutants to trastuzumab R-HSA-9665233	1	0	0/2	1	
Resolution of AP sites via the single-nucleotide replacement pathway R-HSA-110381	1	0	0/2	1	
Resolution of D-Loop Structures R-HSA-5693537	0.498966544921479	1.50933201594162	1/18	1	RAD51AP1
Resolution of D-loop Structures through Holliday Junction Intermediates R-HSA-5693568	0.498966544921479	1.50933201594162	1/18	1	RAD51AP1
Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) R-HSA-5693554	0.437679640112941	1.83398057876147	1/15	1	RAD51AP1
Resolution of Sister Chromatid Cohesion R-HSA-2500257	0.210931831295425	1.75552171084106	4/63	1	TUBB4B;DYNLL1;SEC13;ZWINT
Respiratory Syncytial Virus Infection Pathway R-HSA-9820952	0.397522537430868	1.27151908534998	4/85	1	HSPA8;OAS2;RAB5C;SEC11A
Respiratory electron transport R-HSA-611105	1	0	0/70	1	
Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. R-HSA-163200	1	0	0/85	1	
Respiratory syncytial virus (RSV) attachment and entry R-HSA-9820960	0.291884735022825	3.21357144757802	1/9	1	RAB5C
Respiratory syncytial virus genome replication R-HSA-9834752	1	0	0/2	1	
Response of EIF2AK1 (HRI) to heme deficiency R-HSA-9648895	0.415639234052386	1.97560356752423	1/14	1	EIF2S2
Response of EIF2AK4 (GCN2) to amino acid deficiency R-HSA-9633012	0.867687912251062	0.563311127260511	2/92	1	EIF2S2;RPL17
Response of Mtb to phagocytosis R-HSA-9637690	0.415639234052386	1.97560356752423	1/14	1	MAPK1
Response to elevated platelet cytosolic Ca2+ R-HSA-76005	0.880158648093307	0.470752534355348	1/55	1	PPIA
Response to metal ions R-HSA-5660526	1	0	0/0	1	
Retinoid cycle disease events R-HSA-2453864	1	0	0/1	1	
Retinoid metabolism and transport R-HSA-975634	1	0	0/13	1	
Retinoid metabolism disease events R-HSA-6809583	1	0	0/0	1	
Retrograde neurotrophin signalling R-HSA-177504	0.264172706115377	3.67308504447128	1/8	1	CLTA
Retrograde transport at the Trans-Golgi-Network R-HSA-6811440	1	0	0/26	1	
Reuptake of GABA R-HSA-888593	1	0	0/2	1	
Reversal of alkylation damage by DNA dioxygenases R-HSA-73943	1	0	0/0	1	
Reversible hydration of carbon dioxide R-HSA-1475029	1	0	0/7	1	
Rhesus blood group biosynthesis R-HSA-9037628	1	0	0/0	1	
Rhesus glycoproteins mediate ammonium transport. R-HSA-444411	1	0	0/0	1	
Ribavirin ADME R-HSA-9755088	0.174406148124961	6.42991121082952	1/5	1	NME1
Ribosomal scanning and start codon recognition R-HSA-72702	0.836533202013075	0.553756244640644	1/47	1	EIF2S2
Role of ABL in ROBO-SLIT signaling R-HSA-428890	1	0	0/6	1	
Role of LAT2/NTAL/LAB on calcium mobilization R-HSA-2730905	1	0	0/12	1	
Role of phospholipids in phagocytosis R-HSA-2029485	1	0	0/16	1	
Role of second messengers in netrin-1 signaling R-HSA-418890	1	0	0/2	1	
SARS-CoV-1 Genome Replication and Transcription R-HSA-9679514	1	0	0/4	1	
SARS-CoV-1 Infection R-HSA-9678108	0.39058713198079	1.23880645965995	5/109	1	PPIA;YWHAB;YWHAQ;KPNA2;SUMO1
SARS-CoV-1 activates/modulates innate immune responses R-HSA-9692916	0.381222220846868	1.55895902004401	2/35	1	PPIA;KPNA2
SARS-CoV-1 modulates host translation machinery R-HSA-9735869	1	0	0/33	1	
SARS-CoV-1 targets PDZ proteins in cell-cell junction R-HSA-9692912	1	0	0/0	1	
SARS-CoV-1-host interactions R-HSA-9692914	0.406137605302066	1.25568795858587	4/86	1	PPIA;YWHAB;YWHAQ;KPNA2
SARS-CoV-1-mediated effects on programmed cell death R-HSA-9692913	1	0	0/3	1	
SARS-CoV-2 Genome Replication and Transcription R-HSA-9694682	1	0	0/4	1	
SARS-CoV-2 activates/modulates innate and adaptive immune responses R-HSA-9705671	0.371580519303203	1.32144742881747	4/82	1	KPNA2;SEC13;SEC23A;STAT1
SARS-CoV-2 modulates autophagy R-HSA-9754560	1	0	0/2	1	
SARS-CoV-2 targets PDZ proteins in cell-cell junction R-HSA-9705677	1	0	0/1	1	
SCF(Skp2)-mediated degradation of p27/p21 R-HSA-187577	0.648167032463434	0.91335231310659	2/58	1	CCNA2;CKS1B
SCF-beta-TrCP mediated degradation of Emi1 R-HSA-174113	1	0	0/52	1	
SDK interactions R-HSA-373756	1	0	0/0	1	
SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion R-HSA-399955	1	0	0/5	1	
SHC-mediated cascade:FGFR1 R-HSA-5654688	1	0	0/7	1	
SHC-mediated cascade:FGFR2 R-HSA-5654699	1	0	0/9	1	
SHC-mediated cascade:FGFR3 R-HSA-5654704	1	0	0/7	1	
SHC-mediated cascade:FGFR4 R-HSA-5654719	1	0	0/7	1	
SHC-related events triggered by IGF1R R-HSA-2428933	1	0	0/7	1	
SHC1 events in EGFR signaling R-HSA-180336	1	0	0/13	1	
SHC1 events in ERBB2 signaling R-HSA-1250196	1	0	0/15	1	
SHC1 events in ERBB4 signaling R-HSA-1250347	1	0	0/9	1	
SHOC2 M1731 mutant abolishes MRAS complex function R-HSA-9726840	0.174406148124961	6.42991121082952	1/5	1	YWHAB
SLC transporter disorders R-HSA-5619102	0.759246962958051	0.709393086950025	1/37	1	SEC13
SLC-mediated transmembrane transport R-HSA-425407	1	0	0/75	1	
SLIT2:ROBO1 increases RHOA activity R-HSA-8985586	1	0	0/3	1	
SMAC (DIABLO) binds to IAPs  R-HSA-111463	1	0	0/2	1	
SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes  R-HSA-111464	1	0	0/2	1	
SMAC, XIAP-regulated apoptotic response R-HSA-111469	1	0	0/2	1	
SMAD2/3 MH2 Domain Mutants in Cancer R-HSA-3315487	1	0	0/3	1	
SMAD2/3 Phosphorylation Motif Mutants in Cancer R-HSA-3304356	1	0	0/6	1	
SMAD4 MH2 Domain Mutants in Cancer R-HSA-3311021	1	0	0/3	1	
SOS-mediated signalling R-HSA-112412	1	0	0/7	1	
STAT3 nuclear events downstream of ALK signaling R-HSA-9701898	1	0	0/11	1	
STAT5 Activation R-HSA-9645135	1	0	0/5	1	
STAT5 activation downstream of FLT3 ITD mutants R-HSA-9702518	1	0	0/8	1	
STAT6-mediated induction of chemokines R-HSA-3249367	1	0	0/3	1	
STING mediated induction of host immune responses R-HSA-1834941	1	0	0/8	1	
SUMO E3 ligases SUMOylate target proteins R-HSA-3108232	0.502303969438686	1.0783816361099	5/124	1	SEC13;SUMO1;PCNA;TOP2A;HNRNPK
SUMO is proteolytically processed R-HSA-3065679	0.142129845273879	8.57316652446317	1/4	1	SUMO1
SUMOylation R-HSA-2990846	0.336029659995671	1.29168778368398	6/126	1	SEC13;SUMO1;PCNA;TOP2A;HNRNPK;SAE1
SUMOylation of DNA damage response and repair proteins R-HSA-3108214	0.497326164733823	1.22215401694053	2/44	1	SEC13;SUMO1
SUMOylation of DNA methylation proteins R-HSA-4655427	0.415639234052386	1.97560356752423	1/14	1	SUMO1
SUMOylation of chromatin organization proteins R-HSA-4551638	0.509370491253451	1.19343025904594	2/45	1	SEC13;SUMO1
SUMOylation of immune response proteins R-HSA-4755510	0.291884735022825	3.21357144757802	1/9	1	SUMO1
SUMOylation of intracellular receptors R-HSA-4090294	0.570478706275663	1.22068271949632	1/22	1	SUMO1
SUMOylation of transcription cofactors R-HSA-3899300	0.739894893007977	0.751504626216391	1/35	1	SUMO1
SUMOylation of transcription factors R-HSA-3232118	0.392740848792258	2.14067558250457	1/13	1	SUMO1
Scavenging by Class A Receptors R-HSA-3000480	1	0	0/11	1	
Scavenging by Class B Receptors R-HSA-3000471	1	0	0/5	1	
Scavenging by Class F Receptors R-HSA-3000484	1	0	0/3	1	
Scavenging by Class H Receptors R-HSA-3000497	1	0	0/2	1	
Scavenging of heme from plasma R-HSA-2168880	1	0	0/5	1	
Sealing of the nuclear envelope (NE) by ESCRT-III R-HSA-9668328	0.617370309248053	1.06727882366375	1/25	1	TUBB4B
Selective autophagy R-HSA-9663891	0.12993961127423	2.16374907296985	4/52	1	HSPA8;TUBB4B;DYNLL1;ULK1
Selenoamino acid metabolism R-HSA-2408522	0.974862023746438	0.267628559898999	1/95	1	RPL17
Selenocysteine synthesis R-HSA-2408557	0.959770364975441	0.307759594824728	1/83	1	RPL17
Sema3A PAK dependent Axon repulsion R-HSA-399954	1	0	0/10	1	
Sema4D in semaphorin signaling R-HSA-400685	1	0	0/16	1	
Sema4D induced cell migration and growth-cone collapse R-HSA-416572	1	0	0/13	1	
Sema4D mediated inhibition of cell attachment and migration R-HSA-416550	1	0	0/6	1	
Semaphorin interactions R-HSA-373755	1	0	0/41	1	
Sensing of DNA Double Strand Breaks R-HSA-5693548	0.174406148124961	6.42991121082952	1/5	1	KPNA2
Sensory Perception R-HSA-9709957	1	0	0/64	1	
Sensory perception of salty taste R-HSA-9730628	1	0	0/4	1	
Sensory perception of sour taste R-HSA-9729555	1	0	0/0	1	
Sensory perception of sweet, bitter, and umami (glutamate) taste R-HSA-9717207	1	0	0/3	1	
Sensory perception of taste R-HSA-9717189	1	0	0/7	1	
Sensory processing of sound R-HSA-9659379	1	0	0/31	1	
Sensory processing of sound by inner hair cells of the cochlea R-HSA-9662360	1	0	0/28	1	
Sensory processing of sound by outer hair cells of the cochlea R-HSA-9662361	1	0	0/20	1	
Separation of Sister Chromatids R-HSA-2467813	0.71123264114342	0.828200362202945	4/127	1	TUBB4B;DYNLL1;SEC13;ZWINT
Serine biosynthesis R-HSA-977347	1	0	0/2	1	
Serotonin Neurotransmitter Release Cycle R-HSA-181429	1	0	0/5	1	
Serotonin and melatonin biosynthesis R-HSA-209931	1	0	0/1	1	
Serotonin clearance from the synaptic cleft R-HSA-380615	1	0	0/1	1	
Serotonin receptors R-HSA-390666	1	0	0/0	1	
Severe congenital neutropenia type 4 (G6PC3) R-HSA-3282872	1	0	0/1	1	
Sialic acid metabolism R-HSA-4085001	1	0	0/11	1	
Signal Transduction R-HSA-162582	0.673545852115926	0.936136047476357	47/1306	1	GNAI3;YWHAB;TUBB4B;DYNLL1;TFDP1;E2F1;POLR2K;POLR2L;H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3;YWHAQ;KPNA2;MAPK1;SEC13;CLTA;ADORA3;LAMTOR1;ATP6V1G1;ATP6V1A;ATP6V0B;ZWINT;STAT1;TMED2;CCT2;CCT6A;ULK1;ARPC5;ARPC3;MYC;CCR5;NEDD8;E2F4;CCL20;CCL4;CXCR3;CXCL9;CXCL11;CXCL10;FPR3;ANXA1;SNX3;CCL4L2
Signal amplification R-HSA-392518	0.498966544921479	1.50933201594162	1/18	1	GNAI3
Signal attenuation R-HSA-74749	0.264172706115377	3.67308504447128	1/8	1	MAPK1
Signal regulatory protein family interactions R-HSA-391160	1	0	0/10	1	
Signal transduction by L1 R-HSA-445144	0.415639234052386	1.97560356752423	1/14	1	MAPK1
Signaling by ALK R-HSA-201556	0.586711236520839	1.16491237093854	1/23	1	MYC
Signaling by ALK fusions and activated point mutants R-HSA-9725370	0.675446044614701	0.866242019354573	2/61	1	MAPK1;STAT1
Signaling by ALK in cancer R-HSA-9700206	0.675446044614701	0.866242019354573	2/61	1	MAPK1;STAT1
Signaling by AMER1 mutants R-HSA-4839748	1	0	0/10	1	
Signaling by APC mutants R-HSA-4839744	1	0	0/10	1	
Signaling by AXIN mutants R-HSA-4839735	1	0	0/10	1	
Signaling by Activin R-HSA-1502540	0.368951315033604	2.33577413093742	1/12	1	MAPK1
Signaling by BMP R-HSA-201451	1	0	0/16	1	
Signaling by BRAF and RAF1 fusions R-HSA-6802952	0.381222220846868	1.55895902004401	2/35	1	YWHAB;MAPK1
Signaling by CSF1 (M-CSF) in myeloid cells R-HSA-9680350	0.586711236520839	1.16491237093854	1/23	1	STAT1
Signaling by CSF3 (G-CSF) R-HSA-9674555	0.67207250610081	0.91392634390264	1/29	1	STAT1
Signaling by CTNNB1 phospho-site mutants R-HSA-4839743	1	0	0/11	1	
Signaling by EGFR R-HSA-177929	1	0	0/38	1	
Signaling by EGFR in Cancer R-HSA-1643713	1	0	0/23	1	
Signaling by EGFRvIII in Cancer R-HSA-5637812	1	0	0/13	1	
Signaling by ERBB2 ECD mutants R-HSA-9665348	1	0	0/13	1	
Signaling by ERBB2 KD Mutants R-HSA-9664565	1	0	0/18	1	
Signaling by ERBB2 R-HSA-1227986	1	0	0/38	1	
Signaling by ERBB2 TMD/JMD mutants R-HSA-9665686	1	0	0/15	1	
Signaling by ERBB2 in Cancer R-HSA-1227990	1	0	0/18	1	
Signaling by ERBB4 R-HSA-1236394	1	0	0/38	1	
Signaling by Erythropoietin R-HSA-9006335	1	0	0/19	1	
Signaling by FGFR R-HSA-190236	0.289762862480904	1.64688463938375	3/50	1	POLR2K;POLR2L;MAPK1
Signaling by FGFR in disease R-HSA-1226099	0.228284065853817	1.89078731389846	3/44	1	POLR2K;POLR2L;STAT1
Signaling by FGFR1 R-HSA-5654736	0.659172666796287	0.948013016938371	1/28	1	MAPK1
Signaling by FGFR1 amplification mutants R-HSA-1839120	1	0	0/0	1	
Signaling by FGFR1 in disease R-HSA-5655302	0.631841499343673	1.02437078713227	1/26	1	STAT1
Signaling by FGFR2 IIIa TM R-HSA-8851708	0.132188505977977	3.44430718189997	2/17	1	POLR2K;POLR2L
Signaling by FGFR2 R-HSA-5654738	0.248538086298187	1.80186600778957	3/46	1	POLR2K;POLR2L;MAPK1
Signaling by FGFR2 amplification mutants R-HSA-2023837	1	0	0/1	1	
Signaling by FGFR2 fusions R-HSA-8853333	1	0	0/1	1	
Signaling by FGFR2 in disease R-HSA-5655253	0.283865776727722	1.98210611793963	2/28	1	POLR2K;POLR2L
Signaling by FGFR3 R-HSA-5654741	0.617370309248053	1.06727882366375	1/25	1	MAPK1
Signaling by FGFR3 fusions in cancer R-HSA-8853334	1	0	0/0	1	
Signaling by FGFR3 in disease R-HSA-5655332	1	0	0/11	1	
Signaling by FGFR4 R-HSA-5654743	0.617370309248053	1.06727882366375	1/25	1	MAPK1
Signaling by FGFR4 in disease R-HSA-5655291	1	0	0/10	1	
Signaling by FLT3 ITD and TKD mutants R-HSA-9703648	1	0	0/14	1	
Signaling by FLT3 fusion proteins R-HSA-9703465	1	0	0/15	1	
Signaling by GSK3beta mutants R-HSA-5339716	1	0	0/11	1	
Signaling by Hedgehog R-HSA-5358351	0.986063014703052	0.229889905487852	1/110	1	TUBB4B
Signaling by Hippo R-HSA-2028269	0.344236190036209	2.57008458248319	1/11	1	YWHAB
Signaling by Interleukins R-HSA-449147	0.449283755414881	1.07019022671285	14/351	1	PPIA;HSPA8;H3C1;MAPK1;STAT1;TCP1;MYC;CCR5;VAMP7;HSPA9;CCL20;CCL4;CXCL10;ANXA1
Signaling by KIT in disease R-HSA-9669938	0.536089519856027	1.34983084155226	1/20	1	STAT1
Signaling by LRP5 mutants  R-HSA-5339717	1	0	0/2	1	
Signaling by LTK R-HSA-9842663	1	0	0/9	1	
Signaling by LTK in cancer R-HSA-9842640	0.235383581618475	4.2860969528668	1/7	1	MAPK1
Signaling by Leptin R-HSA-2586552	1	0	0/9	1	
Signaling by Ligand-Responsive EGFR Variants in Cancer R-HSA-5637815	1	0	0/17	1	
Signaling by MET R-HSA-6806834	1	0	0/48	1	
Signaling by MRAS-complex mutants R-HSA-9660537	0.174406148124961	6.42991121082952	1/5	1	YWHAB
Signaling by MST1 R-HSA-8852405	1	0	0/1	1	
Signaling by NODAL R-HSA-1181150	0.368951315033604	2.33577413093742	1/12	1	MAPK1
Signaling by NOTCH1 HD Domain Mutants in Cancer R-HSA-2691230	1	0	0/9	1	
Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer R-HSA-2894858	0.854486511728183	0.519451139120248	1/50	1	MYC
Signaling by NOTCH1 PEST Domain Mutants in Cancer R-HSA-2644602	0.854486511728183	0.519451139120248	1/50	1	MYC
Signaling by NOTCH1 R-HSA-1980143	0.893346025570885	0.445630437873364	1/58	1	MYC
Signaling by NOTCH1 in Cancer R-HSA-2644603	0.854486511728183	0.519451139120248	1/50	1	MYC
Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant R-HSA-2660825	1	0	0/4	1	
Signaling by NOTCH2 R-HSA-1980145	1	0	0/24	1	
Signaling by NOTCH3 R-HSA-9012852	0.777167989010462	0.671713617611832	1/39	1	STAT1
Signaling by NOTCH4 R-HSA-9013694	1	0	0/77	1	
Signaling by NTRK1 (TRKA) R-HSA-187037	0.634391275446562	0.924007968574745	3/86	1	YWHAB;MAPK1;CLTA
Signaling by NTRK2 (TRKB) R-HSA-9006115	1	0	0/17	1	
Signaling by NTRK3 (TRKC) R-HSA-9034015	1	0	0/11	1	
Signaling by NTRKs R-HSA-166520	0.693842802740389	0.841021608243794	3/94	1	YWHAB;MAPK1;CLTA
Signaling by Non-Receptor Tyrosine Kinases R-HSA-9006927	1	0	0/40	1	
Signaling by Overexpressed Wild-Type EGFR in Cancer R-HSA-5638302	1	0	0/8	1	
Signaling by PDGF R-HSA-186797	0.842749602637046	0.541834671405377	1/48	1	STAT1
Signaling by PDGFR in disease R-HSA-9671555	0.415639234052386	1.97560356752423	1/14	1	STAT1
Signaling by PDGFRA extracellular domain mutants R-HSA-9673770	0.368951315033604	2.33577413093742	1/12	1	STAT1
Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants R-HSA-9673767	0.368951315033604	2.33577413093742	1/12	1	STAT1
Signaling by PTK6 R-HSA-8848021	1	0	0/40	1	
Signaling by RAF1 mutants R-HSA-9656223	0.227383328755819	2.34471258236625	2/24	1	YWHAB;MAPK1
Signaling by RAS GAP mutants R-HSA-9753510	1	0	0/3	1	
Signaling by RAS GTPase mutants R-HSA-9753512	1	0	0/3	1	
Signaling by RAS mutants R-HSA-6802949	0.269730400639392	2.06176929638176	2/27	1	YWHAB;MAPK1
Signaling by RNF43 mutants R-HSA-5340588	1	0	0/5	1	
Signaling by ROBO receptors R-HSA-376176	0.998713339167414	0.145924341893257	1/170	1	RPL17
Signaling by Receptor Tyrosine Kinases R-HSA-9006934	0.798352562298046	0.794265303059496	10/327	1	YWHAB;POLR2K;POLR2L;MAPK1;CLTA;ATP6V1G1;ATP6V1A;ATP6V0B;STAT1;MYC
Signaling by Retinoic Acid R-HSA-5362517	1	0	0/15	1	
Signaling by SCF-KIT R-HSA-1433557	0.729647102374803	0.774474188165174	1/34	1	STAT1
Signaling by TCF7L2 mutants R-HSA-5339700	1	0	0/3	1	
Signaling by TGF-beta Receptor Complex in Cancer R-HSA-3304351	1	0	0/8	1	
Signaling by TGFB family members R-HSA-9006936	0.166985636809209	1.67846724122545	6/99	1	TFDP1;MAPK1;STAT1;MYC;NEDD8;E2F4
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) R-HSA-2404192	1	0	0/27	1	
Signaling by VEGF R-HSA-194138	1	0	0/76	1	
Signaling by WNT R-HSA-195721	0.337812664119167	1.20432824094286	10/225	1	H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3;CLTA;MYC;SNX3
Signaling by WNT in cancer R-HSA-4791275	1	0	0/21	1	
Signaling by activated point mutants of FGFR1 R-HSA-1839122	1	0	0/2	1	
Signaling by activated point mutants of FGFR3 R-HSA-1839130	1	0	0/2	1	
Signaling by cytosolic FGFR1 fusion mutants R-HSA-1839117	0.479313103586786	1.60405328615125	1/17	1	STAT1
Signaling by cytosolic PDGFRA and PDGFRB fusion proteins R-HSA-9673766	1	0	0/0	1	
Signaling by extracellular domain mutants of KIT R-HSA-9680187	1	0	0/1	1	
Signaling by high-kinase activity BRAF mutants R-HSA-6802948	0.158472870531307	3.037775775203	2/19	1	YWHAB;MAPK1
Signaling by juxtamembrane domain KIT mutants R-HSA-9669935	1	0	0/1	1	
Signaling by kinase domain mutants of KIT R-HSA-9669933	1	0	0/1	1	
Signaling by membrane-tethered fusions of PDGFRA or PDGFRB R-HSA-9673768	1	0	0/2	1	
Signaling by moderate kinase activity BRAF mutants R-HSA-6802946	0.269730400639392	2.06176929638176	2/27	1	YWHAB;MAPK1
Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants R-HSA-9670439	0.536089519856027	1.34983084155226	1/20	1	STAT1
Signaling by plasma membrane FGFR1 fusions R-HSA-8853336	1	0	0/1	1	
Signaling by the B Cell Receptor (BCR) R-HSA-983705	0.974862023746438	0.267628559898999	1/95	1	PPIA
Signaling downstream of RAS mutants R-HSA-9649948	0.269730400639392	2.06176929638176	2/27	1	YWHAB;MAPK1
Signalling to ERK5 R-HSA-198765	1	0	0/2	1	
Signalling to ERKs R-HSA-187687	0.185620369846663	2.71680916381686	2/21	1	YWHAB;MAPK1
Signalling to RAS R-HSA-167044	1	0	0/13	1	
Signalling to STAT3 R-HSA-198745	1	0	0/2	1	
Signalling to p38 via RIT and RIN R-HSA-187706	1	0	0/3	1	
Small interfering RNA (siRNA) biogenesis R-HSA-426486	1	0	0/3	1	
Smooth Muscle Contraction R-HSA-445355	0.586711236520839	1.16491237093854	1/23	1	ANXA1
Sodium-coupled phosphate cotransporters R-HSA-427652	1	0	0/2	1	
Sodium-coupled sulphate, di- and tri-carboxylate transporters R-HSA-433137	1	0	0/2	1	
Sodium/Calcium exchangers R-HSA-425561	1	0	0/7	1	
Sodium/Proton exchangers R-HSA-425986	1	0	0/5	1	
Somitogenesis R-HSA-9824272	1	0	0/47	1	
Sorafenib-resistant KIT mutants R-HSA-9669936	1	0	0/1	1	
Sorafenib-resistant PDGFR mutants R-HSA-9674404	1	0	0/1	1	
Specification of primordial germ cells R-HSA-9827857	1	0	0/5	1	
Specification of the neural plate border R-HSA-9834899	1	0	0/9	1	
Sperm Motility And Taxes R-HSA-1300642	1	0	0/0	1	
Sphingolipid catabolism R-HSA-9845614	1	0	0/6	1	
Sphingolipid de novo biosynthesis R-HSA-1660661	1	0	0/14	1	
Sphingolipid metabolism R-HSA-428157	1	0	0/39	1	
Spry regulation of FGF signaling R-HSA-1295596	0.437679640112941	1.83398057876147	1/15	1	MAPK1
Stabilization of p53 R-HSA-69541	1	0	0/56	1	
Sterols are 12-hydroxylated by CYP8B1 R-HSA-211994	1	0	0/0	1	
Stimulation of the cell death response by PAK-2p34 R-HSA-211736	1	0	0/1	1	
Stimuli-sensing channels R-HSA-2672351	1	0	0/42	1	
Striated Muscle Contraction R-HSA-390522	1	0	0/28	1	
Sulfide oxidation to sulfate R-HSA-1614517	1	0	0/3	1	
Sulfur amino acid metabolism R-HSA-1614635	1	0	0/14	1	
Sunitinib-resistant KIT mutants R-HSA-9669934	1	0	0/1	1	
Sunitinib-resistant PDGFR mutants R-HSA-9674401	1	0	0/1	1	
Suppression of autophagy R-HSA-9636569	1	0	0/1	1	
Suppression of phagosomal maturation R-HSA-9637687	1	0	0/8	1	
Surfactant metabolism R-HSA-5683826	1	0	0/7	1	
Synaptic adhesion-like molecules R-HSA-8849932	1	0	0/4	1	
Syndecan interactions R-HSA-3000170	1	0	0/15	1	
Synthesis And Processing Of GAG, GAGPOL Polyproteins R-HSA-174495	1	0	0/7	1	
Synthesis and processing of ENV and VPU R-HSA-171286	1	0	0/1	1	
Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE) R-HSA-2142816	1	0	0/3	1	
Synthesis of 12-eicosatetraenoic acid derivatives R-HSA-2142712	1	0	0/3	1	
Synthesis of 15-eicosatetraenoic acid derivatives R-HSA-2142770	1	0	0/4	1	
Synthesis of 5-eicosatetraenoic acids R-HSA-2142688	1	0	0/5	1	
Synthesis of CL R-HSA-1483076	1	0	0/1	1	
Synthesis of Dolichyl-phosphate R-HSA-446199	1	0	0/1	1	
Synthesis of GDP-mannose R-HSA-446205	1	0	0/2	1	
Synthesis of Hepoxilins (HX) and Trioxilins (TrX) R-HSA-2142696	1	0	0/0	1	
Synthesis of IP2, IP, and Ins in the cytosol R-HSA-1855183	1	0	0/6	1	
Synthesis of IP3 and IP4 in the cytosol R-HSA-1855204	1	0	0/8	1	
Synthesis of IPs in the ER lumen R-HSA-1855231	1	0	0/1	1	
Synthesis of IPs in the nucleus R-HSA-1855191	1	0	0/0	1	
Synthesis of Leukotrienes (LT) and Eoxins (EX) R-HSA-2142691	1	0	0/10	1	
Synthesis of Lipoxins (LX) R-HSA-2142700	1	0	0/2	1	
Synthesis of PA R-HSA-1483166	0.392740848792258	2.14067558250457	1/13	1	PLD6
Synthesis of PC R-HSA-1483191	1	0	0/9	1	
Synthesis of PE R-HSA-1483213	1	0	0/3	1	
Synthesis of PIPs at the ER membrane R-HSA-1483248	1	0	0/4	1	
Synthesis of PIPs at the Golgi membrane R-HSA-1660514	0.344236190036209	2.57008458248319	1/11	1	PI4K2A
Synthesis of PIPs at the early endosome membrane R-HSA-1660516	0.318559709069054	2.85600744758908	1/10	1	PI4K2A
Synthesis of PIPs at the late endosome membrane R-HSA-1660517	1	0	0/9	1	
Synthesis of PIPs at the plasma membrane R-HSA-1660499	0.645768849293838	0.984720976687612	1/27	1	PI4K2A
Synthesis of PIPs in the nucleus R-HSA-8847453	1	0	0/2	1	
Synthesis of PS R-HSA-1483101	1	0	0/2	1	
Synthesis of Prostaglandins (PG) and Thromboxanes (TX) R-HSA-2162123	1	0	0/4	1	
Synthesis of UDP-N-acetyl-glucosamine R-HSA-446210	1	0	0/1	1	
Synthesis of active ubiquitin: roles of E1 and E2 enzymes R-HSA-8866652	1	0	0/19	1	
Synthesis of bile acids and bile salts R-HSA-192105	1	0	0/10	1	
Synthesis of bile acids and bile salts via 24-hydroxycholesterol R-HSA-193775	1	0	0/2	1	
Synthesis of bile acids and bile salts via 27-hydroxycholesterol R-HSA-193807	1	0	0/5	1	
Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol R-HSA-193368	1	0	0/9	1	
Synthesis of diphthamide-EEF2 R-HSA-5358493	1	0	0/4	1	
Synthesis of dolichyl-phosphate mannose R-HSA-162699	1	0	0/2	1	
Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET) R-HSA-2142670	1	0	0/2	1	
Synthesis of glycosylphosphatidylinositol (GPI) R-HSA-162710	1	0	0/8	1	
Synthesis of pyrophosphates in the cytosol R-HSA-1855167	1	0	0/2	1	
Synthesis of substrates in N-glycan biosythesis R-HSA-446219	0.517882860165378	1.4251445251651	1/19	1	ALG5
Synthesis of very long-chain fatty acyl-CoAs R-HSA-75876	1	0	0/8	1	
Synthesis of wybutosine at G37 of tRNA(Phe) R-HSA-6782861	1	0	0/1	1	
TAK1-dependent IKK and NF-kappa-B activation   R-HSA-445989	1	0	0/38	1	
TALDO1 deficiency: failed conversion of  Fru(6)P, E4P to SH7P, GA3P R-HSA-6791462	1	0	0/1	1	
TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P R-HSA-6791055	1	0	0/1	1	
TCF dependent signaling in response to WNT R-HSA-201681	0.330111499704173	1.24691179665206	8/174	1	H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3;MYC
TCR signaling R-HSA-202403	0.981641610102654	0.246120083312034	1/103	1	CD3D
TET1,2,3 and TDG demethylate DNA R-HSA-5221030	1	0	0/1	1	
TFAP2 (AP-2) family regulates transcription of cell cycle factors R-HSA-8866911	0.142129845273879	8.57316652446317	1/4	1	MYC
TFAP2 (AP-2) family regulates transcription of growth factors and their receptors R-HSA-8866910	1	0	0/9	1	
TFAP2 (AP-2) family regulates transcription of other transcription factors R-HSA-8866906	1	0	0/3	1	
TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation R-HSA-8869496	1	0	0/4	1	
TGF-beta receptor signaling activates SMADs R-HSA-2173789	0.793763144714459	0.63780152469564	1/41	1	NEDD8
TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) R-HSA-2173791	1	0	0/15	1	
TGFBR1 KD Mutants in Cancer R-HSA-3656532	1	0	0/6	1	
TGFBR1 LBD Mutants in Cancer R-HSA-3656535	1	0	0/4	1	
TGFBR2 Kinase Domain Mutants in Cancer R-HSA-3645790	1	0	0/3	1	
TGFBR2 MSI Frameshift Mutants in Cancer R-HSA-3642279	1	0	0/2	1	
TICAM1 deficiency - HSE R-HSA-5602566	1	0	0/2	1	
TICAM1, RIP1-mediated IKK complex recruitment R-HSA-168927	1	0	0/19	1	
TICAM1,TRAF6-dependent induction of TAK1 complex R-HSA-9014325	1	0	0/10	1	
TICAM1-dependent activation of IRF3/IRF7 R-HSA-9013973	1	0	0/12	1	
TLR3 deficiency - HSE R-HSA-5602410	1	0	0/1	1	
TLR3-mediated TICAM1-dependent programmed cell death R-HSA-9013957	1	0	0/6	1	
TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway R-HSA-5676594	1	0	0/9	1	
TNF signaling R-HSA-75893	0.785625034121675	0.654322867528411	1/40	1	ULK1
TNFR1-induced NF-kappa-B signaling pathway R-HSA-5357956	1	0	0/22	1	
TNFR1-induced proapoptotic signaling R-HSA-5357786	1	0	0/14	1	
TNFR1-mediated ceramide production R-HSA-5626978	1	0	0/5	1	
TNFR2 non-canonical NF-kB pathway R-HSA-5668541	0.938171251492933	0.356462116080611	1/72	1	UBA3
TNFs bind their physiological receptors R-HSA-5669034	1	0	0/7	1	
TP53 Regulates Metabolic Genes R-HSA-5628897	0.383458603753469	1.37905292543158	3/59	1	YWHAB;YWHAQ;LAMTOR1
TP53 Regulates Transcription of Caspase Activators and Caspases R-HSA-6803207	1	0	0/9	1	
TP53 Regulates Transcription of Cell Death Genes R-HSA-5633008	0.617370309248053	1.06727882366375	1/25	1	PRELID1
TP53 Regulates Transcription of DNA Repair Genes R-HSA-6796648	0.169924483522532	2.21817887289549	3/38	1	SUPT4H1;POLR2K;POLR2L
TP53 Regulates Transcription of Death Receptors and Ligands R-HSA-6803211	1	0	0/6	1	
TP53 Regulates Transcription of Genes Involved in Cytochrome C Release R-HSA-6803204	0.392740848792258	2.14067558250457	1/13	1	PRELID1
TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain R-HSA-6804115	1	0	0/14	1	
TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain R-HSA-6803205	1	0	0/6	1	
TRAF3 deficiency - HSE R-HSA-5602571	1	0	0/3	1	
TRAF3-dependent IRF activation pathway R-HSA-918233	1	0	0/13	1	
TRAF6 mediated IRF7 activation R-HSA-933541	1	0	0/27	1	
TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling R-HSA-975110	1	0	0/12	1	
TRAF6 mediated NF-kB activation R-HSA-933542	1	0	0/23	1	
TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation R-HSA-975138	0.954762201117562	0.319697148679627	1/80	1	MAPK1
TRAF6-mediated induction of TAK1 complex within TLR4 complex R-HSA-937072	1	0	0/12	1	
TRAIL  signaling R-HSA-75158	1	0	0/5	1	
TRIF (TICAM1)-mediated TLR4 signaling  R-HSA-937061	0.969415807431685	0.283034766427375	1/90	1	MAPK1
TRIF-mediated programmed cell death R-HSA-2562578	1	0	0/7	1	
TRKA activation by NGF R-HSA-187042	1	0	0/1	1	
TRP channels R-HSA-3295583	1	0	0/8	1	
TWIK related potassium channel (TREK) R-HSA-1299503	1	0	0/0	1	
TWIK-related alkaline pH activated K+ channel (TALK) R-HSA-1299361	1	0	0/0	1	
TWIK-related spinal cord K+ channel (TRESK) R-HSA-1299344	1	0	0/0	1	
TWIK-releated acid-sensitive K+ channel (TASK) R-HSA-1299316	1	0	0/1	1	
TYSND1 cleaves peroxisomal proteins R-HSA-9033500	1	0	0/2	1	
Tachykinin receptors bind tachykinins R-HSA-380095	1	0	0/1	1	
Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK) R-HSA-1299308	1	0	0/1	1	
Tandem pore domain halothane-inhibited K+ channel (THIK) R-HSA-1299287	1	0	0/1	1	
Tandem pore domain potassium channels R-HSA-1296346	1	0	0/3	1	
Terminal pathway of complement R-HSA-166665	1	0	0/4	1	
Termination of O-glycan biosynthesis R-HSA-977068	1	0	0/11	1	
Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation R-HSA-1474151	1	0	0/5	1	
The AIM2 inflammasome R-HSA-844615	1	0	0/2	1	
The IPAF inflammasome R-HSA-844623	1	0	0/2	1	
The NLRP1 inflammasome R-HSA-844455	1	0	0/2	1	
The NLRP3 inflammasome R-HSA-844456	1	0	0/16	1	
The activation of arylsulfatases R-HSA-1663150	1	0	0/1	1	
The canonical retinoid cycle in rods (twilight vision) R-HSA-2453902	1	0	0/4	1	
The fatty acid cycling model R-HSA-167826	1	0	0/0	1	
The phototransduction cascade R-HSA-2514856	1	0	0/10	1	
The proton buffering model R-HSA-167827	1	0	0/0	1	
The retinoid cycle in cones (daylight vision) R-HSA-2187335	1	0	0/1	1	
The role of GTSE1 in G2/M progression after G2 checkpoint R-HSA-8852276	0.945002902801483	0.341743791176929	1/75	1	TUBB4B
The role of Nef in HIV-1 replication and disease pathogenesis R-HSA-164952	0.498966544921479	1.50933201594162	1/18	1	AP1M1
Threonine catabolism R-HSA-8849175	1	0	0/3	1	
Thrombin signalling through proteinase activated receptors (PARs) R-HSA-456926	0.479313103586786	1.60405328615125	1/17	1	MAPK1
Thromboxane signalling through TP receptor R-HSA-428930	1	0	0/12	1	
Thyroxine biosynthesis R-HSA-209968	1	0	0/3	1	
Tie2 Signaling R-HSA-210993	1	0	0/15	1	
Tight junction interactions R-HSA-420029	1	0	0/6	1	
Toll Like Receptor 10 (TLR10) Cascade R-HSA-168142	0.945002902801483	0.341743791176929	1/75	1	MAPK1
Toll Like Receptor 2 (TLR2) Cascade R-HSA-181438	0.968193404783674	0.286326076584362	1/89	1	MAPK1
Toll Like Receptor 3 (TLR3) Cascade R-HSA-168164	0.966922478791855	0.289693043298967	1/88	1	MAPK1
Toll Like Receptor 4 (TLR4) Cascade R-HSA-166016	0.986063014703052	0.229889905487852	1/110	1	MAPK1
Toll Like Receptor 5 (TLR5) Cascade R-HSA-168176	0.945002902801483	0.341743791176929	1/75	1	MAPK1
Toll Like Receptor 7/8 (TLR7/8) Cascade R-HSA-168181	0.956496849308816	0.315618492633763	1/81	1	MAPK1
Toll Like Receptor 9 (TLR9) Cascade R-HSA-168138	0.959770364975441	0.307759594824728	1/83	1	MAPK1
Toll Like Receptor TLR1:TLR2 Cascade R-HSA-168179	0.968193404783674	0.286326076584362	1/89	1	MAPK1
Toll Like Receptor TLR6:TLR2 Cascade R-HSA-168188	0.968193404783674	0.286326076584362	1/89	1	MAPK1
Toll-like Receptor Cascades R-HSA-168898	0.98983419438835	0.213719043732607	1/118	1	MAPK1
Toxicity of botulinum toxin type A (botA) R-HSA-5250968	1	0	0/0	1	
Toxicity of botulinum toxin type B (botB) R-HSA-5250958	1	0	0/3	1	
Toxicity of botulinum toxin type C (botC) R-HSA-5250971	1	0	0/0	1	
Toxicity of botulinum toxin type D (botD) R-HSA-5250955	1	0	0/1	1	
Toxicity of botulinum toxin type E (botE) R-HSA-5250992	1	0	0/0	1	
Toxicity of botulinum toxin type F (botF) R-HSA-5250981	1	0	0/1	1	
Toxicity of botulinum toxin type G (botG) R-HSA-5250989	1	0	0/2	1	
Toxicity of tetanus toxin (tetX) R-HSA-5250982	1	0	0/1	1	
Trafficking and processing of endosomal TLR R-HSA-1679131	1	0	0/4	1	
Trafficking of AMPA receptors R-HSA-399719	1	0	0/14	1	
Trafficking of GluR2-containing AMPA receptors R-HSA-416993	1	0	0/7	1	
Trafficking of myristoylated proteins to the cilium R-HSA-5624138	1	0	0/0	1	
Transcription of the HIV genome R-HSA-167172	0.198574305297833	2.04153273540087	3/41	1	SUPT4H1;POLR2K;POLR2L
Transcriptional  activation of  cell cycle inhibitor p21  R-HSA-69895	1	0	0/2	1	
Transcriptional Regulation by MECP2 R-HSA-8986944	1	0	0/33	1	
Transcriptional Regulation by NPAS4 R-HSA-9634815	0.479313103586786	1.60405328615125	1/17	1	MAPK1
Transcriptional Regulation by VENTX R-HSA-8853884	1	0	0/32	1	
Transcriptional activation of mitochondrial biogenesis R-HSA-2151201	0.381222220846868	1.55895902004401	2/35	1	HCFC1;TFB2M
Transcriptional activation of p53 responsive genes   R-HSA-69560	1	0	0/2	1	
Transcriptional and post-translational regulation of MITF-M expression and activity R-HSA-9856649	0.553612977356495	1.28202882811191	1/21	1	MAPK1
Transcriptional regulation by RUNX1 R-HSA-8878171	0.583985453311666	0.972869813936487	7/191	1	H2BC17;H3C1;H2BC12;H2AC7;H2AC8;H2BC14;H2BC3
Transcriptional regulation by RUNX2 R-HSA-8878166	0.902814158894651	0.505651330246485	2/102	1	MAPK1;STAT1
Transcriptional regulation by RUNX3 R-HSA-8878159	0.97172233648953	0.276669139813744	1/92	1	MYC
Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors R-HSA-8864260	0.185620369846663	2.71680916381686	2/21	1	SUMO1;MYC
Transcriptional regulation of brown and beige adipocyte differentiation R-HSA-9843743	1	0	0/19	1	
Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 R-HSA-9844594	1	0	0/19	1	
Transcriptional regulation of pluripotent stem cells R-HSA-452723	1	0	0/13	1	
Transcriptional regulation of testis differentiation R-HSA-9690406	1	0	0/7	1	
Transcriptional regulation of white adipocyte differentiation R-HSA-381340	1	0	0/54	1	
Transfer of LPS from LBP carrier to CD14 R-HSA-166020	1	0	0/0	1	
Translation initiation complex formation R-HSA-72649	0.842749602637046	0.541834671405377	1/48	1	EIF2S2
Translation of Replicase and Assembly of the Replication Transcription Complex R-HSA-9679504	1	0	0/5	1	
Translation of Replicase and Assembly of the Replication Transcription Complex R-HSA-9694676	1	0	0/5	1	
Translation of Structural Proteins R-HSA-9683701	0.498966544921479	1.50933201594162	1/18	1	SUMO1
Translation of Structural Proteins R-HSA-9694635	0.297977166269642	1.90826119245548	2/29	1	DDOST;SUMO1
Translocation of SLC2A4 (GLUT4) to the plasma membrane R-HSA-1445148	0.258769017639945	1.76050723598692	3/47	1	YWHAB;TUBB4B;YWHAQ
Translocation of ZAP-70 to Immunological synapse R-HSA-202430	0.458894009609797	1.71140093295747	1/16	1	CD3D
Transmission across Chemical Synapses R-HSA-112315	0.413293444539067	1.20313045925882	5/112	1	GNAI3;HSPA8;TUBB4B;KPNA2;MAPK1
Transmission across Electrical Synapses  R-HSA-112307	1	0	0/1	1	
Transport and synthesis of PAPS R-HSA-174362	1	0	0/5	1	
Transport of Mature Transcript to Cytoplasm R-HSA-72202	0.339993571262922	1.71614423431572	2/32	1	SEC13;SLBP
Transport of Mature mRNA Derived from an Intronless Transcript R-HSA-159231	0.437679640112941	1.83398057876147	1/15	1	SEC13
Transport of Mature mRNA derived from an Intron-Containing Transcript R-HSA-159236	0.645768849293838	0.984720976687612	1/27	1	SEC13
Transport of RCbl within the body R-HSA-9758890	1	0	0/3	1	
Transport of Ribonucleoproteins into the Host Nucleus R-HSA-168271	0.344236190036209	2.57008458248319	1/11	1	SEC13
Transport of bile salts and organic acids, metal ions and amine compounds R-HSA-425366	1	0	0/15	1	
Transport of connexins along the secretory pathway R-HSA-190827	1	0	0/2	1	
Transport of connexons to the plasma membrane R-HSA-190872	0.536089519856027	1.34983084155226	1/20	1	TUBB4B
Transport of fatty acids R-HSA-804914	1	0	0/4	1	
Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus R-HSA-159763	1	0	0/2	1	
Transport of glycerol from adipocytes to the liver by Aquaporins R-HSA-432030	1	0	0/1	1	
Transport of inorganic cations/anions and amino acids/oligopeptides R-HSA-425393	1	0	0/40	1	
Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane R-HSA-83936	1	0	0/3	1	
Transport of nucleotide sugars R-HSA-727802	1	0	0/4	1	
Transport of organic anions R-HSA-879518	1	0	0/5	1	
Transport of small molecules R-HSA-382551	0.979855874822852	0.486841873900259	6/309	1	EIF2S2;CLTA;ATP6V1G1;ATP6V1A;ATP6V0B;NEDD8
Transport of the SLBP independent Mature mRNA R-HSA-159227	0.368951315033604	2.33577413093742	1/12	1	SEC13
Transport of vitamins, nucleosides, and related molecules R-HSA-425397	1	0	0/17	1	
Triglyceride biosynthesis R-HSA-75109	1	0	0/6	1	
Triglyceride catabolism R-HSA-163560	1	0	0/14	1	
Triglyceride metabolism R-HSA-8979227	1	0	0/20	1	
Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA R-HSA-450513	0.415639234052386	1.97560356752423	1/14	1	YWHAB
Truncations of AMER1 destabilize the destruction complex R-HSA-5467348	1	0	0/10	1	
Tryptophan catabolism R-HSA-71240	1	0	0/5	1	
Type I hemidesmosome assembly R-HSA-446107	1	0	0/6	1	
Type II Na+/Pi cotransporters R-HSA-427589	1	0	0/1	1	
Tyrosine catabolism R-HSA-8963684	1	0	0/1	1	
UNC93B1 deficiency - HSE R-HSA-5602415	1	0	0/1	1	
Ubiquinol biosynthesis R-HSA-2142789	1	0	0/1	1	
Ubiquitin Mediated Degradation of Phosphorylated Cdc25A R-HSA-69601	1	0	0/50	1	
Ubiquitin-dependent degradation of Cyclin D R-HSA-75815	1	0	0/51	1	
Unblocking of NMDA receptors, glutamate binding and activation R-HSA-438066	1	0	0/11	1	
Unfolded Protein Response (UPR) R-HSA-381119	0.638682226120279	0.930197483218581	2/57	1	EIF2S2;SRPRB
Uptake and actions of bacterial toxins R-HSA-5339562	1	0	0/16	1	
Uptake and function of anthrax toxins R-HSA-5210891	1	0	0/8	1	
Uptake and function of diphtheria toxin R-HSA-5336415	1	0	0/5	1	
Uptake of dietary cobalamins into enterocytes R-HSA-9758881	1	0	0/2	1	
Urea cycle R-HSA-70635	1	0	0/4	1	
Utilization of Ketone Bodies R-HSA-77108	1	0	0/0	1	
VEGF binds to VEGFR leading to receptor dimerization R-HSA-195399	1	0	0/4	1	
VEGF ligand-receptor interactions R-HSA-194313	1	0	0/4	1	
VEGFA-VEGFR2 Pathway R-HSA-4420097	1	0	0/73	1	
VEGFR2 mediated cell proliferation R-HSA-5218921	1	0	0/17	1	
VEGFR2 mediated vascular permeability R-HSA-5218920	1	0	0/21	1	
VLDL assembly R-HSA-8866423	1	0	0/3	1	
VLDL clearance R-HSA-8964046	1	0	0/4	1	
VLDLR internalisation and degradation R-HSA-8866427	0.368951315033604	2.33577413093742	1/12	1	CLTA
Variant SLC6A14 may confer susceptibility towards obesity R-HSA-5619094	1	0	0/0	1	
Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) R-HSA-5619101	1	0	0/1	1	
Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) R-HSA-5660686	1	0	0/1	1	
Vasopressin regulates renal water homeostasis via Aquaporins R-HSA-432040	1	0	0/19	1	
Vasopressin-like receptors R-HSA-388479	1	0	0/1	1	
Vif-mediated degradation of APOBEC3G R-HSA-180585	1	0	0/53	1	
Viral RNP Complexes in the Host Cell Nucleus R-HSA-168330	1	0	0/1	1	
Viral mRNA Translation R-HSA-192823	0.956496849308816	0.315618492633763	1/81	1	RPL17
Virus Assembly and Release R-HSA-168268	1	0	0/2	1	
Visual phototransduction R-HSA-2187338	1	0	0/26	1	
Vitamin B1 (thiamin) metabolism R-HSA-196819	1	0	0/0	1	
Vitamin B2 (riboflavin) metabolism R-HSA-196843	1	0	0/3	1	
Vitamin B5 (pantothenate) metabolism R-HSA-199220	0.174406148124961	6.42991121082952	1/5	1	PPCS
Vitamin B6 activation to pyridoxal phosphate R-HSA-964975	1	0	0/0	1	
Vitamin C (ascorbate) metabolism R-HSA-196836	1	0	0/2	1	
Vitamin D (calciferol) metabolism R-HSA-196791	1	0	0/3	1	
Vitamin E R-HSA-8877627	1	0	0/0	1	
Vitamins R-HSA-211916	1	0	0/0	1	
Voltage gated Potassium channels R-HSA-1296072	1	0	0/7	1	
Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization R-HSA-180897	1	0	0/1	1	
Vpr-mediated nuclear import of PICs R-HSA-180910	0.392740848792258	2.14067558250457	1/13	1	SEC13
Vpu mediated degradation of CD4 R-HSA-180534	1	0	0/51	1	
VxPx cargo-targeting to cilium R-HSA-5620916	1	0	0/10	1	
WNT ligand biogenesis and trafficking R-HSA-3238698	0.291884735022825	3.21357144757802	1/9	1	SNX3
WNT mediated activation of DVL R-HSA-201688	1	0	0/5	1	
WNT5:FZD7-mediated leishmania damping R-HSA-9673324	1	0	0/6	1	
WNT5A-dependent internalization of FZD2, FZD5 and ROR2 R-HSA-5140745	0.291884735022825	3.21357144757802	1/9	1	CLTA
WNT5A-dependent internalization of FZD4 R-HSA-5099900	0.264172706115377	3.67308504447128	1/8	1	CLTA
Wax and plasmalogen biosynthesis R-HSA-8848584	1	0	0/1	1	
Wax biosynthesis R-HSA-9640463	1	0	0/1	1	
XAV939 stabilizes AXIN R-HSA-5545619	1	0	0/1	1	
XBP1(S) activates chaperone genes R-HSA-381038	0.570478706275663	1.22068271949632	1/22	1	SRPRB
Xenobiotics R-HSA-211981	1	0	0/7	1	
YAP1- and WWTR1 (TAZ)-stimulated gene expression R-HSA-2032785	1	0	0/10	1	
Z-decay: degradation of maternal mRNAs by zygotically expressed factors R-HSA-9820865	1	0	0/9	1	
ZBP1(DAI) mediated induction of type I IFNs R-HSA-1606322	1	0	0/19	1	
Zinc efflux and compartmentalization by the SLC30 family R-HSA-435368	1	0	0/0	1	
Zinc influx into cells by the SLC39 gene family R-HSA-442380	1	0	0/0	1	
Zinc transporters R-HSA-435354	1	0	0/0	1	
Zygotic genome activation (ZGA) R-HSA-9819196	1	0	0/8	1	
activated TAK1 mediates p38 MAPK activation R-HSA-450302	1	0	0/22	1	
alectinib-resistant ALK mutants R-HSA-9717316	1	0	0/0	1	
alpha-linolenic (omega3) and linoleic (omega6) acid metabolism R-HSA-2046104	1	0	0/5	1	
alpha-linolenic acid (ALA) metabolism R-HSA-2046106	1	0	0/5	1	
betaKlotho-mediated ligand binding R-HSA-1307965	1	0	0/1	1	
brigatinib-resistant ALK mutants R-HSA-9717319	1	0	0/0	1	
cGMP effects R-HSA-418457	1	0	0/5	1	
ceritinib-resistant ALK mutants R-HSA-9717323	1	0	0/0	1	
crenolanib-resistant FLT3 mutants R-HSA-9702581	1	0	0/0	1	
crizotinib-resistant ALK mutants R-HSA-9717326	1	0	0/0	1	
eNOS activation R-HSA-203615	1	0	0/6	1	
gilteritinib-resistant FLT3 mutants R-HSA-9702590	1	0	0/0	1	
lestaurtinib-resistant FLT3 mutants R-HSA-9702596	1	0	0/0	1	
linifanib-resistant FLT3 mutants R-HSA-9702998	1	0	0/0	1	
lorlatinib-resistant ALK mutants R-HSA-9717329	1	0	0/0	1	
mRNA 3'-end processing R-HSA-72187	1	0	0/23	1	
mRNA Capping R-HSA-72086	0.171956326043045	2.86838050873959	2/20	1	POLR2K;POLR2L
mRNA Editing R-HSA-75072	1	0	0/0	1	
mRNA Editing: A to I Conversion R-HSA-75064	1	0	0/0	1	
mRNA Editing: C to U Conversion R-HSA-72200	1	0	0/0	1	
mRNA decay by 3' to 5' exoribonuclease R-HSA-429958	1	0	0/10	1	
mTORC1-mediated signalling R-HSA-166208	0.199432670053967	2.58052448405812	2/22	1	YWHAB;LAMTOR1
midostaurin-resistant FLT3 mutants R-HSA-9702600	1	0	0/0	1	
mitochondrial fatty acid beta-oxidation of saturated fatty acids R-HSA-77286	1	0	0/6	1	
mitochondrial fatty acid beta-oxidation of unsaturated fatty acids R-HSA-77288	1	0	0/3	1	
p130Cas linkage to MAPK signaling for integrins R-HSA-372708	1	0	0/7	1	
p38MAPK events R-HSA-171007	1	0	0/10	1	
p53-Dependent G1 DNA Damage Response R-HSA-69563	0.912197296936827	0.409162312971513	1/63	1	CCNA2
p53-Dependent G1/S DNA damage checkpoint R-HSA-69580	0.912197296936827	0.409162312971513	1/63	1	CCNA2
p53-Independent DNA Damage Response R-HSA-69610	1	0	0/50	1	
p53-Independent G1/S DNA damage checkpoint R-HSA-69613	1	0	0/50	1	
p75 NTR receptor-mediated signalling R-HSA-193704	1	0	0/55	1	
p75NTR negatively regulates cell cycle via SC1 R-HSA-193670	1	0	0/4	1	
p75NTR recruits signalling complexes R-HSA-209543	1	0	0/12	1	
p75NTR regulates axonogenesis R-HSA-193697	1	0	0/2	1	
p75NTR signals via NF-kB R-HSA-193639	1	0	0/15	1	
pexidartinib-resistant FLT3 mutants R-HSA-9702605	1	0	0/0	1	
ponatinib-resistant FLT3 mutants R-HSA-9702614	1	0	0/0	1	
quizartinib-resistant FLT3 mutants R-HSA-9702620	1	0	0/0	1	
rRNA modification in the mitochondrion R-HSA-6793080	1	0	0/0	1	
rRNA processing R-HSA-72312	0.329268746892219	1.30288417251517	6/125	1	RPL17;NHP2;NOP10;SNU13;RRP9;UTP3
rRNA processing in the mitochondrion R-HSA-8868766	1	0	0/1	1	
rRNA processing in the nucleus and cytosol R-HSA-8868773	0.322527114844954	1.31427028274669	6/124	1	RPL17;NHP2;NOP10;SNU13;RRP9;UTP3
semaxanib-resistant FLT3 mutants R-HSA-9702577	1	0	0/0	1	
sorafenib-resistant FLT3 mutants R-HSA-9702624	1	0	0/0	1	
sunitinib-resistant FLT3 mutants R-HSA-9702632	1	0	0/0	1	
t(4;14) translocations of FGFR3 R-HSA-2033515	1	0	0/0	1	
tRNA Aminoacylation R-HSA-379724	1	0	0/11	1	
tRNA modification in the mitochondrion R-HSA-6787450	1	0	0/2	1	
tRNA modification in the nucleus and cytosol R-HSA-6782315	1	0	0/10	1	
tRNA processing R-HSA-72306	0.353841739128265	1.66037147168254	2/33	1	SEC13;RAN
tRNA processing in the mitochondrion R-HSA-6785470	1	0	0/1	1	
tRNA processing in the nucleus R-HSA-6784531	0.185620369846663	2.71680916381686	2/21	1	SEC13;RAN
tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis R-HSA-9708296	1	0	0/0	1	
tamatinib-resistant FLT3 mutants R-HSA-9703009	1	0	0/0	1	
tandutinib-resistant FLT3 mutants R-HSA-9702636	1	0	0/0	1	
vRNA Synthesis R-HSA-192814	1	0	0/1	1	
vRNP Assembly R-HSA-192905	1	0	0/1	1	
